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ABSTRACT 
Computational models of signaling processes in cells with 
applications: Influence of stochastic and spatial effects 
by 
Roberto Bertolusso 
The usual approach to the study of signaling pathways in biological systems is 
to assume that high numbers of cells and of perfectly mixed molecules within cells 
are involved. To study the temporal evolution of the system averaged over the cell 
population, ordinary differential equations are usually used. However, this approach 
has been shown to be inadequate if few copies of molecules and/or cells are present. 
In such situation, a stochastic or a hybrid stochastic/deterministic approach needs 
to be used. Moreover, considering a perfectly mixed system in cases where spatial 
effects are present can be an over-simplifying assumption. This can be corrected by 
adding diffusion terms to the ordinary differential equations describing chemical reac-
tions and proliferation kinetics. However, there exist cases in which both stochastic 
and spatial effects have to be considered. 
We study the relevance of differential equations, stochastic Gillespie algorithm, 
and deterministic and stochastic reaction-diffusion models for the study of important 
biological processes, such as viral infection and early carcinogenesis. To that end we 
have developed two optimized libraries of C functions for R (r-project.org) to simu-
late biological systems using Petri Nets, in a pure deterministic, pure stochastic, or 
iii 
hybrid deterministic/stochastic fashion, with and without spatial effects. We discuss 
our findings in the terms of specific biological systems including signaling in innate 
immune response, early carcinogenesis and spatial spread of viral infection. 
iv 
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1.1 Summary 
Chapter 1 
Introduction 
The aim of this research is to study stochastic and spatial effects in signaling pathways 
in biological systems and their interaction and particularly to determine when these 
stochastic effects are important. 
The usual approach is to assume that high numbers of perfectly mixed cells and 
molecules within cells are involved and that they are in thermal equilibrium, and 
to study effects averaged over the cell and molecule population. To that end, it 
is customary to approximate the temporal evolution of the system with ordinary 
differential equations. 
However, this approach has been shown to be inadequate for mesoscopic sys-
tems, where few copy numbers of cells and/or molecules are present. In these cases 
a stochastic approach, or a hybrid stochastic/deterministic one, needs to be used. 
Moreover, considering a perfectly mixed system in cases where spatial effects are 
present can be, in certain cases, an over-simplifying assumption. This can be cor-
rected, for example, by adding diffusion terms to the ordinary differential equations 
describing chemical reactions and proliferation kinetics. However, most cases are still 
exclusively treated in a deterministic manner. 
We are interested in studying the relevance of stochastic reaction-diffusion pro-
cesses that may be applicable to the study of important biological systems, such as 
viral infection spread or early carcinogenesis. 
As any but the simplest mass-action systems are mathematically intractable, we 
have developed optimized software, based on Petri nets methodology, to numerically 
solve reaction-only and reaction-diffusion systems, employing deterministic, stochas-
2 
tic, and hybrid methods. 
1. 2 Thesis organization 
The current thesis is organized in the following way: 
• Part I concerns systems where spatial effects can be neglected, and it is covered 
in Chapters 2 to 5 (starting on page 6). 
• Part II concerns systems where spatial effects are relevant, and it is covered in 
Chapters 6 to 9 (starting on page 75). 
• We discuss our findings in Chapter 10 (starting on page 155). 
• Additional material is presented in the Appendix (starting on page 159). 
1.3 Chapter organization 
Chapters are organized in the following way: 
• In Chapter 2 (page 6) we include background information concerning determin-
istic and stochastic simulations without a spatial component. It consists of four 
parts. In part one we introduce modeling of signaling pathways in cells and 
the paradigm of Petri nets as a systematic way to model biological systems. In 
part two we treat the molecular approach to chemical kinetics, presenting both 
the deterministic and stochastic methods of solving a set of coupled chemical 
reactions. In part three we derive the master equation and study when the 
deterministic solution of a set of ordinary differential equations coincides with 
the expected value of the stochastic kinetic model. In part four we review the 
current approaches to algorithmical solutions of deterministic, stochastic, and 
hybrid stochastic/deterministic systems. 
3 
• In Chapter 3 (page 26) we introduce biological background. We present viruses, 
the process of infection, the innate immune system response, and major signal-
ing pathways associated. Key proteins, cytokines and receptors are summarized. 
• In Chapter 4 (page 41) we introduce the software library bioPN (biological 
Petri Nets) and its applications. It consists of three parts. In part one we de-
scribe bioPN. In part two we validate numerical methods used in bioPN against 
analytical solutions. In part three we compare deterministic and stochastic so-
lutions for different simple pathways, and we show a case where hi-stability 
arises. This latter was published paper about crosstalk between the transcrip-
tion factors NF -~B and p53 [58]. 
• In Chapter 5 (page 61) we presents current work on a model of cellular sensing 
of double stranded RNA, which is itself a model of viral infection, by RIG-I pro-
tein and TLR3 receptor. It consists of six parts. In part one we introduce the 
pathway. In part two we describe experiments. In part three we describe exper-
imental results. In part four we introduce the current version of the associated 
computational model. In part five we describe simulations, protocol used, and 
simulation results. In part six we compare the outcomes of the deterministic 
run and of the average of runs of stochastic simulations. 
• In Chapter 6 (page 75) we introduce reaction-diffusion systems. It consists 
of two parts. In part one we discuss the importance of considering spatial 
effects, such as diffusion, as well as incorporating stochasticity in models where 
a deterministic approach is not a viable solution. In part two we summarize the 
mathematical background relevant to modeling of reaction-diffusion systems, 
and deterministic and stochastic numerical approximations. 
• In Chapter 7 (page 85) we present sbioPN (spatial bioPN), a software library 
developed to solve reaction-diffusion systems in deterministic, stochastic, and 
4 
hybrid deterministic/stochastic manner. It consists of six parts. In part one 
we discuss the limitations of bioPN to simulate reaction-diffusion systems. In 
part two we present sbioPN and its characteristics. In part three we explain the 
structures needed to define a reaction-diffusion model in sbioPN. In part four 
we compare diffusion in deterministic and stochastic settings. In part five we 
make some considerations about compartment size in cubic grids. In part six 
we shows two applications from literature simulated with sbioPN. 
• In Chapter 8 (page 101) we present the stochastic version of an original one-
dimensional reaction-diffusion model of early carcinogenesis that exhibits Turing 
instabilities. It consists of five parts. In part one we introduce the model. In 
part two we describe the deterministic and stochastic approaches employed. In 
part three we present results of both approaches and compare them. In part 
four we study the behavior of the system for different rates of diffusion. In part 
five we treat additional material of technical nature. 
• In Chapter 9 (page 127) we compare deterministic and stochastic reaction-
diffusion approaches in a two-dimensional model of viral infection with inter-
feron production. It consists of five parts. In part one we explain the motivation 
for the study. In part two we introduce experimental conditions and how bound-
ary conditions are treated. In part three we introduce the full model. In part 
four we construct the full model incrementally and we compare results of deter-
ministic and stochastic systems at each step. In part five we detail the set of 
reactions of the full model. 
5 
Part I 
Mathematical and biological 
background, comparison of 
deterministic and stochastic effects 
using bioPN modeling, and the 
IRF3/NF-~B model 
Chapter 2 
Mathematical modeling background 
In this chapter we include background information concerning deterministic and 
stochastic simulations without a spatial component. It consists of four parts. In 
part one we introduce modeling of signaling pathways in cells and the paradigm of 
Petri nets as a systematic way to model biological systems. In part two we treat 
the molecular approach to chemical kinetics, presenting both the deterministic and 
stochastic methods of solving a set of coupled chemical reactions. In part three we 
derive the master equation and study when the deterministic solution of a set of ordi-
nary differential equations coincides with the expected value of the stochastic kinetic 
model. In part four we review the current approaches to algorithmical solutions of 
deterministic, stochastic, and hybrid stochastic/deterministic systems. 
2.1 Modeling of signaling pathways in cells 
Models are created as a way to describe, in a system of interest, its elements and 
their interactions. Applied to molecular cell biology, a model can be used to describe 
mechanisms such as gene regulation, transcription, translation, positive and negative 
feedback, diffusion of components, and so forth. 
We start by presenting a simple model of gene auto-regulation suitable for pro-
caryotic cells [69]: 
Gi ~ Ga + Dimer 
Ga ----+ Ga + mRNA 
mRN A ----+ mRN A + Protein 
mRNA ----+ ® 
Protein ----+ ® 
2 Protein ~ Dimer 
where symbol ® denotes that the product is removed from the system. The same 
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symbol on the left of the reaction denotes that the product is added to the system. 
There is a total of 6 chemical reactions, two of them reversible (reactions one and 
six) and the rest irreversible: 
• The first reaction (reversible) represents activation of inactive gene Gi once it 
dissociates from an inhibitor, which is the dimer of the protein expressed by 
the active gene Ga. The reverse binding reaction inactivates the gene (which 
constitutes a negative feedback). 
• The second reaction represents transcription of the gene that produces mRNA 
molecules without being depleted (Ga is on both sides of the expression). 
• The third reaction is translation of the mRNA, producing the corresponding 
protein. 
• The fourth and fifth reactions represent the degradation of the mRN A tran-
scripts and the proteins. 
• Finally, the sixth reaction (reversible) represents dimerization of the protein, 
where two molecules of protein join, and the reverse reaction where the dimer 
dissociates into two proteins. 
2.2 Petri Nets 
Petri nets have been successfully applied to a wide range of applications, mainly 
related to modeling of man-made systems. More recently they have been adopted 
to study molecular networks. [9]. A complete introduction can be found in Ch. 2 of 
Wilkinson [69]. 
In short, a Petri Net is mathematical framework for systems modeling together 
with an associated graphical representation [49, 60]. It is easy to represent the above 
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Figure 2.1 : Petri net graphical representation of the biological network of Section 2.2. 
model as a Petri Net. The only modification needed is decomposing reversible reac-
tions into pairs of irreversible reactions: 
Gi ~ Ga+ Dimer (2.1) 
Ga+ Dimer ~ Gi (2.2) 
Ga ~ Ga+mRNA (2.3) 
mRNA ~ mRNA + Protein (2.4) 
mRNA ~ ® (2.5) 
Protein ~ ® (2.6) 
2 Protein -=?...t Dimer (2.7) 
Dimer ~ 2 Protein (2.8) 
The corresponding Petri Net graphical representation is depicted in Figure 2.1. 
Circles represent chemical species (places in Petri net terminology), and boxes reac-
tions (transitions in Petri net terminology). 
Gi -=-4 Ga + Dimer 
Pre[1,] = ( 1 0 0 0 0) 
Post[1,] = (o 1 0 0 1) 
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Figure 2.2 : Reaction 1: Gene activation. The reaction box is denoted in blue. Incoming 
arc (in red) denotes the stoichiometry of the left side of the chemical reaction (1 is assumed 
if empty) and it is entered in the pre matrix on the column corresponding to the reactant, 
Gi in this case, from which the arc starts. The arcs leaving the reaction box (in green) 
denote the stoichiometry of the right side of the chemical reaction (also 1 in this case) and 
are entered in the post matrix. In both pre and post, the row in which the stoichiometries 
are entered correspond to the actual reaction. 
The arcs leading into each box denote reactants, and the arcs leading out of 
each box denote products. The numbers accompanying the arcs denote reaction 
stoichiometries (by a convention, empty implies stoichiometry of 1). Each node has 
an integer number of tokens associated with it, and the collection of all token numbers 
at a certain time is known as the current state (marking in Petri net terminology) of 
the system. 
The formal definition of a Petri net follows: 
Definition 2.1 A Petri Net, PN , is ann-tuple (Pl, Tr, Pre, Post, M), where Pl = 
{ph,··· ,plu}, (u > 0) is a finite set of places (nodes, species), Tr = {tr1 , · · · , trv}, 
(v > 0) is a finite set of transitions (reactions), and Pl n Tr = 0 . 
Pre is a v x u integer matrix containing the weights (stoichiometries) of the arcs 
from places to transitions (the element (i,j) of this matrix is the weight of the arc 
from place j to transition i), and Post is a v xu integer matrix containing the weights 
(stoichiometries) of the arcs from transitions to places (the element (i,j) of this matrix 
is the weight of the arc from transition i to place j). 
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M is a u-dimensional integer vector representing the current marking of the net 
(i.e. the current state of the system). 
Figure 2.2 shows the Petri net with the first reaction highlighted. Figures with 
the remaining seven reactions highlighted can be found in Appendix A, from page 159 
to 161. 
The complete Petri Net mathematical representation of the previous example has 
the form: 
Pl= 
Gi 
Ga 
mRNA 
Protein 
Dimer 
Pre= 
1 
0 
0 
0 
0 
0 
0 
0 
PN = (Pl, Tr, Pre, Post, M(t)) 
Tr= 
0 0 0 
1 0 0 
1 0 0 
0 1 0 
0 1 0 
0 0 1 
0 0 2 
0 0 0 
Gene activation 
Gene inactivation 
Transcription 
Translation 
mRNA degradation 
Protein degradation 
Protein dimerization 
Dimer dissociation 
0 0 
1 1 
0 0 
0 0 
Post= 
0 0 
0 0 
0 0 
1 0 
1 
0 
1 
0 
0 
0 
0 
0 
m1(t) 
m2(t) 
M(t) = m3 (t) 
0 0 
0 0 
1 0 
1 1 
0 0 
0 0 
0 0 
0 2 
1 
0 
0 
0 
0 
0 
1 
0 
m4(t) 
ms(t) 
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2.3 Molecular approach to chemical kinetics 
In molecular approach, the number of molecules (or their mass) is used as a measure 
of the amount of each chemical species. We will not use concentrations to measure 
chemical species, although it is a common practice when using deterministic methods, 
as they cannot be directly compared to results of stochastic methods. 
However, the conversion between concentrations and number of molecules is straight-
forward, and we present here the relation between them. Suppose M is the number 
of molecules of a certain species from which we know the concentration [M] in moles 
per liter. Then: 
(2.9) 
where nA ~ 6.023 · 1023 is the Avogadro's number and Vis the volume in liters. 
When studying deterministic methods, the quantities are real numbers, and when 
studying stochastic methods, the quantities are integers. 
2.3.1 Mass-action kinetics 
The deterministic time evolution of the amount of chemical species in the system 
described by the set of coupled chemical reactions defined by Equations 2.1 to 2.8 is 
obtained by solving the following system of ordinary differential equations (ODE): 
I 
-e1J + e2AD (2.10) 
A e1J- e2AD (2.11) 
M e3A- e5M (2.12) 
p e4M- e6P- 2e7P 2 + 2e8D (2.13) 
D e1J- e2AD + e7P 2 - e8 D (2.14) 
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where I= Gi, A= Ga, M = mRNA, P =Protein, and D = Dimer, and the commonly 
used notation M = dM / dt for the derivative with respect to time is adopted. 
There are several numerical methods to solve the above system of ODEs, in in-
creasing order of complexity and precision. We will illustrate here the simplest of 
them, called Euler method, by applying it to the first equation. 
We replace the differential equation by its associated difference equation: 
(2.15) 
and substitute in Equation 2.10: 
(2.16) 
The same procedure is applied to Equations 2.11 to 2.14. The resulting system 
can be solved by iteration, for n = 0, 1, · · · , N, starting from initial conditions 10 , A0 , 
Mo, P0 , and D0 . Euler method assumes step tn+l- tn is constant. 
We will introduce in Chapter 4 a software tool called bioPN, which solves such 
systems of equations using the more advanced method of Runge Kutta Dormand 
Prince 45 [11], that allows for dynamic time step adjustments. 
It is important to note that the reaction constants c; (used when considering 
numbers of molecules) may or not be the same as the ones that are used in the case 
of concentrations (usually denoted by ki)· Conversion between them also involves 
expressions containing nA and V, but the laws are different according to the order of 
the reactions. We will summarize conversion between both systems for zero to second 
order reactions. In what follows, M is measured in moles per liter. 
• Zero-order reactions: 
[ci] = moleculesjtu 
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• First-order reactions: 
[Ci] = 1/tu 
• Second-order reactions: 
Mi + Mk ~ · · · Ci = ki/(nA V) [Ci] = !/(molecules tu) 
2Mj ~ · · · ci = 2ki/(nAV) [ci] = 1/(molecules tu) 
where tu stands for time unit. 
2.3.1.1 Volume change in a closed system 
In a closed system, changes in volume of the container will affect systems measured 
either in concentrations or in number of molecules: 
• If concentrations are used, any change in volume will affect the concentrations 
themselves. For example, if the volume doubles, the concentrations halve, while 
the rate constants ki remain unaffected. 
• If number of molecules are used, the opposite holds true. The number of 
molecules remain unaffected. Rate constants ci, instead, may need correction. 
Units of volume do not appear in ci; they vanish in the conversion process from 
ki to Ci, as it can be verified by conducting a dimensional analysis. However, as 
they were obtained for a specific volume, they are sensitive to its change. For 
example, if the volume doubles, a zero order Ci doubles, and a second order Ci 
halves. A first order ci remains unaffected. 
The need of rate constant correction under volume changes will be important for 
the second part of this work, were reaction-diffusion processes are treated. However, 
in that case, we will be interested in partitioning the closed system in compartments, 
not in changing the volume of the container of the whole closed system. In addition 
to the correction of the corresponding ci, number of molecules inside each smaller 
compartment will also need to be corrected to satisfy the constraint that the total 
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number of molecules after partitioning has to match the total number of molecules in 
the original non-partitioned closed system. 
2.3.2 Mass-action stochastic kinetics 
The deterministic approach to chemical kinetics fails to capture the discrete and 
stochastic nature of chemical kinetics at low concentrations. To develop a molecular 
approach, let us consider two perfectly spherical molecules X and Y which react if 
they collide with sufficient energy while they are moving randomly. If the container 
has constant volume and it is well mixed and in thermal equilibrium, the collision 
hazard is constant [19]. 
Each reaction has a stochastic rate constant ci, and an associated rate law (propen-
sity or hazard) hi(M(t), ci)· The form of hi(M(t), ci) (and the units of the rate con-
stant ci) depends on the order of reaction: 
• Zero-order reactions: 
0~··· 
• First-order reactions: 
• Second-order reactions: 
h· (M(t) c·) = C· mj(t)(mj(t)-1) 
' ) ' ' 2 
where mt(t) is the number of reactant molecules of species l at timet. 
Conditional on state M at time t, the probability that reaction i occurs in the 
time interval [t, t + ~t] is given by hi(M(t), ci)~t + o(~t) [19]. In the absence of any 
other reactions taking place, the time to such reaction is an exponentially distributed 
random variable with parameter hi(M(t), ci) [19]. 
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2.3.3 Kolmogorov's forward equation, or "chemical" master equation 
The transition kernel of a Markov chain is defined as the following conditional prob-
ability: 
p(x, t,x', t') _ P (X(t + t') = x'IX(t) = x) (2.17) 
where x is the state of the process at continuous time t, for a finite number of states 
S = 1, 2, · · · , r. If p does not depend on time, the process is called homogeneous and 
can be denoted p(x, x', t'), and expressed as a r x r transition matrix, P(t'). P(O) =I, 
the r x r identity matrix. 
P(t') is a transition matrix. As such, P(t~ + t~) = P(t~)P(t~) = P(t~)P(tD. 
The transition rate matrix is defined as: 
Q = !!:_P(t') I = lim P(8t)- P(O) 
dt' t' =o .st--to M 
(2.18) 
The elements of Q are the hazards of moving to different states. Then the infinitesimal 
transition matrix is 
P(!:t.t) = I+ Q fl.t + o(!:t.t) (2.19) 
o(!:t.t) represents a quantity that is smaller than fl.t, and it satisfies 
o( f:t.t) f5:t --+ 0 when f:t.t --+ 0 (2.20) 
P(!:t.t) is a stochastic matrix. As such, it has non-negative elements and each row 
sums to one. As the off-diagonal elements of I are zero, the off-elements of P(!:t.t) 
and Q fl.t must be the same up to a small with respect to f:t.t. Then the off-diagonal 
elements of Q have to be non-negative. Since the diagonal elements of P are bounded 
above by one and the diagonal elements of I are ones, the diagonal elements of Q 
must be negative. As the rows of both P and I sum to one, the rows of Q must sum 
to zero. 
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A probability row vector 1r will be stationary only if 
1rP(b..t) = 1r ===> 1r(I + Q b..t + o(b..t)) = 1r ===> 1r Q = 0 (2.21) 
Solving this last equation gives a stationary distribution for the system. 
To derive P(t) for a finite timet, we proceed as follows: 
.!!:_P(t) = lim P(t + b..t)- P(t) = lim P(b..t)P(t)- P(t) 
dt ~t-+0 b..t ~t-+0 b..t 
= lim P(b..t)- I P(t) = Q P(t) 
~t--+0 b..t 
(2.22) 
Then, given initial condition P(O) = I, 
P(t) = exp{Q t} (2.23) 
is a solution to the matrix differential equation 
:t P(t) = Q P(t) (2.24) 
Note that exp{ ·} is the matrix exponential function. 
The corresponding component form is 
!p(i,j,t) = tQikP(k,j,t), 
k=l 
i,j = 1,2,· ·· ,r. (2.25) 
System (2.25) is known as the Kolmogorov backward equations. 
Expansion of P(t + b..t) = P(t)P(b..t) yields 
!P(t) = P(t) Q (2.26) 
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the corresponding component form of which is 
!p(i,j,t) = tqkj p(i,k,t), 
k=l 
i,j = 1,2,··· ,r. (2.27) 
System (2.27) is known as the Kolmogorov forward equations. In the language of 
computational biochemistry, these are the "chemical" master equations. 
Wilkinson [69] (page 157) presents the Kolmogorov's forward equations in the 
form suitable for the stochastic Petri nets (SPN): 
(2.28) 
Vt0 E JR., Xo, x E M 
where M is the countable state space of the process, and S(i) the i-th row of the 
matrix S = post - pre. 
2.3.4 Use of ODEs to solve a stochastic kinetic model 
We are interested in exploring the relationship between the continuous deterministic 
approach (solution of the set of ODEs) and the expected value of the stochastic kinetic 
model. These two formulations yield the same results only in special cases. 
The expected value of the state Xt of the process at time t is, by definition, 
E [xt] = 2.::: x p(x, t) (2.29) 
xEM 
Differentiating with respect to time yields 
d [ ] d d dt E Xt = dt 2: x p(x, t) = 2.::: x dtp(x, t) 
xEM xEM 
(2.30) 
Detailed derivation is found in Appendix A, on page 18. We present here there-
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sult. After substituting the Kolmogorov's forward equation and performing algebraic 
manipulation, we obtain 
(2.31) 
This set of differential equations cannot be solved directly, unless all reactions in 
the stochastic system have zero or first order mass action rate laws, in which case 
(2.32) 
by linearity of expectation. 
In this special case, after putting y( t) = E [ Xt J , we get 
(2.33) 
which is the ODE system for the deterministic model expressed in mass (not con-
centration) and using stochastic rate constants (as seen in Section 2.3.1). We will 
numerically verify this fact when comparing deterministic and stochastic methods in 
Section 4.3.1 on page 50. 
As a conclusion, when all the reactions are of the zero or first order mass-action 
kinetics, the deterministic solution coincides with the expected value of the stochastic 
kinetic model. 
2.4 Exact stochastic algorithms 
Rules specified above define a time-continuous Markov chain, which might be simu-
lated using any of the algorithms listed below. 
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2.4.1 Linear time algorithms 
Gillespie, in the seminal paper [19], proposed the Direct Method, or SSA, to simulate 
chemical reactions. The algorithm is as follows: 
1. Initialize the system (set M(O)). 
2. Based on the current state, calculate hi(M(t), Ci) for all reactions. 
3. Calculate h0 (M(t), C) = 2::~= 1 hi(M(t), Ci), the combined reaction hazard. 
4. Simulate the time to the next event, t', as a random variable with Exp(ho(M(t), C)) 
distribution. 
5. Put t = t + t'. 
6. Assigning probability hi(M(t),ci)/h0 (M(t),C) to reaction i {i 1 .. · v} 
' ' ' 
simulate the index j of the reaction that occurred. 
7. Update the state of the system M(t) according to reaction j. 
8. If t < T max return to step 2. 
M(t) is the state (marking) of the system at timet and hi(M(t), ci) is the propensity 
of reaction i, that is a function of the current state and the reaction constant ci· In its 
original formulation, the scaling of the SSA algorithm is linear in time with respect to 
the number of reactions both in the "update" steps 2 and 3, and in the "generation" 
step 6. 
Gillespie also proposed the first reaction method, that replaces steps 3, 4 with 
3. Simulate time to each event, ti, as a Exp(hi(M(t), C)) r.v. 
4. Find t' = ti = min{hi}. 
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and eliminates step 6. 
Instead of using the total propensity to find the time to the next reaction, and 
then simulate which reaction happened, the first reaction method simulates when 
each reaction happens, and then chooses the one that occurs first. For this it has 
to use N random numbers per iteration, instead of the two needed by the SSA. The 
scaling of this method is also O(N). 
2.4.2 Logarithmic time algorithms 
Gibson and Bruck proposed the next reaction method (NRM) [18]. This method is 
based on the first reaction method [19] and is considered by many the best approach 
for an exact method. Gibson and Bruck noted that using the memory-less property 
of the exponential distribution, the firing times of the reactions that did not occur 
can be rescaled. 
In this way, the already generated corresponding random numbers can be reused. 
Consequently, after the initialization step only one random number needs to be gen-
erated per reaction that occurred, instead of two in the direct method. To reduce the 
number of computations, the method introduces a dependency graph in order to only 
update the propensities that need to be recalculated after the last reaction, as well as 
an indexed priority queue to determine which reaction will occur next. To implement 
the indexed priority queue two structures are needed; a binary tree structure with as 
many nodes as reactions, and an index to the memory position of each of the nodes. 
Both the update and the generation parts of the algorithm are performed in log2 (N) 
steps. 
In practice, this method is not always superior to an optimized version of the 
SSA method, also proposed by Gibson and Bruck [18]. The optimization of the SSA 
method consists in introducing the the same dependency graph used in the NRM, 
and introducing a binary tree that has at the leafs the propensities of the reactions, 
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which are accumulated moving towards the root. This ensures that both the update 
and the generation parts of the algorithm are performed in log2(N) steps. 
The complete algorithm is the following: 
1. Initialize 
(a) set initial conditions (M(O)). 
(b) Generate a dependency graph g. 
(c) Calculate hi(M(t), ci) for all reactions i. 
(d) For each i, simulate time for next event, Ti, as a Exp(hi(M(t), C)) r.v. 
(e) Store all the Ti in an indexed priority queue P. 
2. Let j be the reaction where Tj =min{ Ti} (from P). 
3. Set t = Tj· 
4. Update M(t) according to reaction j. 
5. From the dependency graph g, find the subset of reactions whose propensities 
are modified by reaction j, and 
(a) Fori in this subset, calculate hi(M(t), ci)· 
(b) For reaction j (the one that just fired), simulate time for next event, Tj, as 
the sum of a Exp(hi(M(t), C)) r.v. and t, and place it in the corresponding 
place of P. 
(c) fori=/= j in the subset, rescale the reaction times, 
Ti = hi,old(M(t), C)/hi,new(M(t), C)(Ti- t) + t, and put each of them in 
the corresponding place of P. 
6. if t < Tmax return to step 2. 
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2.4.3 Constant time algorithm 
The Constant-Time Composition-Rejection algorithm [64] (SSA-CR) is suitable for 
the simulation of very large number of reactions. This algorithm has 0(1) scaling in 
both generation and update times, independent of the number of reactions [64]. 
The generation portion of the SSA-CR algorithm has two stages, composition and 
rejection. In the composition stage a group of reactions is chosen according to the 
accumulated propensities of the reactions that belong to each group. This requires 
a random number and a selection algorithm similar to the one proposed by Gibson 
and Bruck [18] to optimize the reaction selection for the Gillespie algorithm. As the 
number of total groups can be made constant regardless of the number of reactions, 
this step takes constant time. 
Once the group has been selected, the second stage uses the rejection algorithm. 
First a discrete uniform random number is generated to select one reaction inside the 
group. A second random number between zero and the maximum allowed propensity 
for reactions belonging to that group is generated and compared to the propensity 
of the selected reaction. If the generated number is less than the propensity, the 
rejection stage ends selecting this reaction. If not, the rejection part of the algorithm 
is iteratively repeated until the previous condition is satisfied. 
If the groups are chosen in such a way that the upper and lower bounds of the 
propensities are such that Puwer/Plower = 2, the expected number of iterations for the 
rejection stage is less than two [64]. This happens independently of the number of 
reactions in each group, substantiating the claim that the composition part is 0(1). 
The update portion consists of comparing the old and new values of each reaction 
whose propensity is affected by the firing of the last reaction. If in each case the 
new propensity is still within the boundaries of its original group, only the group 
accumulated propensity and the global propensity need to be updated. If not, the 
reaction is excluded from the original group, and assigned to the corresponding group, 
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and both group propensities and global propensity are updated. If the old propensity 
is zero it means that the reaction is not in any group and it is inserted in one. If the 
new propensity is zero it means that the reaction has to be removed from the group. 
In both cases the corresponding group accumulated propensity and global propen-
sity are updated. In all cases the updating algorithm is an adaptation of the corre-
sponding optimization of the Gillespie algorithms of Gibson and Bruck [18]. As long 
as the average number of reactions affected by the firing reaction does not grow con-
tinuously larger as the number of reactions grow, the update portion of the SSA-CR 
scales as 0(1) [64]. 
2.5 Approximate stochastic algorithms 
An important limitation of exact stochastic algorithms is the great amount of com-
puter time that is needed to simulate a desired amount of system time [21], which 
becomes more evident as the number of different species and reactions increase, as 
well as the number of molecules per species. Approximate stochastic algorithms aim 
at making minor sacrifices in simulation accuracy in order to obtain major gains in 
simulation speed [21]. 
The fundamental difference between exact methods and approximate ones is that 
in the former the question is when will next reaction fire and in the latter how many 
reactions of each kind have fired on a specified amount of time. 
Gillespie [20,21] proposed two approximate methods, the T-leaping algorithm and 
the Chemical Langevin equation algorithm, reviewed below. 
2.5.1 T-leaping algorithm 
This method assumes that it is possible to find a time interval T where the reaction 
propensities hi(M(t), c;) do not change "sensibly". If this is the case, the number 
of reactions of a certain kind that have fired in T time-step is a Poisson distributed 
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random variable with parameter hi(M(t), ci) 7. 
The corresponding algorithm [21] is: 
1. Initialize system (M(O)). 
2. Determine a fixed time step 7 such that the propensities will not change sensi-
tively in that time step. 
3. Based on current state, calculate hi(M(t), ci) for all reactions i. 
4. For each i, generate a P(hi(M(t), ci) 7) r.v. Pi, and update the current state 
using Mi(t + 7) = Mi(t) +Pi· 
5. Putt=t+7. 
6. if t < Tmax return to step 2. 
The critical aspect of applying this and the following algorithms is choosing the right 
leaping step, for which several approaches have been proposed [7,8,22]. 
2.5.2 Chemical Langevin Equation ( CLE} algorithm 
Under the same assumptions of 7-leaping algorithm, Gillespie noted that, if the num-
ber of reactions of each kind in the specified amount of time is significantly high, the 
Poisson random variable can be further approximated using a normally distributed 
random variable. 
This negligible loss of accuracy allows for an sensible increase in speed, as it 
is far less computationally demanding to generate a pseudo-random normal variate 
compared to a Poisson one. On the other hand, using this method introduces the use 
of continuous variables, instead of integer ones. 
The corresponding algorithm [21] is: 
1. Initialize system (M(O)). 
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2. Determine a fixed time step T such that the propensities will not change sensi-
tively in that time step. 
3. Based on current state, calculate hi(M(t), ci) for all reactions i. 
4. For each i, generate a N(O, 1) r.v. ri, and update the current state using 
Mi(t + r) = Mi(t) + hi(M(t), Ci) T + Jhi(M(t), Ci) Tri· 
5. Putt=t+r. 
6. if t < Tmax return to step 2. 
2.6 Deterministic methods 
Often, biological systems are studied deterministically, usually using systems of ordi-
nary differential equations. As already noted, the deterministic approach to chemical 
kinetics fails to capture the discrete and stochastic nature of chemical kinetics at low 
concentrations, and does not model the expected value of the stochastic process if 
reactions other than zero and first order are present. Generally, a linear integration 
with a predefined step, or Euler method, is used. More advanced integrators have 
been proposed to improve accuracy of integration. We have adopted the Runge Kutta 
modification proposed by Dormand and Prince [11], which allows adaptive time step 
selection, according to absolute and relative error bounds. 
2. 7 Hybrid stochastic/deterministic algorithms 
Haseltine and Rawlings [27] noted that in most biological systems there are reactions 
that happen very often (fast reactions), while others rarely (slow reactions). They 
proposed the use of a hybrid algorithm that simulates slow reactions with the direct 
method, and the fast either deterministically or with CLE algorithm. 
We will expand the treatment of the hybrid stochastic/deterministic algorithms 
in Chapter 4, where the bioPN library is presented. 
Chapter 3 
Biological Background 
In this chapter we introduce biological background. We present viruses, the pro-
cess of infection, the innate immune system response, and major signaling pathways 
associated. Key proteins, cytokines and receptors are summarized. 
3.1 Biology of virus infection 
The section on viral biology is mostly based on Chapter 24 of Alberts et al. [1]. 
3.1.1 Viruses 
A virus is a very small and relatively simple particle that cannot be observed with a 
light microscope. Virus diameters are in the order of 10- 450nm (1nm = 10-3J-Lm = 
10-9m). As a rough comparison, on average prokaryotic cells (bacteria) are hundred 
times larger (0.5- 5J-Lm), while eukaryotic cells are thousand times larger (5- 20J-Lm). 
Some viruses, as well as some bacterial, fungal and protozoan cells, are agents 
that cause infectious diseases. They are collectively known as pathogens, and usually 
exploit deleteriously the biological attributes of their hosts in order to survive and 
reproduce. Viral infections are responsible of acute and chronic diseases that range 
from the common cold to AIDS. Some cancers are known to have viral origin. For 
example, human papillomavirus causes genital warts, which are a pre-stage of cervical 
cancer. 
All viruses carry genetic information either in the form of deoxyribonucleic acid 
(DNA) or ribonucleic acid (RNA), which encodes a relatively small number of genes. 
This genetic information is protected by a protein coat known as capsid. Some viruses 
have an ulterior surrounding envelope of fat. A simple virus is shown in Figure 3.1. 
Figure 3.1 : Virus. On the left, a sample enveloped virus (figure from 
http:/ /www.microbiologybytes.com/introduction/ graphics/ glyco.gif). 
On the right an electron micrograph of the Swine Flu virus (photo from 
http:/ /www.digitaljournal.com/img/8/9/9/i/5/0/5/o/SwineFluCells.jpg) 
3.1.2 Virus propagation cycle 
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Viruses lack independent metabolic activity and therefore cannot replicate by them-
selves. They have to rely on the basic protein synthesis machinery of a cellular host as 
well as host's transcription machinery. To achieve this goal, they have to infect a cell 
(be internalized by a cell). Once inside , the protective capsid uncoats exposing the 
genetic material that carries the information to replicate itself and produce various 
viral proteins. The transcription/translation machinery of the cell produces repli-
cates that spontaneously reassemble as new virus progeny of the order of thousands 
virions per cell, which then leave the cell, often in a burst that kills it. The process 
is illustrated in Figure 3.2. 
3.1.3 Virus morphology 
Viruses differ among themselves with respect to shape, size, genetic content, and if 
they are enveloped or not. It is not possible to systematically classify them into a 
single phylogenetic tree according to their relatedness. 
Among the smallest in size are the virions of parvovirus, which are less than 
20nm in diameter , containing a single-stranded DNA genome with less than 5, 000 
nucleotides. On the other end, the virions of poxvirus range among the largest. Their 
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Figure 3.2 : Life cycle of a simple virus. Typical propagation cycle of a simple double-
stranded DNA virus with a single coating protein (figure from Ref. [1]) . 
size is about 450nm, containing a double-stranded DNA genome of about 270 , 000 
nucleotide pairs. Examples are shown in Figure 3.3. 
The genome (DNA or RNA) of the smallest viruses contain just a few genes. 
The largest ones , with double-stranded DNA, may contain hundreds of genes. Some 
of the genomes are circular , while others have ad-hoc ends needed to replicate the 
nucleotides at the extremes of the strand. Examples are shown in Figure 3.4. 
All viral genomes encode three types of proteins: 
• Proteins to replicate the genome. 
• Proteins for packaging the genome. 
• Proteins to alter the normal functioning of the host cell and favor the replication 
of the virions. 
Some viruses encode also another class of proteins aimed to change or repress the 
immune defense mechanisms of the host. 
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Figure 3.3 : Virus Morphology. Figure from Ref. [1]. 
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The capsid enclosing the genome may be composed of a single or different proteins , 
regularly arranged in repeating patterns and layers. The module formed by the 
genome and the capsid is collectively known as the nucleocapsid. 
Enveloped viruses have the nucleocapsid enclosed by a lipid bilayer membrane 
acquired by the virus when budding from the host cell plasma membrane (see fig-
ure 3.5). Viruses of this kind usually do not kill the cell as a result of infection, and 
often are responsible for chronic diseases. Non-enveloped viruses, on the other hand, 
often kill the host cell by lysing it (breaking the cell open). 
3.1.4 Infection of a host cell by a virus 
In order to infect a cell , a virus first needs to bind to its surface. To this end, the viral 
coating proteins target a specific receptor on the surface of the cell. This receptor 
can be a protein or not. For example, herpes simplex virus binds to heparan sulfate 
proteoglycans. Depending on the specificity of the virus, it can target either an 
abundant type of receptor, or one that is very specific to certain type of cell. Some 
viruses target only one kind of receptor, other several. Often virions, beyond their 
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primary receptor, need a secondary one (a co-receptor) to attach and enter the host 
cells. An example of this is HIV, shown in Figure 3.6. 
Virions use different strategies to enter the cell. Enveloped viruses enter the host 
either by fusion with the plasma membrane or, after endocytosis , i.e. the process 
by which cells engulf external entities with the cell membrane, with the endosomal 
membrane (the membrane bound compartment inside eukaryotic cells). HIV is an 
example of the first type, influenza virus of the second. These processes are illustrated 
in Figure 3. 7 parts A and B. They then undergo a conformational change, releasing 
the genome. 
The mechanisms used by non-enveloped viruses are less clear, as it is not trivial 
how relatively large structures are able to cross the plasma or endosome. They gener-
ally either form a pore in the endosome to inject the genome, or disrupt the endosome 
after endocytosis , and then release the genome. Poliovirus is an example of the first 
mechanism, and adenovirus of the second (see Figure 3.7 parts C and D). 
Enveloped viruses need to acquire their membrane from host cell phospholipids. 
In the simplest cases , viral proteins are inserted into the endoplasmic reticulum (ER) 
membrane and follows a path through the Golgi apparatus to the plasma membrane 
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Figure 3.5 : Virus with lipid envelope. Figure from Ref. [1]. 
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that surrounds the cell. Nucleocapsids then assemble at the plasma membrane , bud-
ding of. This is the mechanism used by HIV. For a more complicated strategy used 
by herpes virus , see Figure 3. 8. 
3.1.5 Virus evolution 
Even if the complexity and specificity of the interactions between viruses and the 
infected cells should almost rule out random mutation, new strains are constantly 
emerging, and old viruses are constantly changing making it difficult to treat famil-
iar infections. On one side, they replicate very quickly. As an example, poliovirus 
undergoes a 2% change in its genome in 5 days. Humans, instead, needed about 
8 million year of divergent evolution to acquire a 2% genome difference compared 
to chimpanzees. Moreover, selective pressures such as those exerted by the host's 
adaptive immune system or drugs favor fast genetic change. 
The replication mechanisms are among the main causes of mutation. In retroviral 
genomes, for example, point mutations are acquired during the replication cycle as 
~-chemokine 
(Rantes. Mip1a. 
or Mip1~) 
macrophage 
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helper T cell , 
Figure 3.6 : HIV virus interacting with receptor and co-receptor. Figure from Ref. [1]. 
the viral transcriptase that produces DNA from the viral RNA is unable to correct 
nucleotide misreadings. The high mutation rate is in some way beneficial for the 
virus, as the process of mutation and selection within each host produces variants 
best adapted and resistant to immune responses and drugs. 
Only about one third of the viral genome is invariant , while nucleotide sequences 
in certain parts of the genome may differ by about 30%, making it very difficult to 
develop vaccines for certain types of viruses, such us HIV. 
3.1.6 The innate immune system 
Innate immune responses, different from the adaptive immune responses, are not 
specific to a particular pathogen. Among the different kinds of innate immune re-
sponses, one that effectively combats virus infections is the ability of host cells to 
aggressively degrade double-stranded RNA, a common intermediate in viral repli-
cation [2], as well as any single-stranded RNA sharing sequence identity with the 
associated double-stranded trigger. Another kind is related to specialized sets of 
proteins that become activated once they recognize conserved features of pathogens, 
or pathogen-associated molecular patterns (PAMPs), starting a cascade of reactions 
aiming to stop the infection. 
Many of the mammalian pattern recognition receptors that trigger innate 1m-
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murre responses belong to the family of Toll-like receptors (TLR). Pathogens produce 
immunostimulants that are recognized by TLRs. Most of them are on the cellular 
surface of macrophages, dendritic cells and certain epitheliar cells, but some of them 
are associated with intracellular membranes. 
As host cell ribosomes translate viral proteins and host cell membranes form 
the membranes of enveloped viruses, the only general way that the host cell has to 
recognize a virus is through particular motifs of the viral genome. 
3.1.7 Interferons (IFNs) 
Double-stranded RNA (dsRNA) induces production and secretion of two cytokines: 
interferon-a (IFNa) and interferon-,8 (IFN,B), which act in both an autocrine (di-
rected towards the infected cell) and a paracrine fashion (directed towards uninfected 
Golgi 
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Figure 3.8 : Viral envelope acquisition. Herpes virus nucleocapsids assemble in the nu-
cleus. They then bud through the inner nuclear membrane into ER, acquiring a membrane 
coat. The virus particles then lose this coat while fusing with the outer nuclear membrane 
to escape into the cytosol. Then, the nucleocapsids bud into the Golgi apparatus and bud 
out again on the other side, acquiring two new membrane coats. The external is lost when 
budding from the cell (figure from [1]). 
neighbors). Interferons bind to their cell-surface receptors stimulating transcription 
of specific genes through the JAK/STAT intracellular signaling pathway [62] (see fig-
ure 3.9). This activates more than 300 genes, including many cytokines. Interferon 
response seems to be a non-specific reaction of mammalian cells to a viral infection, 
and different viral components (not only dsRNA) can initiate it. 
Beyond the effects on host cell gene transcription, interferons activate a latent 
ribonuclease, which degrades ssRNA in a non-specific way. Moreover , they indirectly 
activate a protein kinase that inactivates via phosphorylation the protein synthesis 
initiation factor elF -2 [1]. This shuts down most protein synthesis in the infected cell. 
Then , by degrading most of its RNA and temporarily stopping most of its protein 
synthesis , the infected cell inhibits viral replication without killing itself. 
However, if this does not suffice, the cell kills itself by apoptosis , often through 
the action of a killer lymphocyte. 
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Figure 3.9 : TLR3, IFNs and dsRNA. Viral dsRNA can be endocytosed and start TLR3 
mediated signaling cascade activating IRF -3. Cytoplasmic dsRN A, by a TLR3 independent 
pathway using RIG-I, also activates IRF-3. Type I IFNs start JAK/STAT signaling pathway 
by binding to IFN receptor (IFNAR) and activating ISGF3G. Both IRF-3 and ISGF3G 
bind to the same cis-element, ISRE, in the promoter regions of viral stress-inducible genes 
(VSIGs) (figure from Ref [62]). 
3.2 Nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-K:B) 
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-K:B), whose most 
abundant form is the heterodimer p50/p65 (NF-K:Bl/RelA), is a gene regulatory pro-
tein , or a transcription factor. NF-K:B is a key player in many stressful, inflammatory, 
and innate immune responses. In unstimulated cells, NF -K:B is in a dormant state, 
sequestered in the cytoplasm by a family of inhibitors, mainly by the Inhibitor of K:B 
As shown in the simplified schematic of Figure 3.10, when an external stimuli 
(such as Tumor Necrosis Factor a, or TNFa) activates specific receptors , the IK:B 
Kinase (IKK) becomes activated, subsequently phosphorylating IK:Ba and leading to 
its degradation. The freed NF-K:B then enters the nucleus, activating a number of 
target genes. Among them, at least two are important to regulate NF-K:B itself: A20 
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http: / /upload.wikimedia.org/wikipedia/commons/5/5e/NFKB_mechanism_oLaction.png 
and IK:Ba. A20 inactivates IKK, and IK:Ba binds NF-K:B inhibiting its action. NF-K:B 
is one of the key activators of INF ,B gene, as shown in Figure 3.11. 
3.3 Interferon regulatory factor 3 (IRF-3) 
IFN regulatory factor 3 (IRF-3) belongs to the family of nine human IRFs that have 
been identified so far (IRF-1 to IRF-9). IRF-3 is a key component in the induction 
of type I interferons after viral infection or double stranded RNA induction , and 
it is constituted by 427 amino acids. Transcriptional activation is mediated by the 
IKK-related kinases TBK-1 and IKKE, whose C-terminal phosphorylation induces 
a conformational change in IRF -3 that allows dimerization and binding to IRF-7 
and nuclear translocation [66]. Inactive IRF -3 constitutively translocates into and 
out of the nucleus, while phosphorylated IRF-3 is retained in the nucleus where it 
induces transcription of IFN,B and other genes [30]. IRF-3 role in signaling pathway 
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is summarized in F igures 3.1 1. 
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Figure 3.11 Signaling pathways that recognize virus infection. F igure from Ref [30]. 
3.4 RIG-I like receptors and Toll-like receptors 
3.4.1 RIG-I like receptors 
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Figure 3.12 RLR family of cytoplasmic proteins . Figure from Ref [4] . 
RIG-I like receptors (RLR) are a family of cytoplasmic viral sensors, composed 
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by three members [4]: 
• Retinoic acid-inducible Gene 1 (RIG-I), also known as Ddx58. 
• Melanoma-differentiation-associated gene 5 (MDA5), also known as Ifih1 or 
Helicard. 
• Laboratory of Genetics and Physiology 2 (LGP2). 
Both RIG-I and MDA5 contain a typical ATP-dependent helicase domain. TheN-
terminus of these proteins encodes two caspase recruitment domains (CARDs) RIG-I 
recognizes dsRNA with 5ppp U-rich 5ppp containing RNA, sensing the majority or 
RNA viruses, while MDA5 recognizes long dsRNA (over 2 kb), sensing the majority of 
picornaviruses. LGP2 lacks the card domain [4]. We will concentrate in the signaling 
pathway driven by RIG-I. 
3.4.2 Toll-like receptors 
Toll-like receptors (TLRs) are a family composed, up-to date, of 13 mammalian mem-
bers [4]. These receptors are constituted by an extracellular leucine-rich repeat do-
main which recognized pathogens, and a cytoplasmic domain with homology to IL-1R 
which is involved in downstream signaling [4]. TLRs function as pattern-recognition 
receptors sensing PAMPs found in pathogens [36]. We will concentrate in TLR3, 
being the more specific among TLRs in sensing dsRNA. 
3.4.3 RIG-I, Mitochondrial anti-viral signaling protein (MAVS), and TNF 
receptor-associated factor 3 (TRAF3) 
Double- and single-stranded viral RNAs bind to RIG-I [34, 35, 40] inducing its ubiq-
uitylation [17, 52]. This complex then binds to Mitochondrial Anti-Viral Signaling 
protein (MAVS; also known as IPS-1, VISA, and CARDIF) [3]. This oligomer, known 
as RIG-I-MAVS, recruits TNF Receptor-Associated Factors (TRAFs) 2, 3 and 6 [38]. 
39 
This resulting complex activates the complex TANK-binding kinase 1 (TBK1) and 
Inhibitor of ~B kinase E (IKKE) [23, 71], which in turn activates IRF3 [16,63], that in-
duces the production of type I interferons (IFN s) [41]. Figure 3.13 depicts a schematics 
of this pathway. 
3.4.4 Toll-like receptor 3, TIR-domain-containing adapter-inducing interferon-
(3 (TRIF), and TNF receptor-associated factor 6 (TRAF6) 
dsRNA activates TLR3 [2, 62], which binds to the adaptor molecule TIR-domain-
containing adapter-inducing interferon-(3 (TRIF) [70] and to TRAF6 [62], phospho-
rylating I~Bo: via IKKo:-IKK(3-IKKy [62], which frees NF-~B that translocates into 
the nucleus [31,65]. See Figure 3.14 for a schematics of this pathway. 
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Figure 3.14 TLR3-TRIF-TRAF6 signaling pathway. Figure from Ref [36]. 
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Chapter 4 
Comparison between deterministic and stochastic 
effects using bioPN 
In this chapter we introduce the software library bioPN (biological Petri Nets) 
and its applications. It consists of three parts. In part one we describe bioPN. In 
part two we validate numerical methods used in bioPN against analytical solutions. 
In part three we compare deterministic and stochastic solutions for different simple 
pathways, and we show a case where hi-stability arises. This latter was published 
paper about crosstalk between the transcription factors NF -KB and p53 [58]. 
4.1 bioPN 
bioPN is a R library of C functions that can be used to simulate time-dependent 
evolution of biochemical reactions. 
The model is defined as a place/transition Petri Net (defined in Chapter 2). It can 
be either deterministically solved using an explicit Runge Kutta Dormand Prince 45 
method, simulated using four highly optimized variants of the stochastic simulation 
algorithm, or as a deterministic/stochastic hybrid, according to the Haseltine and 
Rawlings' algorithm, or using the Partitioned Leaping Algorithm (PLA). 
The library has been optimized for speed and flexibility, allowing to choose among 
several simulation methods with a single model definition. 
4.1.1 Background 
Analytical solutions to most but the basic stochastic systems of biochemical reactions 
in cells are intractable, making necessary the use of computers to perform runs of 
stochastic simulations. For better approximations, high numbers of runs are needed, 
-----r ---7 
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so that optimized methods are necessary to perform the task in an acceptable time. 
Many approaches to perform exact simulations have been proposed. In the case of 
eukaryotic cells, the number of reactions of protein production and degradation is 
so high that exact methods, such as the stochastic simulation algorithm (SSA) [19] 
may become impractical. Several approximations have been developed to speed-up 
algorithms (for review see Chapter 8 of [69]). 
Of the software available, STOCKS [37] is a non-optimized C++ implementation 
of the Gillespie SSA method. COPAS! [32] is a multi-platform C++ application that 
allows pure stochastic and pure deterministic simulation. The software also imports 
SBML files. StochKit [39] is a C++ application that includes the SSA algorithm and 
approximate stochastic methods. The model is defined as a Systems Biology Markup 
Language (SBML) file. GillespieSSA [56] is a package programmed in R capable of 
performing direct and approximate stochastic methods. The user defines structures 
for the constants and the stoichiometry matrix, and provides expressions for reaction 
propensities. 
In this chapter, we describe and discuss a new software tool, bioPN, which we 
developed to optimize the computation speed without compromising accuracy. The 
user of bioPN is offered the choice of several methods, ranging from variants of SSA 
to various approximate algorithms and their combinations. 
4.1.2 Approach 
As a means of representing the biochemical networks, we chose the paradigm of Petri 
Nets (reviewed in 2.2) as it is closely related to the way reactions are defined. 
R [59] was chosen as the backbone because it is a robust language for statistical 
data analysis that allows post-processing of the results and has plotting capabilities. 
It is licensed under the GPL, available free of cost, runs on several architectures 
(including Unix, Linux, Windows, and Mac), and has an active and growing developer 
43 
and user community. 
R is an interpreted language, which makes it slow compared to compiled ones. 
However, this limitation does not apply in our case, as the bioPN functions run en-
tirely in a compiled C code. Moreover, R provides a C library that can be called from 
compiled code. Uniform random numbers are generated by the R library functions 
uniLrand() and rexp(), which have passed strict tests for randomness. BioPN allows 
the user to choose a specific generator, or use R's default, currently the Mersenne-
Twister [48]. 
In the deterministic and hybrid mode [27] fast reactions are approximated with an 
explicit Runge Kutta Dormand Prince 45 method [11]. The Partitioned Leaping Al-
gorithm (PLA) [24] dynamically divides the reactions into four categories. Very slow 
reactions are simulated using Next Reaction method, slow ones with the T-leaping 
algorithm, medium ones with chemical Langevin equation, and fast ones determinis-
tically (Euler method). 
To explain the principles of bioPN, consider the following set of chemical reactions: 
Gi c Ga (4.1) 
----+ 
Ga b Gi (4.2) 
----+ 
Ga H Ga+mRNA (4.3) 
---+ 
mRNA K mRN A + Protein (4.4) 
---+ 
mRNA m ® (4.5) ---+ 
Protein r ® (4.6) ----+ 
This model is composed by 4 places (reactants, products) and 6 transitions (re-
actions) that define this model. The places are: the inactive gene (Gi), the active 
gene (Ga), the mRNA and the Protein. The transitions are: gene activation, gene 
inactivation, transcription, mRNA degradation, translation, protein degradation. 
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More generally, consider p places and t transitions. To parametrize it as a Petri 
Net, we need to define two t x p matrices: pre will have in each row (for each 
transition) the stoichiometry of the reactants (left side of the reaction), while post 
the stoichiometry of the products (right side of the reaction). 
Another needed structure is h, a list with t elements, which is used to identify 
reaction propensities. For flexibility, each of its elements can be either a number, an 
R function, or a pointer to a C function. If it is a number, it is considered a rate 
constant and the corresponding mass-action kinetic propensity is calculated on the 
fly according to the order of the reaction and its stochastic or deterministic nature. 
The other two options are used for more complicated or ad-hoc situations, such as 
negative feed-backs. In these cases the functions supplied are called with the current 
time and marking (state) of the system as arguments, and the returned value is used 
as the propensity. 
The p x 1 vector M (marking) is used to define the initial conditions. For our 
example, and assigning values to the rate constants and initial conditions (the gene 
is originally inactive), the model R code reads as follows: 
1 model <- list ( 
2 pre<- matrix(c(1,0,0,0, 0,1,0,0, 0,1,0,0, 
3 0,0,1,0, 0,0,1,0, 0,0,0,1), 
4 ncol=4,byrow=T), 
s post<- matrix(c(0,1,0,0, 1,0,0,0, 0,1,1,0, 
6 0,0,0,0, 0,0,1,1, 0,0,0,0), 
7 ncol=4,byrow=T), 
s h <- list (c=3, b=2, H=10, m=1, K=6, r=0.25), 
9 M<- c(1,0,0,0)) 
This model definition can be used to simulate the system by different methods. 
For a deterministic solution, the library automatically creates the system of ordinary 
differential equations (ODEs). The call to the function has the form: 
1 Sim <- RungeK uttaDormandPrince45 (model, T = 200, delta = 1) 
which simulates the system for 200 time units (T = 200), saving the results each 1 
time unit (delta = 1). 
For an exact stochastic run, four methods can be invoked. For example, for an 
~---- -----------------
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optimized version of Gillespie SSA, the call has the form: 
1 set.seed(19761111) 
2 Sim <- GillespieOptimDirect(model, T = 200, delta= 1, runs= 1000) 
A series of exact stochastic simulations can be performed in one call to the function 
(runs= 1000), so the optimization of the data structures used by the algorithms is 
performed only once. The exact stochastic simulation algorithms included are: 
• GillespieOptimDirect, which reorders reactions so the ones occurring more often 
are moved to the top minimizing the linear search to find the "reaction that 
occurred". 
• GillespieDirectGB, that optimizes the SSA according to Gibson and Bruck [18]. 
• GibsonBruck, the next reaction method by Gibson and Bruck [18]. 
• GillespieDirectCR, that applies the constant-time composition/rejection algorithm [64]. 
The different algorithms perform better in different situations. The composi-
tion/rejection algorithm, for example, excels when the number of reactions is very 
large [64]. 
We do not include pure approximate algorithms, such as 7-leaping or chemical 
Langevin equations, as we have not found any cases that would justify their use. 
Their implementation, if needed, would be straightforward. Both approaches are 
implemented as a part of the partitioned leaping algorithm (PLA) [24], which dy-
namically partitions the transitions into four groups, according to their propensities. 
Very slow reactions are simulated using the next reaction method, slow ones using 
the 7-leaping algorithm, medium ones using the chemical Langevin equation, and fast 
ones deterministically. The corresponding function is PartitionedLeaping. 
In most biological systems there are reactions that occur very often (fast reac-
tions), while others occur rarely (slow reactions). Haseltine and Rawlings [27] pro-
posed to use a hybrid algorithm that simulates slow reactions using SSA, and the fast 
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reactions either deterministically or using the chemical Langevin equations (CLE) 
algorithm. In this case, an extra parameter (slow) is used to determine which reac-
tions are considered slow and fast. If, for the previous example, gene activation and 
deactivation are considered slow reactions, whereas mRNA and protein production 
and degradation are considered fast, we set model$slow <- c(1,1,0,0,0,0).The call to the 
function in this case has the form: 
1 Sim <- HaseltineRawlings (model, T = 200, delta = 1, runs = 10000) 
To account for the cases with times at which the behavior of the system changes, 
T can be assigned an R function or a pointer to a C function. This function receives 
the current state and time of the system and modifies the state. As an example, 
one of the places can be a yes/no flag that allows some reactions to happen during a 
section of the run, but disallows them in other sections. 
4.1.3 Discussion 
The definition of the model as a Petri Net is convenient as it is closely related to the 
way reactions are defined. However, it has the side effect of generating very sparse 
matrices. To account for this, the pre and post matrices are analyzed before the first 
run, and the relevant information is stored in internal non sparse structures, to avoid 
unnecessary computations, such as multiplications by zero followed by summation of 
the zeros. Other structures are aimed at speeding the algorithm, such as identifying 
the propensities to be recalculated after the last transition occurred or propensities 
affected by the deterministic evolution in hybrid models. 
The matrix formulation of this paradigm can be advantageously used to perform 
exploratory search of models using mass-action laws, by automatically modifying the 
coefficients of both pre and post matrices before calling the functions. Fitting criteria 
could then be applied to the results to create a ranking of successful models. 
R has functions to import SBML files. If needed, methods could be added to 
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bioPN to perform the translation from SBML to Petri Net structures. 
The differential equation solver, an explicit Runge Kutta Dormand Prince 45 
method, is a very accurate integrator with adaptive step size selection. A parameter 
controls the level of accuracy, with a default of 1e-9. Reducing the accuracy produces 
acceleration, with negligible loss of precision. For hybrid models, time-dependent 
propensity is computed using a trapezoidal approximation that is fast and accurate 
for the required purposes. 
In principle, PLA should represent the best compromise between precision and 
performance. However, the repeated re-partitioning and step selection, and rejections 
of steps in which negative number of species are generated, can prove computationally 
costly in some situations. The method of Haseltine and Rawlings [27] appears to be 
most successful, in the sense of an acceptable loss of accuracy compared to a great 
gain of performance. 
4.2 Validation of bioPN against derived analytical expres-
sions 
The model defined by Equations 4.1 to 4.6 was studied by Paszek [53], who derived 
steady state analytical expressions for the mean and variance of mRNA and protein 
for the stochastic problem and two hybrid variants of stochastic and deterministic 
treatment of the reactions. 
Our goal is to compare the results from analytical expressions with simulations 
performed with bioPN to verify the correctness of the implemented algorithms. 
We will use the parameter values suggested by Paszek for procaryotic cells: c = 3, 
b = 2, H = 10, K = 6, m = 1, and r = 0.25. 
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4.2.1 Deterministic integration of system of ODEs 
Analytical expressions for the expected values of mRNA and Protein are given by [53): 
E [Protein J 
_c_H 
c+b 
~ E [mRNA] 
(4.7) 
(4.8) 
These expressions are not only valid in the deterministic case, but also for the stochas-
tic and any deterministic/stochastic hybrid case. Expressions for the variance, how-
ever , will be different for each situation. 
Using the parameters defined above , the results are: E [mRNA) = 6 and E [Protein) = 
144. These values (green lines) are compared with the result of performing the de-
terministic integration with the bioPN function RungeKuttaDormandPrince45 (blue 
lines) and shown in Figure 4.1. The results agree validating the deterministic Runge 
Kutta Dormand Prince 45 integration algorithm programmed. 
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Figure 4.1 : Deterministic system. Horizontal axis: time units. Vertical axis: number of 
units. Green lines: Analytical results. Blue lines: Deterministic integrations using bioPN. 
4.2.2 Completely stochastic simulations 
Expressions for the variances of mRNA and Protein when all the reactions are con-
sidered stochastic are given by [53): 
Var [mRNA] (4.9) 
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Var [Protein J =rb E 2 Prote1n + 1+c+b+r [ . J 
c( 1 + r) ( 1 + c + b) ( r + c + b) 
r E 
2 [Protein J [ . J 
-1-- [ J + E protmn +r E mRNA 
( 4.10) 
This case was used to validate the four completely stochastic functions in bioPN 
(GillespieOptimDirect, GibsonBruck, GillespieDirectGB, GillespieDirectCR) , which 
showed conformance with analytical results. Results for means and variances for 
1000 runs for GillespieOptimDirect are shown in Figure 4.2. 
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Figure 4.2 : All reactions stochastic. Horizontal axis: time units. Vertical axis: number 
of units. Green lines: Analytical results. Red lines: Simulations using bioPN (1000 runs). 
Comparisons for hybrid algorithms were also performed showing similar concor-
dance to analytical results, and equations and plots are presented in Appendix A , 
starting on page A.2.1. Results for extended series of 10,000 runs are also presented 
in Appendix A, starting from page 164. 
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4.3 Comparison between deterministic and stochastic sys-
tems 
In this section we will compare deterministic integration (i.e. solving a system of 
ordinary differential equations) against averages of stochastic runs, for the solution 
of time evolution of gene regulatory networks. 
We will study the following systems: 
• Model by Paszek [53] used in Section 4.2 to validate bioPN against steady state 
analytical expressions of mean and variance. 
• Model by Paulsson et al. [54], used to introduce the key concept of "stochastic 
focusing". 
• Expansion of Paszek's model by introduction of gene repression (negative feed-
back) by the produced protein. 
• Modification of this last model by replacing the repressing protein by its dimer. 
This final model will coincide with the one used to illustrate Petri nets in Chap-
ter 2. 
4.3.1 Unregulated gene 
We will start by comparing deterministic and stochastic methods for the model de-
scribed by Equations 4.1 to 4.6. This illustrates the "central dogma of molecular 
biology". The chemical species considered are a given gene and the corresponding 
mRNA and protein molecules. The gene becomes activated with constant rate and 
inactivated with a rate depending only on the state of the gene itself. As the gene 
state does not depend on the presence of other molecules (mainly proteins), it is called 
an unregulated gene. This gene transcribes mRNA, which translates a protein. Both 
mRNA and protein degrade. The rate constants used are the same as the ones used 
to validate bioPN (c = 3, b = 2, H = 10, K = 6, m = 1, and r = 0.25). 
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Results for active gene (Ga), mRNA, and protein are presented in Figure 4.3 where 
it is represented: 
• in blue: the time evolution of the solution of the system of ODEs (deterministic 
integration) , 
• in orange: the time evolution of a given stochastic run, 
• in red: the time evolution of the average of 1000 stochastic runs with the cor-
responding pointwise 99.73% confidence interval (average ± 3 standard error). 
These colors will have the same meaning for all the plots in this section. 
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F igure 4 .3 : Time evolution of mRNA and protein for unregulated gene. Horizontal axis 
is time units. Vertical axis is number of molecules. 
The three panels of the figure show an excellent concordance between the deter-
ministic and stochastic results , from which we can conclude that, for this case, the use 
of a system of ODEs to explain the evolution of the mean of the system is justified. 
This verifies what we have already discussed in Subsection 2.3.4 on page 17. 
However, this agreement will fail soon, once we introduce a negative feedback to 
the gene. To provide justification to this fact, we will illustrate in the next subsec-
tion the case from literature that first pointed out (to our knowledge) a discrepancy 
between both approaches. 
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4.3.2 "Stochastic focusing" and its relation to Jensen's inequality 
Paulsson et al. [54] studied the effect of signal amplification in a stochastic system, 
when compared to the corresponding deterministic system. The example they used 
was a Michaelis-Menten problem expressed by the chemical reactions: 
0 k I (4.11) ----+ 
S+I ~ s ( 4.12) 
I kp 
---=--+ p ( 4.13) 
p 1 0 (4.14) ----+ 
® ~ s (4.15) 
s kd 
----=-+ 0 ( 4.16) 
Random variables I, P, and S are not independent in a statistical sense, but from 
the construction of the problem it is evident that the evolution of S is unrelated to 
the values that I and P at all times. In fact, the reactions that modify the values 
of S are expressed in Equations 4.15 (a zero order reaction), and 4.16 (a first order 
reaction only depending on S). The contrary is not true. Both I and P are strongly 
dependent on the values of S. I directly, as expressed by Equation 4.12, and P that 
is an amplified version of I. 
When the number, per unit of time, of events corresponding to reactions expressed 
in Equations 4.12 and 4.13 are sufficiently high, the resulting number of molecules of 
I is very low and the number of molecules of S does not change in a significant way 
for the life span of a specific molecule of I [54]. Then Equations 4.11 to 4.14 can be 
replaced with the following simplified scheme: 
p 1 
----+ 
(4.17) 
( 4.18) 
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where q is given [54] by: 
1 
q=---
1 +S/K 
( 4.19) 
where 
( 4.20) 
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Figure 4.4 : Stochastic focusing. Time evolution of S, I and P. Horizontal axis is time 
units. Vertical axis is number of molecules . 
We studied the system given by Equations 4.11 to 4.16 for the following rate 
constant values: k = 10, 000, ka = k/2, kp = 500, kd = 100. These parameters 
were kept unaltered for all time points (0 ::; time ::; 150) of both the deterministic 
integration and of the series of stochastic simulations (100 runs performed). The 
reaction constant of Equation 4.15 changed according to the following law: 
• ks = 10kd, for (0 ::; time < 50) 
• ks = 2.5kd, for (50 ::; time < 100) 
• ks = 1.5kd, for (100 ::; time < 150) 
• ks = kd, for (150 ::; time ::; 200) 
We performed both the deterministic and stochastic studies using bioPN. The 
results of the evolutions of the three species are presented. The left panel of Figure 4.4 
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shows the time evolution of S. In this case, we can conclude that the deterministic 
integration has a good concordance with the averages of the stochastic realizations. 
However, this is not the case for I , and even less for P , shown in the second 
and third panel of Figure 4.4, respectively. In these cases the concordance between 
the deterministic integration and the corresponding averages of the stochastic runs 
is poor. Using the deterministic approach to draw conclusion about the running 
stochastic process in a system with these characteristics is an inadequate approach. 
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Figure 4 .5 : Convexity of function q. 
Jensen inequality provides a justification of the observed behavior: if X 1s a 
random variable and cp is a convex function, then: 
cp(E[X]) ::; E[cp(X)] (4.21) 
Function q of Equation 4.19 is convex, as it can be verified in Figure 4.5. As a con-
sequence, the deterministic integration ( cp(E[X]) ), cannot be greater than the average 
of the stochastic runs (E[cp(X)]). Paulsson et al. [54] called this signal amplification 
effect "stochastic focusing" . 
If the function cp is concave, the opposite inequality holds. In this case, instead 
of an amplification effect , a damping effect will be in place. We show this kind of 
behavior in Section 4.3.4 , and examples with these characteristics will also appear in 
further chapters concerning reaction-diffusion systems applied to early carcinogenesis 
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and spread of viral infection (Chapters 8 and 9), respectively. 
A final question stays unanswered. Why is that, in the case of S, the deterministic 
integration agrees with the average of the stochastic runs? As mentioned before, the 
reaction propensities affecting S are: a constant, and a linear function. As both cases 
are straight lines, they are neither convex nor concave, then the equality replaces 
Jensen inequality and both results agree. 
As a consequence it is possible that, m a given studied system, any possible 
combination of the different effects (agreement, amplification, dampening) may be 
coexisting simultaneously for different species. 
4.3.3 Gene repressed by its produced protein 
In this section we introduce the following modifications to our base model (Equa-
tions 4.1 to 4.6): Equations 4.1 and 4.2 are replaced by 
Gi ~ Ga + Protein 
Protein+ Ga ~ Gi 
(4.22) 
(4.23) 
while the rest of the equations remain unaffected. The reaction constants are the 
same as the ones used in Section 4.3.1. 
The introduced change establishes a negative feedback, i.e., the produced protein 
blocks the gene that produces it with an intensity proportional to the number of 
proteins present at a given time. 
Results are presented in Figure 4.6. Left and middle panel present results for 
mRN A and protein that show that in both cases the averages of the stochastic runs 
(red lines) lie above the deterministic mean (blue lines), albeit the disagreement 
does not seem important. However, by modifying three parameter values (H = 0.1, 
K = 60, m = 0.01) the difference of the deterministic and stochastic protein values 
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differ by a factor of 4 approximately (right panel of same figure). 
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Figure 4.6 : Time evolution of mRNA and protein for gene repressed by its produced 
protein. Horizontal axis is time units. Vertical axis is number of molecules. Left and 
middle panel were obtained using H = 10, K = 6, and m = 1, while right panel using 
H = 0.1, K = 60, m = 0.01. 
4.3.4 Gene repressed by dimer of produced protein 
We modify the system by: 
• Introducing dimerization of the produced protein and dissociation of the dimer. 
2 Protein ~ Dimer ( 4.24) 
Dimer 2 Protein ( 4.25) 
• Replacing the protein by the dimer as the repressor of the gene. 
Gi ~ Ga + Dimer ( 4.26) 
Dimer + Ga ~ Gi ( 4.27) 
Simulations using different values of the introduced parameters D and d do not show 
a relevant change in structure of the solutions, so the simple arbitrary values D = 2 
and d = 1 are assumed. As already noted, this modified model coincides with the 
one used to illustrate Petri nets in Chapter 2. 
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We show results for the dimer in Figure 4. 7 using three combinations of values 
assigned to parameters H and m: 
1. the original values ( H = 10 and m = 1) , for the case on the left panel; 
2. H = 1 and m = 0.1, for the case on the middle panel, 
3. H = 0.1 and m = 0.01, for the case on the right panel. 
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Figure 4. 7 : Gene repressed by dimer of produced protein. Time evolution of protein and 
dimer. 
The ratio H/m in all cases is the same (H/m = 10). However , the behavior of 
the system changes: on the left panel the mean of the stochastic runs lies below the 
deterministic mean, on the middle panel both means agree, and on the right panel it 
lies above the deterministic mean. 
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4.4 Hi-stability 
We will illustrate the concept of bi-stability using as example published work were 
bioPN library was successfully used in a large-scale system [58] : the model of cross-
talk between regulatory modules of p53 and NF-~B. 
Bi-stability emanates when a system has two stable states. Deterministic meth-
ods fail to capture this behavior that only stochastic methods (pure of hybrid) can 
uncover. 
We will not describe the model in detail here and refer the reader to the pa-
per for further detail [58]. The model is composed by 46 chemical species and 66 
reactions. The system was simulated using the Haseltine and Rawlings hybrid deter-
ministic/stochastic algorithm [27], where gene activation-inactivation, DNA damage 
and repair , and receptors activation-inactivation were considered slow reactions (15 
stochastic reactions) , while the rest were considered fast (deterministic). 10,000 runs 
were performed for three different protocols [58]. 
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Figure 4.8 : Bi-stability. Comparison of mean values of deterministic and stochastic cases. 
Horizontal axis is time in hours. Vertical axis is number of units. In all cases it is shown 
phosphorylated nuclear P53. Green lines: 30 stochastic runs. Red line: average of 1000 
stochastic runs. Orange line: average of 1000 hybrid deterministic/stochastic runs. Blue 
line: deterministic integration 
For comparison purposes, we performed two series of 1000 runs, one with the 
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same hybrid simulation specified above, and the other with a completely stochastic 
algorithm. The protocol simulated is the following: 
1. Cells rest for 30 hours. 
2. Cells are stimulated during 4 hours with 10 ng/ml of tumor necrosis factor 
(TNF), 3 hours before 'Y irradiation of 2 Gy during 1 hour. 
3. Cells are studied for 48 hours of evolution to decide cell fate. 
Figure 4.8 shows results for one of the involved proteins, nuclear P53. The system 
exhibits bi-stability for the chosen parameter values. As expected, the deterministic 
run (blue line) fails to capture it, and follows only one of the two possible paths. 
Figure 4.9 presents another view, and includes on the right column results of the 
amounts of cells that survive the treatment and of the ones that commit apoptosis. 
The results for the hybrid and completely stochastic algorithms are very close, which 
justifies the use of the hybrid algorithm instead of the purely stochastic. The de-
terministic approach not only fails to capture bi-stability, it also "predicts" that all 
cells survive for the chosen parameter values, while both the hybrid and stochastic 
approaches show that the number of cells that become apoptotic (around 60%) is 
higher that the number of surviving cells (around 40%). 
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Figure 4 .9 Bi-stability. Comparison of deterministic, hybrid, and stochastic cases (1000 
runs). Left panel horizontal axis is time in hours. Left panel vertical axis is number of 
units. Green lines depict phosphorylated nuclear P53. Red lines depict phosphorylated 
nuclear Mdm2. Blue lines depict double strand breaks (multiplied by 1000 for comparison 
purposes). Right panel horizontal and vertical axes are number of units (dots are values 
at end of simulation). Top row shows results for the deterministic run. Middle row shows 
runs for the hybrid deterministic/ stochastic approach used in the paper. Bottom row shows 
runs for a completely stochastic approach. 
Chapter 5 
Transcription factors IRF3 and NF~B acting in a 
coordinated way under double stranded RNA 
stimulation 
In this chapter we presents current work on a model of cellular sensing of double 
stranded RNA, which is itself a model of viral infection, by RIG-I protein and TLR3 
receptor. It consists of six parts. In part one we introduce the pathway. In part 
two we describe experiments. In part three we describe experimental results. In 
part four we introduce the current version of the associated computational model. 
In part five we describe simulations, protocol used, and simulation results. In part 
six we compare the outcomes of the deterministic run and of the average of runs of 
stochastic simulations. 
5.1 Introduction 
We present current work on a model of cellular sensing of double stranded RNA, 
which is itself a model of viral infection, by RIG-I and TLR3. Since its inception, the 
model has undergone five mayor revisions, as experimental results become available. 
The current version is still a work in progress. The experiments performed verify 
some of the results found in literature (already reviewed in chapter 3), while others 
raise the possibility that an alternative explanation may be possible, at least when 
studying double stranded RNA electroporated into A549 epithelial cells. 
The simulations on this study were performed entirely using bioPN, presented in 
chapter 4. This is study aided by Dr. Allan Brasier group at University of Texas 
Medical Branch (UTMB), Dr. Tomasz Lipniacki, Institute of Fundamental Techno-
logical Research of the Polish Academy of Sciences, and Dr. Marek Kimmel, Rice 
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U ni versi ty. 
Dynamics of innate immunity system under viral attack is still not understood in 
detail. We provide an introduction to viral infection and innate immune defense with 
references to literature in Chapter 3. New insights are emerging based both on novel 
experiments and on system modeling approach. We report a model of coordinated 
response of two transcription factors, IRF3 and NF-KB, under double stranded RNA 
stimulation, itself a model for viral RNA. 
A brief description of the signaling network follows: double stranded RNA is 
sensed both by RIG-like family of helicases (RIG-I) and toll-like receptor 3 (TLR3). 
RIG-I undergoes a conformation change and binds to mitochondrial antiviral signal-
ing adapter (MAVS) and to TNF receptor-associated factor 3 (TRAF3), leading to 
the nuclear translocation of IFN regulatory factor 3 (IRF3). TLR3 becomes acti-
vated, binding to TIR-domain-containing adapter-inducing interferon-,8 (TRIF) and 
to TRAF6, triggering phosphorylation and degradation of inhibitor of KB a (IKBO:'), 
and freeing an active form of nuclear factor KB (NF-KB) which also translocates into 
the nucleus. Both IRF3 and NF-KB are independently responsible of the activation 
of a number of genes involved in innate immune and inflammatory responses. NF-KB 
also activates the IKBO:' and tumor necrosis factor, and alpha-induced protein 3 (TN-
FAIP3, also known as A20) genes that act as inhibitors of the path. Both IRF3 and 
NF-KB are needed for the activation of the cytokine interferon ,B. 
dsRNA was chosen because it rapidly activates the IRF3 and NF-KB pathways, 
much more so than, for example, respiratory syncythial virus (RSV), and the timing 
of dsRNA exposure is more accurate than when working with a virus. 
5.2 Experiments 
Three kind of experiments were performed at University of Texas Medical Branch 
(UTMB) by Dr. Allan Brasier's team: 
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1. Time series of key mRNAs were measured for changes in NFkB and IRF3 sig-
naling pathway. The experiment was performed by Dr. Muping Lu. 
2. Time series of key phosphorylated proteins at same time points as above us-
ing strong cation exchange (SCX) fractionation experiments, performed by Dr. 
Yingxin Zhao. 
3. Knock-down experiments using small interfering RNA (siRNA) on NF-fi;B, IRF3, 
RIG-I, and IKKy with and without electroporation of dsRNA were performed 
to study the effect on NF -1'\;B and IRF3 induced genes. The experiment was 
performed by Dr. Bing Tian. 
5.2.1 Knock-down experiments 
RelA, IRF3, RIG-I and IKKy siRNA were transfected into A549 cells using siQUEST 
reverse transfection method. 4 J-tg of dsRNA was electroporated into siRNA trans-
fected cells 6 hours before harvesting mRN A. 72 hours after siRN A reverse trans-
fection, the RNA was harvested and reversely transcribed into corresponding eDNA 
and run for Q-RT-PCR to examine the target gene expression level. The target genes 
that were examined are: 
• RelA, IRF3, RIG-I, and IKK)', to verify the effect of the knock-downs. 
• A20, Ifi;Ba, IL8, and IL6, that are considered pure NF -1'\;B dependent genes. 
• ISG56, ISG54, CIG5, and ISG60, that are considered pure IRF3 dependent 
genes. 
• IFN and RANTES, that are considered controlled by both IRF3 and NF-1'\;B as 
their promoter have binding sites for both transcription factors. 
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5.3 Experimental results 
Time series experiments of mRN A and proteins are presented in Figure 5.1, together 
with simulation results. 
5.3.1 Knock-down experimental results 
The experimental results, performed in A549 cells, showed that all variants of siRNA 
could knock-down their corresponding basal gene expression level when compared 
with the basal gene expression level of control siRNA treated cells (Figure 5.2). 
• The basal RelA expression level in RelA siRNA treated cells was 15.8% when 
compared to control siRNA. 
• The basal IRF3 expression level in IRF3 siRNA treated cells was 35% when 
compared to control siRNA. 
• The basal RIG-I expression level in RIG-I siRNA treated cells was 8.2% when 
compared to control siRNA. 
• The basal IKK)' expression level in IKK'Y siRNA treated cells was 14.4% when 
compared to control siRNA. 
We observed that dsRNA can sharply increase RIG-I expression level and slightly 
increase RelA and IRF3 expression levels, while it has no effect on IKK 'Y expression 
level. 
Results suggest that a cross inhibitory effect between NF -KB and IRF3 pathways 
could be in place: RelA siRNA treated cells exhibited an elevation in both basal and 
dsRNA induced levels of IRF3, while IRF3 siRNA treated cells exhibited an elevation 
in both basal and dsRN A levels of RelA. 
However, the effect on the genes induced by both transcription factors is not 
straightforward: 
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Figure 5.1 : Time evolution of deterministic simulation (blue lines) , compared to rescaled 
experimental results (black dots) . 
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• IRF3 siRN A treated cells exhibited and increase in the expression of RelA 
controlled genes, such as A20, li,-;Ba, and IL8. 
• RelA siRNA treated cells did not exhibited the expected increase in the expres-
sion of IRF3 controlled genes: with the exception of ISG56, RelA siRNA did 
not increase the expression of other IRF3 controlled genes such as ISG54, CIG5, 
and ISG60. 
Dr. Tian notices that, from experience related to previous studies where siRNA 
was used, in order to have confidence on the experimental results, the level at which a 
specific siRNA is able to knock down its own gene is critical. Considering that IRF3 
siRNA treated cells could knock down IRF-3 gene by 65% of basal IRF3 expression 
level, Dr. Tian points out we could probably see a stronger effect of IRF3 siRNA 
treated cells on the level of RelA -dependent gene expression if the previous level ( 65%) 
could be increased to 90%. Moreover, the cross inhibitory effect hypothesis could be 
tested in future experiments, that would require acquisition of RelA, IRF3, RIG-I, 
and IKK "( deficient cells. 
The basal RIG-I expression level in RIG-I siRNA treated cells was 8.2% when 
compared to control siRN A, which is a satisfactory level. For these experiments, we 
observe that IRF3 dependent genes are sensitive to the level of RIG-I inhibition, while 
RelA dependent genes are not. This suggests that dsRNA induced NF-KB pathway 
activation is probably independent of RIG-I, at least in A549 cells. 
5.4 Proposed model 
As mentioned before, the current definition of the model is still a draft version. More 
experiments need to be conducted to validate it, or to suggest further modifications. 
The model is being constructed from both literature review (Chapter 3), and inter-
pretation of experimental results. A schematic of the model is depicted in Figure 5.3. 
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The current version of the signaling pathway is composed by 93 chemical species 
and 173 reactions. We present a simplified schematic where mRNAs and inactive 
forms of the proteins are omitted for clarity. 
The main sensors of dsRNA, as reviewed in 3.4 on page 37, are RIG-I and TLR3. 
According to literature, both pathways are capable of activating both IRF3 and NF-
r;;B depending on the variant of virus studied, and/ or the cell line used. Knock-down 
experiments presented in the previous section suggest that, in the case of electropo-
ration of dsRNA in A549 cells, RIG-I seems to activate the IRF3 dependent path, 
but not the NF -r;;B dependent one. 
As a consequence, in our current model we consider two independent paths, one for 
IRF3 regulated by RIG-I, an one for NF-r;;B, that we assume regulated by TLR3, as 
literature supports. However, further experiments with TLR3 knocked-down should 
be performed to assess the validity of this assumption. 
Certain complexes have been named to simplify notation: 
• The complex TBK1-IKKE is termed IKK1 and simplified as a single kinase that 
has a gene and mRNA associated. 
• The same treatment is done for the complex IKKa-IKK,B-IKKy, termed IKK2. 
• TLR3 dependent transcription factor (TLR3dTF) is an hypothetical transcrip-
tion factor activated exclusively by TLR3-TRIF-TRAF6 pahtway. Our main 
candidate is AP -1. 
Full coupled chemical reactions are presented on section C.2. 
5.5 Simulations 
The model was simulated using bioPN. Knock down simulations are performed by 
increasing the corresponding mRN A degradation rate by a factor that achieves the 
same level of down-regulation as shown in the experimental results. 
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Figure 5.3 : Simplified schematics of IRF3-NFKB model. Only proteins (in the cytoplasm) 
and genes (in the nucleus) are shown. Green lines imply activation when destination is 
in cytoplasm and up-regulation when in nucleus. Solid green lines on top mean dsRNA 
activates while binding to destination. Red dotted lines imply inhibition. Transcripts and 
inactive forms of the proteins, as well as nuclear translocated proteins, are omitted to avoid 
cluttering. 
5.5.1 Protocol 
Initial conditions are set to zero number of molecules for all species , with the exception 
of the number of free (not bound to transcription factor) genes, which is set to 2 
copies. The simulation is started at time t = -500 hours (-100 hours would have 
been more than enough) to assure the system reaches steady state values. At time 
t = 0 hours, electroporation is simulated by inserting 5 x 105 molecules of dsRNA , 
which corresponds to the experimental values of 4 J-Lg. The system is allowed to evolve 
for 6 hours. 
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5.6 Simulation results 
5.6.1 Simulations of full model experiments 
Simulation results of full model experiments are presented in Figure 5.1. The upper 
panel shows the fit of the model to mRNA time series of experimental results after 
rescaling the experimental data using least squares. The rescaling is needed because 
the absolute quantification of mRNA as well as of proteins is, in many situations, 
irreconcilable with physiological levels (as an example, 105 molecules of RIG-I mRNA 
per cell). 
The rest of the panels show the fit of the model to protein time series of experi-
mental results, again after rescaling of experimental results by least squares. 
5.6.2 Simulations of knock-down experiments 
Figure 5.2 shows, in each panel, the effect of all knock-down on a specific gene ex-
pression. The bars in these figures are the results of the experimental results, and 
the red segments are the corresponding simulation values at six hours under dsRNA 
stimulation. The vertical axis is in log-scale with a fixed maximum to comparison 
purposes across panels. A different presentation can be found in the Appendix C 
(page 180). 
5.6.3 Comparison of simulations with experiments 
The fit of the current model to the experimental data shows good agreement in most 
cases, while in some it does not agree. There is a trade off when modifying coefficients, 
and we are interested in achieving a global agreement, even if it may not work for 
a particular case. More experiments are needed and planned. The complete set of 
experiments will provide a better understanding of the dynamics involved, and may 
suggest modifications to the actual structure of the model. 
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5. 7 Comparison between deterministic and stochastic sys-
tems 
The experiments performed involve the introduction of a high amount of dsRNA (in 
the order of 5 x 105), which provokes a strong reaction on the signaling pathways. 
As such, we performed this study deterministically by numerically solving the corre-
sponding set of ordinary differential equations. In this section we will compare the 
deterministic results with single stochastic runs and the averages of 1000 stochastic 
runs, to see the level of agreement between both approaches. 
To shorten the time needed to run the stochastic simulations, the initial run for 
this series of simulations is reduced to 100 hours, as our intention is to compare both 
deterministic and stochastic methods, and not to assure that all species are at steady 
state values. 
Results are presented in Figure 5.4. As in previous chapters, blue lines represent 
deterministic results, orange lines represent single stochastic runs, and red lines rep-
resent averages of 1000 stochastic runs. We have included in these plots the standard 
deviations of 1000 stochastic runs, depicted in red dotted lines. We show only pro-
tein results. On the left it is depicted the evolution before dsRNA electroporation, 
starting from initial conditions set to two copies of inactive gene for each species, and 
zero for the rest of the components. On the right we show 30 hours of evolution since 
dsRNA electroporation, modeled by introducing at time zero 5 x 105 molecules of 
dsRNA. This amount of dsRNA is depleted in about 8 hours, after which the system 
evolves to a similar behavior as before treatment. 
TRIF protein is depicted on the top panel. In our model TRIF has an unregulated 
gene associated. As such, the reactions that lead to its creation and degradation 
are of first order, so deterministic and stochastic approaches should agree, (as we 
have established in Section 2.3.4 on page 17). Numerical simulations verify this and 
the agreement between both is remarkable (the deterministic blue line covers the 
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Figure 5.4 : Comparison between deterministic and stochastic systems for IRF3/NF-K:B 
signaling pathway. Left panel shows evolution of the system for 100 hours before dsRNA 
treatment , while right panel shows the evolution of 30 hours from dsRNA treatment ad-
ministration. 
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stochastic red line at all times). 
In the structure of the model, the majority of the proteins have associated genes 
that are regulated by transcription factors (IRF3 and TLR3dTF) that only get ac-
tivated as a consequence of dsRNA electroporation. As such, these genes are not 
active in the initial 100 hours and produce mRNA only at basal level. Therefore, 
their corresponding proteins act as produced by unregulated genes. We omit showing 
these cases, as they look a similar concordance as the observed for TRIF. 
In the model, NF -~B is a protein tightly regulated by I~Ba and A20. Before 
treatment A20 does not play a regulating role, but I~Ba does. As a consequence, 
proteins regulated by NF -~B have interesting dynamics, that can be observed on 
the left column on second to fourth rows of the figure. In these shown cases, the 
disagreement between deterministic and stochastic results is evident in levels, and in 
certain cases, in dynamics. 
The strong stimulating effect produced by dsRNA electroporation seems to over-
come any other effect, and deterministic and stochastic results closely agree during the 
first hours after treatment for all species, as it can be observed on the right column. 
At later times each species evolves to similar behavior as it had before treatment. 
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Part II 
Reaction-diffusion systems, sbioPN 
and applications to early 
carcinogenesis and viral infection 
Chapter 6 
Reaction-diffusion modeling background 
In this chapter we introduce reaction-diffusion systems. It consists of two parts. 
In part one we discuss the importance of considering spatial effects, such as diffusion, 
as well as incorporating stochasticity in models where a deterministic approach is not 
a viable solution. In part two we summarize the mathematical background relevant 
to modeling of reaction-diffusion systems, and deterministic and stochastic numerical 
approximations. 
6.1 Introduction to reaction-diffusion systems 
The methods used so far in the studied systems assume the reactants are perfectly 
mixed and new species, created by reactions, are also instantaneously mixed in a 
perfectly homogeneous medium where position is irrelevant. This simplification eases 
the mathematical treatment of the system, and this approach has proved adequate 
to solve numerous problems. 
However, sometimes spatial patterns are present and cannot be neglected without 
incurring in an over-simplification far apart from reality. In these cases reaction-
diffusion methods need to be used. 
There are two approaches to the mathematical modeling of chemical reaction-
diffusion systems: deterministic models based on systems of ordinary and partial 
differential equations; and stochastic simulations [15]. 
Deterministic methods are commonly used when high number of molecules are 
present and the interest is in studying effects averaged over the cell population. We 
have already discussed the implications of using deterministic methods on stochastic 
non-spatial systems in Part I. In reaction-diffusion systems where low copy numbers 
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of molecules or cells are present, deterministic models are inaccurate or even it is 
not possible to apply them [15]. In these cases stochastic modeling provides a more 
detailed understanding of the reaction-diffusion processes. 
Reaction-diffusion approaches may me suitable to study biological systems. We 
are interested in the effects of reactions and diffusion within- and among-cells. 
The first case is applicable to situations where a cell cannot be simplistically 
conceived as a perfectly mixed tank. One example is the interaction between a cy-
toplasmic protein and a receptor that is located on the boundary of the cell. Only 
proteins that are close to the boundary are in position to bind to the receptor. The 
heterogeneity present in this system cannot be neglected. Moreover, if only few copies 
of the receptor are present, treating the system deterministically would be incorrect. 
The second case is applicable when different cells signal each other through cy-
tokines, or to model the effect on cells of viral infection. Again, stochasticity may 
play a major role. We aim to explore the importance of stochastic effects in these 
type of models. 
6.2 Background on modeling reaction-diffusion systems 
6.2.1 Diffusion 
Diffusion is the effect of random movement of molecules in a medium due to thermal 
energy [5]. The governing law is Brownian motion (see Def 6.1). There is a unique 
diffusion constant D that characterizes diffusion, that depends on the size of the 
molecule, viscosity and absolute temperature of the solution. The value of D for a 
typical protein molecule is D = 10-4mm2sec-1 [15]. 
In Cartesian coordinates, let M(x, y, z, t) be the number of molecules (or con-
centration) of a given species at point (x, y, z) at time t. Given initial conditions 
M(x, y, z, 0), a diffusive system will behave according to the partial differential equa-
tion (PDE) [61], also known as the heat equation: 
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(6.1) 
where yr2 is the Laplace operator, defined in 6.3.2 for different systems of coordinates. 
6.2.2 Deterministic approximation of diffusion 
6.2.2.1 One spatial dimension 
We will first solve the deterministic problem. Limiting the analysis to one dimension, 
the previous expression simplifies into 
aM= Da2M 
at ax2 (6.2) 
To numerically solve this PDE, we can break the continuous space into discrete 
spatial points: 0, ~x, 2~x, · · · , i~x, · · ·, defining xi = i~x. Also, we discretize the 
time in ~t intervals. Calling Mi(xi) the approximation to M(i~x,j~t), we can 
numerically integrate this system using the iterative forward Euler method: 
(6.3) 
Estimating 82~;Jx;) using a centered difference approximation [61], we obtain: 
(6.4) 
Suitable initial conditions M0 (xi) need to be defined for all discretized spatial 
points, as well as suitable boundary conditions. 
Boundary conditions can be of two types: Dirichlet boundary conditions specify 
the values at the boundaries for each time t, and can be a constants or variable 
functions; Neumann boundary conditions are imposed on the derivatives of the values 
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at the boundaries. For this last case, the centered difference approximation cannot 
be used, as the values at the extremes are undefined. For example, to update x1, the 
following approximation can be used for 82 ~;~x1 ): 
82 Mn(Xl) Mn(x2)- Mn(X1)- ~x8Ma;xo) 
8x2 ~ (3/2)~x2 (6.5) 
where aMa;xo) is the Neumann boundary condition at the left extreme. 
Rearranging (6.4) as 
we can interpret each side as an approximation to a derivative: 
(6.7) 
which suggests that, in general, we want ~t"" ~x2 so that both sources of error have 
similar magnitudes. 
6.2.2.2 Three spatial dimensions 
Discretizing equation ( 6.1) we obtain 
Mn+l(xi, Yi, Zk)- Mn(Xi, Yi, Zk) 
~t 
DMn(Xi+l' Yi, Zk) + Mn(Xi-1, Yi> Zk)- 2Mn(Xi, Yi> Zk) 
~x2 
+DMn(Xi, Yi+l' Zk) + Mn(Xi, Yj-1, Zk)- 2Mn(Xi, Yi> Zk) 
~y2 
+DMn(Xi, Yi, Zk+l) + Mn(Xi, Yi, Zk-1)- 2Mn(Xi, Yi, Zk) 
~z2 
(6.8) 
for which initial conditions and suitable boundary conditions need to be defined. Also 
we want ~t "" ~x2 "" ~y2 "" ~z2 . 
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6.2.3 Reaction-diffusion equations 
The general form of a reaction-diffusion equation is: 
(6.9) 
where M is a vector of places (species), Dis a diagonal matrix with the diffusion rate 
of each species (D'\J2 M is a vector called the diffusion term), f(M) is a vector where 
the elements are the standard system of mass-action differential equations, and it is 
called the reaction term. 
6.2.4 Stochastic approximation of diffusion 
6.2.4.1 Discretization of stochastic differential equation approach 
Let [X(t), Y(t), Z(t)] E ~3 be the position of a diffusing molecule at timet. Choosing 
a time step !lt, the following discretized versions of the stochastic differential equa-
tions (SDEs) (defined in Section 6.3.6) can be used to track the evolution of diffusing 
single molecules [15]: 
X(t + !lt) = X(t) + V2D !lt ~X 
Y(t + flt) = Y(t) + V2D !lt ~y 
Z(t + flt) = Z(t) + V2D flt~z 
where ~x' ~Y' and ~z are N(O, 1). 
(6.10) 
(6.11) 
(6.12) 
Suitable boundary conditions need to be defined. These equations are related to 
the chemical Langevin equations, introduced in Section 2.5.2. 
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6.2.4.2 Compartment-based approach 
We divide the computational domain [0, L] into K compartments of length h = L/ K. 
As long as, regardless of dimension [15, 33], 
D 
d= h2 (6.13) 
the following chain of first order reactions will be a correct approximation for simu-
lating diffusion with a stochastic simulation algorithm (SSA): 
d d d d 
A1~A2~A3~···~AK (6.14) 
d d d d 
6.3 Mathematical definitions and numerical methods. 
6.3.1 Del, gradient and divergence operators 
Let us limit for now to n-dimensional Euclidean space to introduce some preliminary 
concepts. 
Del (V') is a vector differential operator, defined as: 
(6.15) 
where { ei : i = 1, · · · , n} is the standard basis in this space. 
Applying del to a scalar field f (a function that for each point of the space returns 
a scalar) is defined as the gradient of the scalar field: 
(6.16) 
The gradient converts a scalar field into a vector. 
Given a vector V = (v1 , · · · , vn) = v1e 1 + · · · + vnen, the divergence (V'·) is an 
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operator that first applies the components of del to each of the components of the 
vector, and then sums the components (reminiscent to a dot product), giving a scalar 
as a result. The representation V' · is considered an abuse of notation. In mathematical 
notation: 
(6.17) 
6.3.2 Laplace operator 
Given n-dimensional Euclidean space, the Laplace operator or Laplacian is a second 
order differential operator, defined as the divergence (V' ·) of the gradient of a function 
(V' !). 
Iff is a twice differentiable real-valued function, the Laplacian off (6..!) is defined 
as: 
!::lf = V'2 f = V' . V' f (6.18) 
In n-dimensional Cartesian coordinates: 
(6.19) 
Considering n = 3 Cartesian coordinates: 
(6.20) 
In cylindrical coordinates: 
(6.21) 
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In spherical coordinates: 
1 a ( of) 1 a ( . of) 1 82 f ~ - __ r 2 - + - smO- + . 2 2 f - r2 or or r 2 sin 0 ao ao r 2 sm 0 [)cp (6.22) 
where 0 is the polar angle and cp the azimuthal angle. 
If n = 2, in Cartesian coordinates: 
(6.23) 
whereas in radial coordinates: 
(6.24) 
6.3.3 Brownian motion 
Definition 6.1 Brownian motion (or a standard Wiener process) [29] is a random 
process 
W(t) (t E [0, T]) (6.25) 
for which: 
1. W(O) = 0 a.s. 
2. if 0:::; s < t:::; T then W(t)- W(s)'""' ..;t=S N(O, 1) 
3. if 0:::; s < t:::; u < v:::; T then W(t)- W(s) and W(v)- W(u) are independent. 
6.3.4 Discretized Brownian motion 
It is usually considered for computational purposes. We set 6t = T / N for some 
positive integer N and let Wi = W ( ti = j 6t). Then W0 = 0 a.s., and 
wj = wj-1 + dWj (j = 1, 2, ... , N) (6.26) 
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where dWi are iid distributed as vftiN(O, 1). 
6.3.5 Stochastic integral 
The stochastic integral of the function h(t) with respect to a Brownian motion W(t) 
can be defined as an Ito integral 
T N-1 
r h(t) dW(t) = lim L h(tj)(W(tj+l)- W(tj)) 
Joo N--+oo j=O 
(6.27) 
or a Stratonovich integral 
(6.28) 
Note that the two stochastic sums give different answers, no matter how small the 
time step. 
A Stratonovich integral can be expressed as an Ito integral as 
{T 1 {T {T 
Jo f(W(t)) o dW(t) = 2 Jo f'(W(t)) dt + Jo f(W(t)) dW(t) (6.29) 
6.3.6 Stochastic differential equations (SDE) 
A scalar, autonomous stochastic differential equation (SDE) can be written 
dX(t) = f(X(t))dt + g(X(t))dW(t), X(O) = X 0 , 0 :-:; t :-:; T (6.30) 
The integral form is 
X(t) = Xo + 1t f(X(t))ds + 1t g(X(s))dW(s), 0 :-:; t :-:; T (6.31) 
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where f and g are scalar functions, X 0 a random variable, and X(t) a random variable 
for each t. 
6.3. 7 Euler-Maruyama {EM) method 
To numerically solve the previous SDE over [0, T], we discretize the interval, setting 
f:lt = T / L for a positive integer L, and Tj = j f:lt. Denoting X ( Tj) = Xi, the EM 
method is: 
W(Tj)- W(Tj_1) will be obtained from the discretized Brownian motion. For conve-
nience f:lt = R M for an integer R ~ 1. 
Chapter 7 
sbioPN, the reaction-diffusion extension to bioPN 
library 
In this chapter we present sbioPN (spatial bioPN), a software library developed 
to solve reaction-diffusion systems in deterministic, stochastic, and hybrid determin-
istic/stochastic manner. It consists of six parts. In the first part we discuss the 
limitations of bioPN to simulate reaction-diffusion systems. In the second part we 
present sbioPN and its characteristics. In the third part we explain the structures 
needed to define a reaction-diffusion model in sbioPN. In the fourth part we compare 
diffusion in deterministic and stochastic settings. In the fifth part we make some 
considerations about compartment size in cubic grids. Finally, in the sixth part we 
shows two applications from literature simulated with sbioPN. 
7.1 Introduction 
bioPN, the library presented in chapter 4, could in principle be used to simulate 
reaction-diffusion systems, partitioning the container in compartments and creating 
instances for each chemical species in each compartment, as reviewed in Chapter 6 
(Subsection 6.2.4.2 on page 80). 
For example, we may call the instances of chemical species A A1 , A2 , A3 (species 
A in compartment 1, 2 and 3). Proceeding this way, we should repeat each specific 
reaction as many times as different compartments are considered, modifying the in-
stances of the chemical species that react (using A1 for the first reaction, A2 for the 
second, and so on). Following the principles of compartment-based approach, diffu-
sion can be modeled as first order reactions (A1 transforming into A 2 and vice versa, 
and so on), with the reaction rate constant as defined in Equation 6.13. 
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However, this approach could only be considered successful in small systems, and 
would be error prone. The use of an algorithmical approach to create the instances 
of the reaction could be a solution. However, in systems with a large number of 
compartment, sparse matrices Pre and Post could potentially exhaust the available 
memory during the definition of the model. 
7.2 Characteristics of sbioPN 
sbioPN, for spatial bioPN, is an extension to bioPN that can be used to simulate 
reaction-diffusion systems. By design it is not tied to any specific spatial configura-
tion, even if it has been used up to date only for one- and two-dimensional Cartesian 
systems, where the compartment, called voxel in sbioPN, is considered, respectively, 
a segment or a square. Three dimensional Cartesian system is a natural extension for 
which sbioPN is already prepared. Theoretically, sbioPN could be used for cylindrical 
or spherical coordinate systems, and the container been considered an hexagon, or a 
ring, or a hollow sphere, according to the case. This is possible because there are two 
kind of reactions considered: 
• reactions that occur inside a specific container and depend on species only 
belonging to that specific container. 
• reactions that involve the migration of a species from one container to another. 
Only the second type of reaction requires awareness of the spatial configuration. 
A system that only has transitions of the first type can be conceived as several inde-
pendent simulations performed at once, with the same type of outcome that would 
be obtained by performing a sequential series of runs of a non-spatial system. 
It is then a correct definition of the migration rules which suffices to unambiguously 
define the model. However, more study is needed to correctly define the reaction rates 
for models in coordinate systems other that Cartesian, so we will limit our attention 
87 
in this thesis to one- or two-dimensional. We plan on improving sbioPN so it can 
simulate reaction-diffusion processes on unstructured meshes [13]. 
sbioPN is not limited by design to diffusive systems. It could potentially be used 
to solve, for example, reaction-convective systems, or any other conceivable law of 
migration. A data structure with rules detailing how species migrate is used. This 
gives the modeler the possibility to design the desired scheme. sbioPN allows to 
implement different sets of migration rules for different species. 
We have only used sbioPN so far to solve reaction-diffusion systems, and we 
provide in the Appendix code to create rules for one and two dimensional Cartesian 
grids with Neumann and periodic boundary conditions. 
As happens with bioPN, sbioPN allows to define the model once, and then de-
cide which function to call depending if a deterministic, stochastic, or hybrid deter-
ministic/stochastic simulation is desired. Following bioPN, functions that perform 
simulations are programmed in C and optimized for performance. 
7.3 Model definition in sbioPN 
7.3.1 Structures needed to define the model 
To define the model, an R list with the following named elements is constructed. 
1. Pre and Post matrices (required). These matrices are defined as in bioPN. 
Their interpretation changes in the fact that now the places and transitions 
are general. The library generates instances of each place (column) for each 
container. Each transition (row) is not required to occur in every container; it 
can occur in any subset of containers. 
2. h list (required). Same as in bioPN. 
3. M matrix (required), used to set the initial conditions. It has as many rows as 
containers and columns as places. If only one container is defined, it can be a 
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vector. 
4. Voxels scalar (required), indicating the total number of containers in the model. 
5. VoxelSubset list (required). Each element of the list is a vector, whose ele-
ments are the indexes corresponding to the containers included on a particular 
subset. 
6. TransitionlnVoxelSubset vector (required). It is used to assign transitions to 
subsets of containers. It has as many elements as transitions, and each element 
is an index to the VoxelSubset list defined above. 
7. JumpingPattern list (optional). Each element of the list is a matrix with 3 
columns and as many rows as jumps this particular jumping pattern will have. 
The first column indicates the index of the source container of the jump, while 
the second the index of the destination one. The third column indicates the 
stoichiometry of the post matrix. See 7.3.2 for further explanation. 
8. JumpingPlace list (optional). Used to indicate which places migrate. Each 
element is a list with four elements: 
• Place 
• jumping rate 
• index to the J umpingPattern list defined above. 
• 1 if the reaction is slow or 0 if it is fast (for Haseltine and Rawlings function 
only). 
The same place may appear more than once, with different jumping rate and 
jumping pattern. 
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7.3.2 JumpingPattern structure 
A successful definition of the jumping patterns is required, as those patterns are the 
ones that confer the spatial characteristic to the model, as well as the law of migration 
of places. As mentioned before, code for diffusive patterns for systems with Neumann 
and periodic boundary conditions are provided in the Appendix. 
A deterministic diffusive system with Neumann boundary conditions requires tak-
ing care of second order effects for containers on the boundary. To implement it in 
sbioPN, each boundary container has to: 
• receive two units from the neighbor container (even if only one unit is leaving 
that container). 
• destroy one unit. 
• send one unit to the neighbor container. 
All other containers have a simpler structure, sending one unit and receiving one. 
For a complete treatment of this matter, see Dai's work [10]. 
In Figure 7.1 a one dimensional case with four interconnected containers is shown 
and the corresponding jumping matrix definition is presented in Table 7.1. 
Each square represents a container. Green number indicates index to correspond-
ing container. Arrows indicate jumps (first order transitions). Small number on 
arrow tails indicate index of jump. Gray numbers are the stoichiometry of the pre 
matrix (source of jump). Note: they are always ones. Red and Blue numbers are the 
stoichiometry of the post matrix (destination of jump). 
The stochastic case is simpler, as no second order effects are considered. All the 
communicating containers need to send one unit to the neighbor and receive one from 
it. Figure 7.2 and Table 7.2 illustrate this case for the corresponding one dimensional 
case. 
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Figure 7.1 : Jumping pattern for deterministic diffusive system with Neumann bound-
ary conditions, one dimensional case. Refer to Table 7.1 for the complete matrix definition 
for this case. 
Jump index Source Destination Stoichiometry of destination 
1 1 0 0 
2 1 2 1 
3 2 1 2 
4 2 3 1 
5 3 2 1 
6 3 4 2 
7 4 3 1 
8 4 0 0 
Table 7.1 : Matrix for the jumping pattern in Figure 7.1. Only the last three columns 
belong to the matrix. The first column is implicit in the matrix indexing, and included for 
a better understanding of the relation with Figure 7 .1. 
For periodic boundary conditions, the same pattern can be used both for deter-
ministic as for stochastic diffusion. See Figure 7.3 and Table 7.3 for the corresponding 
one dimensional case. 
Diagrams for two dimensional cases are shown in Appendix F (Figure F.1 to F.3 
on page 212). Following the keys from Tables 7.1 to 7.3 it is trivial but tedious to 
derive the corresponding jumping matrices. An algorithmical approach to generate 
them is advised. For example code in R see F .2 to F.4 starting on page 211. 
7.4 Comparison of diffusion in a deterministic and stochastic 
settings 
The compartment-base approach used in the previous section treats diffusion as a 
series of first order reactions. We have already seen in Chapter 2 that in a system 
where only zeroth and first order reactions happen, deterministic integration and 
averages of stochastic simulations should agree. 
91 
1 2 3 4 
I I I I I 1 
- 3 _ s_ 
.. 
1.- ... ~ 
6 
-
2 
-
4 
-I I 1 I I I 
Figur e 7 .2 : Jumping pattern for stochastic diffusive system with bf Neumann boundary 
condit ions, one dimensional case. 
Jump index Source D estination St oichiometry of d estinat ion 
1 1 2 1 
2 2 1 1 
3 2 3 1 
4 3 2 1 
5 3 4 1 
6 4 3 1 
Table 7.2 : Matrix for the jumping pattern in Figure 7.2. 
To verify this in sbioPN we defined a spatial model where a zeroth order reaction 
fires only in the center of a 60 x 60 grid , creating a molecule that is allowed to diffuse. 
Both a deterministic integration and 100 stochastic simulations were performed. The 
deterministic integration is depicted in the upper panel of Figure 7.4 , while the average 
of the stochastic runs is depicted in the bottom panel. In both cases contour lines 
were draw and vertical lines tangent to the contours of the deterministic case are also 
tangent to the corresponding level contour lines of the stochastic case, verifying that 
both systems evolve with the same speed and intensity. 
7.5 Appropriate choice of compartment size h. 
This section reviews some conclusions by Erban and Chapman (2009) [14) about the 
correct choice of compartment size h in cubic grids for bi-molecular reactions, both 
heteroreactions and homoreactions. They get to the conclusion that the compartment 
size has to be appropriate: it has to be a sufficient fine grid for discretization , but 
it cannot be arbitrarily small. There is a limit on h from below. They also note 
that it is recommended to use cubic grids, as it might be difficult to tell results 
that show a property of the system from the ones that are consequence of the non-
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Figure 7.3 : Jumping pattern for deterministic and stochastic diffusive system with 
periodic boundary conditions, one dimensional case. Green numbers outside containers 
are index to destination container (on opposite side). 
Jump index Source Destination Stoichiometry of destination 
1 1 4 1 
2 1 2 1 
3 2 1 1 
4 2 3 1 
5 3 2 1 
6 3 4 1 
7 4 3 1 
8 4 1 1 
Table 7.3 : Matrix for the jumping pattern in Figure 7.3. 
uniform grid. On the other side, Engblom et al. (2009) [13] treat simulation of 
stochastic reaction-diffusion processes on unstructured (triangular) grids , which is a 
future planned addition to sbioPN. 
Erban and Chapman corrections to the SSA reaction rates are summarized in the 
following subsections. 
7.5.0.1 Heteroreactions 
A+B~··· (7.1) 
The usual propensity is 
(7.2) 
Considering that 
(7.3) 
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Figure 7.4 : Comparison of deterministic and stochastic diffusion. Top panel shows the 
deterministic run, while bottom panel shows the average of 100 stochastic runs. 
where f3oo ~ 0.25272, the proposed propensity is 
where f3 is adimensional and obtained from 
1 1 
f3 = 2K3 
i,j,k=O 3- cos(i1rjK)- cos(j1rjK)- cos(k1rjK) 
( i,j,k );;f(O,O,O) 
where K = Ljh. 
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(7.4) 
(7.5) 
If there is no information about the system (or if K is large), f3oo is suggested. 
7.5.0.2 Homoreactions 
The usual propensity is 
A+A~··· 
kl 
a 1(t) = A(t) (A(t)- 1)-
v 
NOTE: It seems it should be divided by 2 
In this case, the proposed propensity is 
(7.6) 
(7.7) 
(7.8) 
7.6 Validation of sbioPN using two examples from literature 
7.6.1 Complex patterns in a simple system. Pearson 1993. 
The author of this work describes a simple reaction-diffusion model with a variety of 
irregular spatia-temporal pattens (Turing instabilities) [55]. The system is a modifi-
cation of the auto-catalytic model of glycolysis by Selkov due to Gray-Scott (original 
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references in [55]). The mathematical model is: 
au 2 2 at = Du \l U- UV + F(1 - U) 
~~ = Dv'V2V + UV2 - (F + k)V 
The system size is 2.56 x 2.56 (dimensionless units), with periodic boundary con-
ditions. The initial state is defined as U = 1, V = 0. The 20 x 20 grid area in the 
middle is set to U = ~' V = ~ and perturbed with ±1% random noise to break the 
square symmetry. 
The original system was deterministically integrated for 200,000 time steps using a 
forward Euler method with time step equal to 1. The sbioPN integration is performed 
with a Runge-Kutta Dormand Prince 45 method [11] with adaptive step size. 
The original results are found in Figure 7.5, for values ofF and k as defined in 
the phase diagram at the top. The paper does not specify the exact values used for 
each case, and each pattern can be obtained by several combinations ofF and k. The 
extracted parameters used for the sbioPN simulation are presented in Table 7.4. The 
corresponding results appear in Figures 7.6 and 7. 7 for an early and the latest stage 
of the simulation. 
It is not possible to reproduce exactly the same plots for the following three 
reasons: 
• different integration technique (simple Euler method with fixed step size vs 
Runge Kutta Dormand Prince 45 with adaptive step-size) 
• lack of specification of exact pair of parameters used for each case 
• different initial random perturbation of 20 x 20 middle grid area 
However, by comparing the end results of simulations ( 7.7) to Figure 7.5, a good 
correspondence is observed for the parameter chosen (in Table 7.4). 
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Figure 7.5 : Pearson 1993 [55]. On top: phase diagram of the reaction kinetics. Greek 
letters represent the location where the patterns in the figure at the bottom were found. 
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Figure 7.6 : sbioPN: Early stage of simulation. 
Figure 7. 7 : sbioPN: End of simulation. 
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Case F k Case F k 
a 0.02 0.05 77 0.024 0.058 
fJ 0.02 0.046 e 0.03 0.06 
'Y 0.024 0.056 {, 0.05 0.06 
5 0.033 0.056 K 0.044 0.063 
E 0.016 0.056 .X 0.038 0.064 
~ 0.033 0.064 J-l 0.042 0.064 
Table 7.4 : Values ofF and k used in sbioPN simulation of Pearson 1993 model. 
7.6.2 Okubo et al. (1989) 
We present one second example from literature to illustrate that the use of sbioPN 
is not limited to biological networks, and that it can be used in any system in which 
number of elements are considered. 
The authors introduce a reaction-diffusion competition model aimed at describing 
interactions between an exotic introduced gray squirrel and the indigenous red squirrel 
in Great Britain, using Lotka-Volterra type equation with isotropic diffusion [51]. 
The system is mathematically described by the following set of partial differential 
equations: 
(7.9) 
where i = 1 for gray and i = 2 for red squirrels, ai are net birth rates, 1/bi are 
carrying capacities, ci are competition coefficients, and Di are diffusion coefficients. 
It is assumed that grays out-compete the reds, so b2 > c1 and c2 > b1 . 
It was used a 4.9x2.4 rectangular grid with Newman boundary conditions. The 
initial distribution is as follows: red squirrels are at unit normalized density, and there 
are 4 pockets of gray squirrels with density 0.1. Results are presented in Figure 7.8 
and 7.9. 
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Figure 7.8 : Okubo et al. [51] . t = 5 and t = 10. On the left , results by Okubo et al. On 
the right, results using sbioPN. 
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Figure 7.9 : Okubo et al. [51]. t = 20 and t = 30. On the left, results by Okubo et al. On 
the right, results using sbioPN. 
Chapter 8 
Stochastic reaction-diffusion model of early 
. . 
carcinogenesis 
In this chapter we present the stochastic version of an original one-dimensional 
reaction-diffusion model of early carcinogenesis that exhibits Thring instabilities. It 
consists of five parts. In part one we introduce the model. In part two we describe the 
deterministic and stochastic approaches employed. In part three we present results of 
both approaches and compare them. In part four we study the behavior of the system 
for different rates of diffusion. In part five we treat additional material of technical 
nature. 
8.1 Introduction 
We consider the early carcinogenesis model originally proposed as a deterministic 
reaction-diffusion system. The model has been conceived to explore the spatial effects 
stemming from growth regulation of precancerous cells by diffusing growth factor 
molecules. 
The model exhibits Thring instability producing transient spatial spikes in cell 
density, which might be considered a model counterpart of emerging foci of malignant 
cells. However, the process of diffusion of growth factor molecules is by its nature a 
stochastic random walk. An interesting question emerges as to whether the dynamics 
of the deterministic diffusion model is an approximation of the stochastic process 
generated by the model. 
We address this question by simulations using sbioPN, presented in Chapter 7. 
The conclusion is that whereas single-realization dynamics of the stochastic process is 
very different from the behavior of the reaction diffusion system, it is becoming more 
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similar when averaged over a large number of realizations. The discrepancy increases 
as the rate of diffusion decreases. 
The large-sample mean of the stochastic simulations seems to display different 
spatial patterns from those caused by the Thring instability in the reaction-diffusion 
system. Despite the differences, typical realizations of the stochastic process include 
spikes of cell density, which however are spread more uniformly and are less dependent 
of initial conditions than those produced by the reaction-diffusion system. 
8.1.1 Model of early carcinogenesis 
The model of a precancerous cell population is as in reference [46], which adopts 
elements of the models of a homogeneous population of cells of one type previously 
proposed in references [43,45]. The present model is based on the following hypothe-
ses: 
• Precancerous cells c, existing in a spatial domain, proliferate at a rate a(b, c), 
which is reduced by cell crowding but enhanced in a paracrine manner by a 
hypothetical bio-molecular growth factor b bound to cells. 
• Pre-cancerous cells are supplied at a constant rate 1-£ by mutation of normal 
cells. 
• Free growth factor g is secreted by the cells at the rate K(c), then it diffuses 
among cells with diffusion constant l/"f, and binds to cell membrane receptors 
at a rate a(c), becoming the bound factor b. It then dissociates at a rate d, 
returning to the free factor pool. 
• Free and bound growth factor particles decay at rates d9 and db, respectively. 
Discussion of possible geometries for the spatial variable x can be found in previous 
papers [43, 44]. One natural geometry is that of a line of cells, occupying the interval 
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x E [0, 1]. There are three substances distributed over the line's length: Cells and 
free and bound growth factor molecules, with densities c(x, t), g(x, t) and b(x, t), 
respectively. The resulting equations are as follows: 
oc 
at - (a(b, c)- dc)c + J-l, 
ab 
at 
og 1 
at - -;:y!::l.xg- a(c)g- dgg + K(c) +db, 
with homogeneous Neumann (zero flux) boundary conditions for g 
oxg(O, t) = 8xg(1, t) = 0 
(8.1) 
(8.2) 
(8.3) 
(8.4) 
The kinetics were derived from the stochastic model describing the transitions be-
tween different states of the growth factor molecules [43, 44]. Diffusion equation is 
a macroscopic approximation of the microscopic process of growth factor binding to 
membrane receptors, under homogeneity hypotheses; it has been derived in [4 7]. Co-
efficient 1/'Y is a composite parameter including the diffusion constant and scaling 
parameters, 'Y = 1/d. Proliferation rate has the Hill function form 
(8.5) 
where a 1 = (2p- 1 )a0 and p is the efficiency of divisions. We will consider the special 
case m = 1. Production of free growth factor by cells has the Michaelis-Menten form 
KC K(c) = -1 -+c (8.6) 
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The form of growth factor binding rate a(c) has been obtained from conditions for 
diffusion-driven instability investigated in ref. [44]. It assumes the form, 
s>O (8.7) 
i.e., the process of binding free growth factor particles to cells is super-linear. 
The differential equations where transformed to the corresponding set of coupled 
chemical reactions. The set as well as considerations about diffusion and boundary 
conditions are described in Section 8.6. 
8.2 Deterministic reaction-diffusion system 
8.2.1 Spatially homogeneous steady state 
From reference [46], the spatially homogeneous steady state of pre-cancerous cells (c) 
is the solution to: 
(8.8) 
The corresponding expression for bound growth factor is: 
(8.9) 
and the one for free growth factor is: 
(8.10) 
The resulting values using parameters specified in Table 8.1 are c = 5.86, b = 
8.07, and [j = 0.47. Numerical integration of the deterministic system agrees with 
these results, which are presented in the upper panel of Figure 8.3. 
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Parameter Value 
a1 1/12 
a 10-1 
K 1 
s 1 
de 5 x 10-2 
1-l 10-2 
d =db= dg 1o-1 
Table 8.1 : Values of the parameters used in all studied systems. 
5.86 
20 40 60 80 100 
Figure 8.1 : Deterministic reaction-diffusion system. Red line shows perturbation of c 
(black line), according to Equation 8.11, withE= 10-2 and n = 5. 
8.2.2 Perturbation of spatially homogeneous steady state 
To break the spatially homogeneous equilibrium, a cosinusoidal perturbation is ap-
plied to c using the expression 
c0 = c + ccos(2nnx), 0::; x::; 1 (8.11) 
where E = 10-2 is the amplitude used [46], and n is the number of peaks. The case 
n = 5 is illustrated in Figure 8.1. 
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8.2.3 Numerical integration of perturbed system 
Ten different grid densities, five different 'Y values ('Y = 1; 10; 100; 1000; and 10, 000), 
and five different n values (1 to 5) were considered. As a consequence, we studied 
a total of two hundred and fifty perturbed deterministic reaction-diffusion systems. 
In all cases, including the stochastic simulations, the parameter values used were the 
same and are summarized in Table 8.1. 
Each perturbed deterministic system was numerically integrated for 2000 time 
units, and the values at 2000 time units, rounded to the nearest integer, were used as 
the initial conditions for stochastic simulations. 
We refer as "main case" the one having the following parameter values: 'Y = 100, 
and n = 5, as this is the case from reference [46] that motivated our study and it 
was the most studied case. It shares the same characteristics than the rest of the 
cases with equal 'Y, but its behavior is different when compared to cases with other 'Y 
values. Those cases will be treated in Section 8.4. We will start by only considering a 
grid density of 100 nodes. We will later (Section 8. 7) analyze the change of behavior 
of the main case as the grid density changes. 
The time evolution of the main case is presented in the upper panels of Figure 8.4. 
The left column shows the time evolution of pre-cancerous cells, and the right column 
the corresponding time evolution of free growth factor. Bound growth factor is not 
included in the plots as it follows the exact shape of the pre-cancerous cell plots in a 
different scale. 
As a result of the integration, this case shows, at 2000 time units, a symmetric 
configuration of four full spikes and two "half spikes" at the boundaries. This case 
was also integrated for 4000 time units, not showing a change in behavior. 
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8.3 Stochastic reaction-diffusion system 
To study the behavior of the stochastic system, simulations with three different initial 
conditions were performed: 
1. with all the initial quantities set to zero, 
2. with the spatially homogeneous steady states rounded to the nearest integer, 
3. with the end values of the deterministic perturbed systems rounded to the near-
est integer. Two hundred and fifty stochastic simulations have been performed 
with this kind of initial conditions, i.e., the same number as in the deterministic 
case. 
Rounding to the nearest integer is an unavoidable requirement for stochastic sim-
ulation. Potential implications and further studies are deferred to Section 8.8. 
8.3.1 Single runs 
1000 runs were performed for each stochastic simulation. In this section we show 
sample realizations using two of the initial conditions specified above (the last one 
corresponding to the main case). We only show the evolution of pre-cancerous cells. 
Results for bound growth factor, albeit not exactly identical, are very similar to those 
for pre-cancerous cells with a rescaling factor, and runs of free growth factor do not 
show any discernible structure, and are deferred to figures of mean values. 
Left panel of Figure 8.2 depicts a typical run with zero initial conditions. Spikes 
appear in a mostly uniform way along the x axis which last for a variable amount of 
time, being replaced by spikes formed in different places. The spikes do not seem to 
form in any preferential spot. 
Stochastic simulations using as initial conditions the spatially homogeneous steady 
state values of the deterministic system rounded to the nearest integer (not shown) 
rapidly evolve to a similar behavior as the corresponding to zero initial values. 
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Figure 8 .2 Single runs of the stochastic reaction-diffusion system. Left panel depicts a 
run with zero initial conditions, while the right panel depicts a run with initial condition 
set t o the end values of the deterministic system rounded to nearest integer. In both cases 
'Y = 100 was used. 
The right panel of Figure 8.2 depicts a typical stochastic runs with initial con-
ditions set to the values of solutions of the perturbed main case at 2000 time units , 
rounded to the nearest integer. The initial conditions in this case have four full spikes 
and two half spikes at the boundaries. Results show that the stochastic system does 
not preserve all the spikes. Most of them disappear rapidly, and no more than two 
spikes coexist in some runs. 
8.3.2 Averages of 1000 runs 
Figure 8.3 shows a comparison between deterministic and stochastic systems before 
perturbation of the deterministic system. The average of the number of pre-cancerous 
cells in the stochastic simulation using zero initial conditions is significantly lower than 
the result of the deterministic simulation (5.86 compared to values below 1). This 
behavior is also mimicked by bound growth factor (not shown). In the case of free 
growth factor , instead, both cases seem to converge to values close to the deterministic 
one. 
To further analyze the cause of this behavior, we performed deterministic and 
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Figure 8.3 : Deterministic/stochastic reaction-diffusion and non diffusive systems com-
parison. Zero initial conditions are used. Depicted are, on the left, pre-cancerous cells and, 
on t he right, free growth factor. First row shows deterministic averages, while second row 
averages of 1000 stochastic runs. Third row shows the non diffusive system, where blue lines 
correspond to deterministic mean and red lines correspond to averages of 1000 stochastic 
runs. The values in the legends correspond to time 2000. 
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stochastic simulations for the associated non diffusive model, and we present the 
results in the lower panel of Figure 8.3. The deterministic and stochastic mean values 
of pre-cancerous cells differ by almost four folds, in a similar way as what is observed 
in the spatial case. The deterministic mean values for free growth factor are identical 
for spatial and non-spatial cases. 
However, the stochastic mean of free growth factor differs with respect to the non-
spatial stochastic mean, both in initial shape as in the equilibrium values achieved. 
The first rapidly increases and decreases at the initial time units, reaching a stable 
plateau at about 0.4 at time 500. The second, instead, rapidly grows until reaching 
a plateau at about 0. 7 in a very short time. 
The initial increase and decrease in mean values for the spatial case may be related 
to the diffusive characteristic of free growth factor: as it is not produced equally 
along the x axis, the observed effect may be related to an initial imbalance that 
is compensated as time progresses. However, we do not have and explanation that 
justifies why the diffusive and non diffusive systems achieve a different equilibrium 
level. 
Figure 8.4 shows a comparison of the perturbed deterministic main case system 
and the averages of 1000 runs of the stochastic system, assuming as initial conditions 
the end values of the deterministic system rounded to nearest integer. The initial-
value spikes of the pre-cancerous cells rapidly lower to about two thirds of the initial 
value, and then continue to decrease at a lower rate. Based on this alone, it is not 
clear if after 2000 time units the spike values continue to decrease until they reach 
a limit value or until reaching the same level as in Figure 8.3. Vanishing of the half 
spikes at the boundaries suggests the second option. 
To address this issue a new series of 1000 runs was performed for the main case 
with time ranging up to 8000 units. The results are depicted in Figure 8.5 which 
show that, in the long run, the averaged spikes disappear from the stochastic system. 
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Figure 8.4 : Deterministic/stochastic reaction-diffusion systems comparison, after pertur-
bation. On the left are depicted pre-cancerous cells, while in the right are depicted free 
growth factor molecules. First row corresponds to deterministic evolution after perturba-
tion. Second and third rows correspond to averages and standard deviation, respectively, of 
1000 stochastic runs with initial conditions set to the end values of the deterministic system 
rounded to nearest integer. 
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Figure 8.5 : Stochastic reaction-diffusion system studied for 8,000 time units. Depicted 
are averages of 1000 stochastic runs of pre-cancerous cells, with initial conditions set to the 
end values of the deterministic system rounded to nearest integer. 
8.4 Behavior of the system for different rates of diffusion 
Let us remind that in the so-called main case, the par~meter values assumed were 
n = 5 and r = 100. In this section we will present a comparison of deterministic and 
stochastic results obtained when studying the case n = 3 for the range of r values that 
we studied: r = 1; 10; 100; 1000; and 10, 000. As r is the reciprocal of the diffusion 
constant, lower values of r imply higher diffusion rates. 
We have chosen n = 3 because the associated deterministic systems exhibits two 
full and two half spikes for r assuming values 1 and 10, providing good initial values for 
the stochastic simulations. Deterministic cases associated to other n values provide 
less interesting initial values for these r values (most of them only show the half 
spikes at the boundaries for at least one of the r values, as it happens for the main 
case). Other parameter combinations are not shown because they lead to the same 
conclusions as the case of n = 3. 
The results, presented in Figures 8.6 and 8. 7 for increasing values of r, are orga-
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nized as follows: each figure shows two different values of "(, one on the left column 
and one on the right column. Top panels show the deterministic simulations of the 
corresponding perturbed system. Middle panels show the average of 1000 stochastic 
runs. Bottom panels show one representative stochastic run. 
Interestingly, it seems that the stochastic system better preserves the averaged 
spikes of the pre-cancerous cells and bound growth factor (not shown), if lower values 
of 'Y are assumed, or, equivalently, if diffusion rate increases. It even seems to be 
able to indefinitely preserve the average spike height constant in time for "( = 1 (left 
column of Figure 8.6). Single runs show that one of the original spikes is maintained 
through completion of simulation, while the rest disappear rapidly. By observing the 
plot of the averages, it seems that the internal full spikes are preserved with greater 
probability with respect to boundary ones. 
In the right column of Figure 8.6 ( "( = 10) a similar behavior can be observed 
for the internal but not for the boundary spikes. Single runs show that the bound-
ary spikes disappear rapidly while one of the internal spikes is maintained through 
completion of simulation. 
The left column of Figure 8.7 depicts the case using"( = 100 that, as expected, 
shows behavior similar to that observed for the main case for the average values 
(Figure 8.4): a marked drop from the initial values followed by a gradual decay. The 
same can be said about the similarities found among single runs with respect to the 
ones of the main system (Figure 8.2). 
The right column of Figure 8. 7 depicts how the deterministic system becomes 
numerically unstable for 'Y = 1000. In contrast, the stochastic system, exhibits the 
type of behavior observed in Figure 8.3. 
Finally, for"(= 10,000 (not shown) both the deterministic and stochastic systems 
revert to the equilibrium state. 
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F igure 8.6 : Deterministic/stochastic comparison for different values of parameter ry . First 
row depicts evolutions of perturbed deterministic systems. Second row depicts averages of 
1000 stochastic runs. Third row depicts single stochastic runs. The stochastic simulations 
had initial condition set to the ending values of the deterministic system rounded to nearest 
integer. All cases correspond to n = 3. Results for ry = 1 are on the left , while results for 
ry = 10 are on the right. 
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Figure 8. 7 Deterministic/stochastic comparison for different values of parameter I· 
Continuation. First row depicts evolutions of perturbed deterministic systems. Second row 
depicts averages of 1000 stochastic runs. Third row depicts single stochastic runs. The 
stochastic simulations had initial condition set to the ending values of the deterministic 
system rounded to nearest integer. All cases correspond ton= 3. Results for 1 = 100 are 
on the left, while results for 1 = 1000 are on the right. 
116 
8.5 Additional material of technical nature 
We will treat now arguments of technical nature that can be skipped without loosing 
general understanding of the topics treated in this body of work (next chapter starts 
on page 127). 
The additional material is organized as follows: 
• We present the chemical reactions that describe the system of differential equa-
tion presented in equations 8.1 to 8.3, as well as the treatment of diffusion and 
boundary conditions (Section 8.6 starting on page 116). 
• We examine the consequences of modifying the grid density (Section 8. 7 starting 
on page 119). 
• We analyze potential consequences of rounding to nearest integer the initial 
conditions of the stochastic system (Section 8.8 starting on page 123). 
8.6 Modeling the deterministic and stochastic reaction-diffusion 
systems 
To have a consistent definition for the deterministic and stochastic systems, the orig-
inal differential equations were transformed into the corresponding coupled chemical 
reactions. The description of each coupled reaction is as follows: 
• Proliferation of pre-cancerous cells: 
b a1bcj(b+c) 2 b c+ c+ (8.12) 
• Pre-cancerous cell death: 
(8.13) 
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• Mutation of normal cells into pre-cancerous ones: 
(8.14) 
• Binding of free growth factor to pre-cancerous cells: 
(8.15) 
• Degradation of bound growth factor: 
(8.16) 
• Dissociation of bound growth factor from pre-cancerous cell, returning to the 
pool of free growth factor: 
• Degradation of free growth factor: 
b db 
---+ g 
dgg 
g--=---+ ® 
• Secretion of free growth factor by pre-cancerous cells: 
~~:c/{l+c) 
c c+g 
(8.17) 
(8.18) 
(8.19) 
As not all the reaction propensities are of mass-action nature, in this case the quan-
tities appearing above the arrows represent the reaction propensities corresponding 
to each reaction, instead of the reaction constants. 
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8. 7 Consequences of varying the grid density 
8. 7.1 Deterministic system 
Equations 8.12 to 8.19 are only valid for a grid density of 100 nodes. To be able to 
analyze other grid densities, some of the reaction propensities need to be modified to 
a more general form: 
• The propensity of Equation 8.14 is replaced by: 
100 p,--
nodes 
• The propensity for Equation 8.15 is replaced by: 
( 100 ) -(s+l) a -- cs+lg 
nodes 
• The propensity for Equation 8.19 is replaced by: 
100 ( 100 ) -l 
K,C-- --+c 
nodes nodes 
where nodes is the number of nodes of the interval 0 ::; x ::; 1. 
(8.27) 
(8.28) 
(8.29) 
Figure 8.8 shows cross sections of time evolution of pre-cancerous cells in the per-
turbed deterministic system for different number of nodes: 25, 50, 100, 200, and 400. 
The main case (100 nodes) is presented in the middle. Orange lines that look like hor-
izontal straight lines are the cosinusoidal perturbations of the corresponding spatially 
homogeneous steady state (that are number above orange lines). The perturbation is 
better appreciated in Figure 8.1. 
The spatially homogeneous steady states double if the number of nodes are halved, 
and the opposite holds true if the number of nodes are doubled. Values at 2000 time 
units (red lines) do not follow the same behavior. Spikes seem to decrease following a 
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Figure 8 .8 Cross sections of evolution of perturbed deterministic systems for different 
grid densities. Depicted are pre-cancerous cells. Horizontal axis shows number of grid nodes 
of interval 0 ::; x ::; 1. 
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shifted exponential law to what appear to be a limiting value, as the number of nodes 
increase. In all cases, spikes form in one node. A potential misleading interpretation 
of rescaling the results is treated in Section 8. 7.2. 
The same behavior and conclusion can be drawn for bound growth factor. Re-
sults are not shown because they look exactly the same as a rescaled version of 
pre-cancerous cells. 
Free growth factor follows a more expected behavior, and the results are presented 
in Appendix D (Figure D.1 on page 204). Values tend to double as number of nodes 
half, and vice versa. Increased number of nodes favor smoother results. 
8.7.2 Rescaling the results of deterministic system to match spatially 
homogeneous steady state values 
A potentially misleading presentation of Figure 8.9 depicts the results of simulations 
of the deterministic system for different grid densities rescaled so that all the plots 
show the same spatially homogeneous steady state. This way of presentation may 
suggest the interpretation that, as the density of the grid increases, the spikes diverge 
toward infinity (becoming "Diract deltas"). As Figure 8.8 shows, this interpretation 
is incorrect. The effect is caused by rescaling and the fact that, numerically, the 
spikes only occur in one voxel, no matter how small the voxel is. 
In the case of free growth factor plots, which are smoother, this artifact does not 
occur, as presented in Appendix D (Figure D.2 on page 205). 
8.7.3 Stochastic system 
Simulations of the main case were also performed for the same number of nodes 
presented in the previous subsection, using as initial conditions the end values of the 
corresponding perturbed deterministic systems rounded to the nearest integer. 
Results for pre-cancerous cells are presented in Figure 8.10, which seems to lead to 
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Figure 8.9 : Cross sections of evolution of perturbed deterministic systems for different 
grid densities, rescaled to show the same spatially homogeneous steady state as the main 
case (100 grid nodes). Depicted are pre-cancerous cells. Horizontal axis shows number of 
grid nodes of interval 0 ~ x ~ 1. 
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the conclusion that the stochastic system sustains better the level of averaged spikes 
for coarser grids, and the opposite for finer grids. 
Results for free growth factor are presented in Appendix D (Figure D.3 on page 206). 
Lower number of nodes convey cross-sectional structure to the averaged values, which 
is increasingly lost as the number of nodes increase. 
8.8 Analysis of potential consequences of rounding to nearest 
integer the initial conditions of the stochastic system 
This section studies eventual consequences of rounding to the nearest integer the 
results of the perturbed deterministic systems that are used as initial conditions for 
the stochastic simulations. The eventual source of problems is relate to the initial 
conditions for free growth factor. As both the spatially homogeneous steady state 
(0.47), as the end value of the perturbed system ( < 0.2) are below 0.5, initial values 
for growth factor are always rounded to zero. 
To verify if the initial values of free growth factor affect in a sensible way the 
evolution of the stochastic system, we modified two reaction propensities in order to 
rescale growth factor by a given factor so that the new level of growth factor is less 
sensitive to the rounding effect, without affecting the original level of pre-cancerous 
cells. To achieve this 
• Equation 8.12 was replaced by 
• Equation 8.19 was replaced by 
be 
al-----
b+ c · rescap 
"'· rescap · c(1 +c) 
(8.30) 
(8.31) 
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Figure 8.10 : Stochastic reaction-diffusion system. Averages of 1000 runs for different 
grid densities. The number of grid nodes appear on top of each panel. 
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were rescaF is the rescaling factor for growth factor chosen. It was selected reseaF = 
100, and the results for deterministic as well as stochastic systems are shown in 
Figure 8.11. 
The perturbed deterministic system with growth factor rescaled looks exactly the 
same as the original (already presented in Figure 8.4), with the levels of free growth 
factor multiplied by 100. Interestingly, the same congruency seems to happen on the 
stochastic case. Pre-cancerous cells look almost indistinguishable, both in average as 
in standard deviation values, which seems to disregard a potential negative effect of 
the initial rounding to zero of free growth factor. 
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Figure 8.11 : Effect of rescaling growth factor in perturbed system. On the left are 
depicted pre-cancerous cells , while in the right are depicted free growth factor molecules. 
First row corresponds to deterministic evolution after perturbation. Second and third row 
correspond to averages and standard deviation, respectively, of 1000 stochastic runs with 
initial conditions set to the end values of the deterministic system rounded to nearest integer. 
Chapter 9 
Deterministic and stochastic reaction-diffusion 
model of viral infection with interferon production 
In this chapter we compare deterministic and stochastic reaction-diffusion ap-
proaches in a two-dimensional model of viral infection with interferon production. It 
consists of five parts. In part one we explain the motivation for the study. In part 
two we introduce experimental conditions and how boundary conditions are treated. 
In part three we introduce the full model. In part four we construct the full model 
incrementally and we compare results of deterministic and stochastic systems at each 
step. In part five we detail the set of reactions of the full model. 
9.1 Motivation 
Haseltine et al. [26] published a deterministic simulation model, based on reaction-
diffusion partial differential equations describing experiments involving in vitro in-
teraction of viral spread and interferon defenses. Their predecessors [12] modeled 
the evolution of the infection front. We present calculations, based on Haseltine et 
al. [25, 26] data, which point at the need to use a stochastic model, and we build a 
model to compare deterministic and stochastic effects. Diffusion constants for viral 
particles and interferon are extracted from the published work of Haseltine et al. [26] 
group and their predecessors [12]. 
9.1.1 Need for a stochastic model 
Haseltine et al. [26] built reaction-diffusion models to account for spatio-temporal pat-
terns formed by the spreading viral infection, in systems with and without interferon-
mediated antiviral response [12,25,26]. The experimental setup is shown in Figure 9.1. 
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Figure 9 .1 Experiments of Haseltine et al. [25]. 
The model of Haseltine et al. is deterministic, although the authors comment that 
a possible extension might be exploring stochastic effects . 
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Figure 9.2 : Results of Haseltine et al. [25]. 
The experimental setup is as follows [25 , 26]: In the center of a Petri dish of 
radius 1. 75 em a 1 mm radius circular opening is made using a pipette. We adopt all 
concentration and cell size measurements in Ref. [25 , 26]. Considering the cell volume 
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Vc = 3.4 x 10-9 ml, the radius of a spherical cell is: 
(3V) 1/3 rc = 4; ~ 9.328 · 10-6 m = 9.328 J-Lm. (9.1) 
The perimeter of the rim is 2n-r. If we accept that the boundary cells are located 
in the way shown in Figure 9.3, the approximate number of cells on the boundary is: 
21rr 
ncbound = -2 ~ 337 cells. rc (9.2) 
In the opening nvir,o = 8.0·104 virions are inoculated. Assuming they are perfectly 
mixed, we only consider infection by virions that are at one cell radius distance from 
the rim (between the dashed-line circle and the solid-line circle in Figure 9.3). 
Figure 9.3 : Viral inoculum region with boundary cells. The outer circle (r = 1 mm) 
represents the rim of the hole made by the pipette. Gray circles represent cells on that 
boundary. The inner circle represents the limiting region where viruses are consider to be 
close enough to react with the cells. Not drawn to scale. 
The number of virions within this ring-shape region is: 
rc(2r- rc) "' .. 
nvirbound 0 = nvir 0 2 = 1486 VlriOnS , , r (9.3) 
Finally, the number of virions in the ring per cell is approximately equal to 
2 
nvir,O rc (2 ) "' 4 41 . . / ll nvir/cell = --3 r- rc = . VlriOnS Ce 
7r r 
(9.4) 
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Considering a Poisson distribution of the number of virions infecting a cell, the 
mean and variance are equal to nvir/cell· The coefficient of variation is then equal to 
Jnvirjcell "' O 48 CV= = . 
nvir/cell 
(9.5) 
This simplified calculation indicates the importance of stochastic fluctuations in 
low-concentration viral in vitro and in vivo infection. 
9.2 Experimental conditions 
The background for the experimental conditions was extracted from Haseltine et 
al. [25, 26, 28]. 
Cells are grown at a density of 1 x 106 per 35 mm diameter well. Haseltine 
et al. assumed that the infection propagation is approximately radially symmetric, 
after noting that some of the experimental images demonstrated radial asymmetry. 
Therefore they modeled a one-dimensional reaction-diffusion system, discretizing the 
spatial dimension, using central differences, with an increment of 0.25 mm [25, 26, 28], 
that corresponds to 140 grid nodes. 
We do not assume radial symmetry and study the two dimensional problem, in-
scribing the well in a square of 35 mm per side. Cell density of 1 x 106 per well 
corresponds to almost 65 cells per compartment. In order to have a square represen-
tation of cells for display purposes, we study 8 x 8 = 64 cells per compartment. As a 
result, we consider a total of 1,254,400 cells in a square of 35 mm per side on a grid 
of 140 x 140 = 19,600 compartments (or voxels in sbioPN terminology). 
Haseltine et al. studied non age-dependent and age-dependent infection. In the 
latter case they discretized the age dimension using 17 points [26]. We discretize 
infection in 5 stages, that will be described later. Non age-dependent infection is 
considered as well in the last of the intermediate incremental models. 
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Our intention is to compare deterministic and stochastic systems in a model that 
describes in-vitro viral infection in a general way. We do not pretend to analyze any 
specific viral strain nor cell line. We use arbitrary rate constants beyond the diffusion 
rates. We reviewed a number of combinations of parameter values, and found that the 
systems are not highly sensitive to small variations from the assumed values, which 
are presented in Table 9.1. However, the parameter space is eleven-dimensional, so it 
is most likely that other combinations of parameter values might result in radically 
different dynamics. 
9.2.0.1 Diffusion and boundary conditions 
The rates of diffusion were extracted from Haseltine's PhD thesis [25]. As in the case 
of interferon two independent rates are provided, one by Porterfield et al. [57] and 
the other by Nichol and Deutsch [50], we use the mean value of both. The rate of 
diffusion of the vesicular stomatitis virus used is due to Ware et al. [68]. 
Only viral particles and interferon molecules diffuse. We choose periodic boundary 
conditions to have the same computational scheme for both deterministic and stochas-
tic systems. Neumann boundary conditions, which might seem the natural choice, 
require two different computational schemes for the deterministic and stochastic cases, 
as it was explained in Chapter 7 (page 89), and applied in Chapter 8. 
In our simulations, the infection is started in the middle of the grid, so boundary 
conditions only affect the results at late times. 
The implementation of periodic boundary conditions is illustrated in Figure F .3 
on page 213. The R code to generate the required pattern is listed in Section F.4 
(page 215). Effective rates of diffusion were calculated using Equation 6.13 (page 80). 
9.3 Description of the full model 
A diagrammatic representation of the full model is shown in Figure 9.4. 
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The model includes the following objects: 
• UC: Uninfected cell. 
• IC( Infected cell, i-th stage (i = 1, · · · , 5). 
• RC: Resistant cell. 
• Vir: Virion. 
• Ifn: Interferon molecule. 
Virions and interferon molecules diffuse, whereas cells remain in fixed grid com-
partments. 
Uninfected cells (UC) bind competitively to viral particles (Vir) , becoming in-
fected (IC1) , and to interferon molecules (Ifn), becoming resistant (RC). 
F igure 9.4 : Full model diagram. 
We consider in the full model a discrete five-stage infection of the cell. First 
and second stages are dormant. In the first stage, viral particles uncoat releasing 
their genome and use the cell's machinery to produce viral RNA and proteins. In 
the second stage, innate immune system recognizes the presence of viral RNA and 
activates defensive and apoptotic pathways. 
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Step 1 Step 2 
· .. ;;B ·--~ 
Figure 9.5 : Incremental construction of the model: steps 1 to 5. 
In our model, cells at third stage of infection produce interferon at full rate, while 
cell at fourth stage of infection produce interferon and virions at half rate. Finally, 
cells at fifth stage of infection produce viral particles at full rate. Infected cells at 
stages 3, 4, and 5 have a chance to die (or enter apoptosis) at relative rates of 1/4, 
1/2 and 1, respectively. Eventually, all infected cells die (DC). 
As already mentioned, in the model only viral particles and interferon diffuse. 
Resistance in cells is temporary, and eventually resistant cells return to the pool of 
uninfected cells. To avoid adding extra second order reactions, once a cell is infected 
or resistant , it does not bind to further viral particles or interferon molecules. We 
compensate this by considering degradation of viral particles and interferon molecules. 
9.4 Incremental construction of the model 
To better understand when differences between deterministic and stochastic methods 
arise, we will construct the model in six incremental steps and analyze the results of 
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the incremental models. The rate constants, identical for each step, are summarized 
in Table 9.1. 
The incremental steps include: 
1. Viral production and diffusion of viral particles. 
2. Viral particles internalization by cells, or viral particles degradation. 
3. Cell infection. 
4. Infected cell death. 
5. Interferon production and acquisition of cell resistance. 
6. Infection stages. 
Diagrammatic representations for steps 1 to 5 are depicted in Figure 9.5, and for step 
6, corresponding to the full model, in Figure 9.4. 
9.4.1 Viral production and diffusion of viral particles 
The simple initial model is composed by two species only: Infected cells (IC1) and 
viral particles (Vir). The corresponding coupled chemical equations are: 
Vir ---+ b:..xy 
(9.6) 
(9.7) 
In this model we will assume as initial conditions 48 infected cells (3/4 of the 
total) in one of the four central compartments (as the grid has an even number of 
compartment and no unique central compartment exists). Virus is produced only in 
the central compartment, from where it diffuses. 
The results of the deterministic and stochastic runs are presented in the top por-
tion of Figure 9.6. Deterministic and stochastic systems closely agree. We show a 
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close-up (as intensity of viral diffusion is low) of the state of viral particles for both 
systems at 100 h. 
Deterministic Stochastic 
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Figure 9.6 : Steps 1 and 2. 
In Figure 9. 7, we present a view from above that shows that evolution of both 
deterministic and stochastic systems is radially symmetric with center in the central 
compartment and of similar intensity. 
9.4.2 Viral particles internalized by cells, or viral particles degradation 
In this section, we model internalization of viral particles that do not change the 
status of the cell. As already mentioned, we assume that once a cell is infected, new 
Step 1 
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Deterministic Stochastic 
Figure 9. 7 : Step 1. View from above. 
internalized viral particles do not increase viral particles yield. Moreover, we assume 
that not all viral particles internalized by an uninfected cell infect it. We assume the 
first order reaction of viral particles degradation. 
The corresponding new reaction is: 
Vir ----t 0 (9.8) 
Compared to the model of the previous step, the distance that a viral particle 
can reach from the central compartment is diminished considerably, even bounded in 
the deterministic case. We show a close-up of results at 100 hours (lower panel of 
Figure 9.6). It is important to note that the evolution looks unaltered since the first 
few hours until the end of runs. Both deterministic and stochastic runs continue to 
closely agree. 
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9.4.3 Viral infection 
We model infection as a second order reaction: one viral particle (Vir) reacts with 
one uninfected cell (UC) and the product is an infected cell (ICl). Initial conditions, 
from now on, will be the following: at time zero, there are 64 uninfected cells in each 
compartment, with the exception of the central compartment in which there are six 
infected cells and 58 uninfected cells. All other quantities are set to zero. 
This step adds the following reaction: 
Vir+ UC -t IC1 (9.9) 
Results for viral particles are displayed in the top portion of Figure 9.8. Cells 
(uninfected in gray and infected in red), are displayed in the top portion of Figure 9.9. 
The introduction of the second order reaction produces an important change in be-
havior of the system. In comparison with simpler previous models without infection, 
three things can be noted: 
1. Both deterministic and stochastic infection models evolve faster than models 
without infection. Figure 9.6 shows close-ups at 100 hours. Figures 9.8 and 9.9 
show views of the complete system at 5 hours, where the deterministic system 
is about to reach the boundaries of the squared well. 
2. Radial symmetry is lost. Figure 9. 7 shows a radially symmetric viral expan-
sion, while in Figures 9.8 and 9.9 both the deterministic and stochastic systems 
exhibit a diamond shape. This is further analyzed in Section 9.6. 
3. The deterministic system evolves faster than the stochastic system. 
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Figure 9.8 : Results for viral particles (in red) and interferon molecules (in blue) , for steps 
3 to 5, at 5 hours. 
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Deterministic Stochastic 
Step 3 
Step 4 
Step 5 
Figure 9.9 : Results for cells, for steps 3 to 5, at 5 hours. 
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9.4.4 Infected cell death 
Death of an infected cell is modeled with the first order reaction: 
(9.10) 
Results at 5 hours for viral particles are displayed in the middle portion of Fig-
ure 9.8. Cells (uninfected in gray, infected in red, and dead in black), are displayed 
in the middle portion of Figure 9.9. 
Infection, in this case, seems to evolve with the same speed similar to the observed 
on the step 3 model. As cells die, they stop producing viral particles, which is observed 
in the convex shape the viral particle surface assumes. As in the previous model, the 
deterministic evolution is faster than the stochastic evolution, and the diamond-shape 
artifact is maintained. 
9.4.5 Interferon production and cell resistance 
Infected cell produce interferon (Ifn), which binds to uninfected cells making them 
resistant (RC). This last reaction is of second order. Interferon binds to cells, no 
matter which the cell status is. However, to avoid including second order reactions, 
we follow the same approach as done with viral particles, and assume that interferon 
degrades. 
This step adds the following reactions: 
IC1 --+ IC1 + Ifn 
Ifn + UC --+ RC 
RC --+ UC 
Ifn --+ ® 
Ifn --+ .6.xy 
(9.11) 
(9.12) 
(9.13) 
(9.14) 
(9.15) 
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Results at 5 hours are depicted in the bottom portions of Figures 9.8 and 9.9. 
Interferon particles and resistant cells are displayed in blue. The deterministic system 
continues to evolve faster than the stochastic system and it does not capture the 
structure that the stochastic system exhibits. 
9.5 Full model , with infection stages 
Deterministic Stochastic 
Vir/Ifn 
Cells 
100 
50 
100 
Figure 9.10 : Results for full model at 100 hours. 
The final incremental step adds five infection stages, which were already described. 
The set of coupled chemical reactions with the corresponding explanation, are pre-
Det 
Stoch 
142 
sented in Section 9.9. The diagrammatic representation is depicted in Figure 9.4. 
Results at 100 hours for the full model are presented in Figure 9.10. In contrast 
with models without infection age , this model evolves orders of magnitude slower. 
As in previous cases since infection was introduced, the deterministic system evolves 
faster than the stochastic counterpart, and the stochastic system exhibits structure 
that is not captured by the deterministic system. The diamond-shape artifact is still 
present , but the effect is less noticeable in the external front of the resistant cells than 
in the internal front of the infected and dead cells. 
9 .6 Analy sis of diamond-shape artifact and remedial m ea-
sures 
As the diamond-shape artifact first appears in the step 3 model, we analyze this 
simpler case as it only has three reactions (viral production, viral particle degradation, 
and cell infection) and one diffusion element (viral particles) . 
Oh 0.04 h 0.12 h 0.18 h 0.24 h 
Figure 9 .11 : Close-up view of early times of viral infection, corresponding to the model 
with viral infection added. Squares represent compartments, each populated by 64 cells 
(infected cells in red, uninfected cells in gray). The complete system is partitioned in 
140x140 compartments. 
Figure 9.11 shows close-ups of evolution of uninfected (gray) and infected cells 
(red) at early time points (0 , 0.04, 0.12 , 0.18 , and 0.24 hours). The deterministic 
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run is shown at the top and the stochastic run at the bottom. There are 64 cells per 
compartment, and cells are displayed in 8 x 8 squares. 
The left column shows the initial state: 6 infected cell (in red) and 58 uninfected 
cells (in gray) on one of the four central compartments. The rest are uninfected cells. 
The second column (0.04 hours) shows that most cells in the central compartment 
are infected, but only one cell, and only for the stochastic run, is infected in a different 
compartment. 
The third column (0.12 hours) shows that all the cells of the central compartment 
are infected, as well as about one third of the cells in each of the compartments that 
share a side with the central compartment. Only one cell is infected, again for the 
stochastic run, on one of the compartments that only share a vertex with the central 
compartment. 
The fourth column (0.18 hours) shows a cross shape where all the side compart-
ments are almost full of infected cells. 
The last column (0.24 hours) shows a square of 3 x 3 compartments almost full of 
infected cells, and new arms of infection evolving in a preferred vertical and horizontal 
directions, that will evolve in a diamond shape. In this last column it is evident that 
the deterministic system starts evolving faster than the stochastic one, while in the 
previous two columns, at least for this stochastic run, the impression is the contrary. 
This artifact is related to the fact that diffusion rate is too small when compared 
with the size of the compartment and the infection rate. As well mixed assumptions 
inside compartment are made, once infection starts in a given compartment, the new 
generated viral particles are more likely to infect local cells than to diffuse to neighbor 
compartments. Local infected cells produce more viral particles. As the number of 
viral particles increase, so does the propensity associated with the diffusion term, 
and viral particles eventually reach neighbor compartments and a new local infection 
starts. It is then the anisotropy of the square grid system that favors a vertical and 
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horizontal expansion what produces the diamond shape observed. 
Deterministic Stochastic 
Vir/Ifn 
Cells 
100 
50 
80 
Figure 9.12 : Full model with viral diffusion rate increased by an order of magnitude. 
If we increase the rate of diffusion by a corresponding factor, we observe an in-
fection evolving with a radially symmetric shape. We obtained almost perfect circles 
for the deterministic case by increasing the diffusion rate by two orders of magnitude. 
Results for the complete model where a perfectly radially symmetric deterministic 
infection expansion is obtained by increasing the diffusion rate by one order of mag-
nitude are shown in Figure 9.12. The lower needed increase of diffusion for the full 
model seems to be related to the fact that infection progresses orders of magnitude 
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slower than in the step 3 model, and this allows viral particles to diffuse faster than 
the infection front, conveying the expected radially symmetric diffusive shape, instead 
of the infective diamond shape. The deterministic system still evolves faster than the 
stochastic system, but there is less discrepancy observed. 
140 X 140 280 X 280 560 X 560 1120 X 1120 
Det 
Stoch 
Figure 9.13 : Comparison of deterministic and stochastic infection-only model for different 
compartment sizes, step 3 model. All cases display infected cells (red) at 1.8 hours. The 
same scale applies to all figures. Legends on top denotes number of compartments. From 
left to right, each compartment has: 64, 16, 4, and 1 cells respectively. Each case has its 
compartment area equal to one quarter the compartment area of the case on its left. 
The effect of reducing the compartment area by increasing the number of com-
partments is shown in Figure 9.13. As the number of compartment increases (or the 
area of each compartment decreases): 
• the diamond-shape artifact in both the deterministic and the stochastic systems 
becomes less noticeable. 
• the infection spread speeds in both the deterministic and the stochastic systems 
slow down. 
Det 
Stoch 
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• the comparative infection spread of the deterministic and the stochastic systems 
does not change: the deterministic system evolves faster than its corresponding 
stochastic system. 
Figure 9.14 shows the same corrective effect happening in the full model. In this 
case the diamond-shape artifact completely disappears for a partition of the whole 
system in 560 x 560 compartments. It can also be observed here than the infection 
spread speed also decreases as the number of compartments increase. 
140 X 140 280 X 280 560 X 560 
Figure 9.14 : Results for the full model for different grid densities. 
The diamond-shape artifact seems to play a diagnostic role, as it disappears when 
a balanced selection of compartment size and of diffusion, infection, viral production 
and degradation rate constants are chosen. The use of a different compartment shape, 
such as triangular or hexagonal, would certainly reduce the diamond-shape artifact. 
However , the associated problem of infection spread speed may not be detected in 
those cases. 
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Figure 9.15 : Deterministic and stochastic comparison for the non-spatial full model. 
Vertical axes: number of units. Horizontal axes: time in hours. Deterministic evolution is 
depicted in blue. Stochastic mean± 3 standard errors (99.73% confidence band) is depicted 
in red. 
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9. 7 Analysis of difference in evolution speed between deter-
ministic and stochastic simulations: non spatial model 
The model without diffusion is shown in Figure 9.15. Blue lines depict deterministic 
runs, red lines depict averages of 1000 runs, and dotted red lines depict standard 
deviations of 1000 runs. In line with the reaction-diffusive systems, deterministic 
evolutions over-estimate or under-estimate the mean of the stochastic process. 
Deterministic Stochastic (\ ~\ 
I I I 
Vir/Ifn 
I I 
I I 
Cells 
Figure 9 .16 : Full model with infection rate= 1/(250 mol h), at 250 hours , for the system 
partitioned in 560 x 560 compartments. 
As the non-spatial system shows discrepancy between the deterministic and stochas-
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tic formulations, due to the fact that some reactions are of second order, the associated 
diffusive models will also exhibit the same behavior. 
9.8 Effect of decreasing infection rate 
Figure 9.16 shows the effect of decreasing infection rate to 1/(250 mol h). The de-
terministic system completely fails to capture the evolution of the stochastic system: 
while infection in the stochastic system performs a sort of random walk around the 
central region for extended simulation times (Figure 9.17), that includes splitting and 
rejoining of small infection fronts, the deterministic evolves radially, as in previous 
cases. 
9.9 Set of chemical reactions of the full model 
All the reactions considered follow mass action kinetic laws. For further clarification, 
see 2.3.1 on page 11. 
9.9.0.1 First stage of infection: viral particle gets internalized by unin-
fected cell 
Viral particles interact with uninfected cells in a competitive fashion with interferon 
molecules (see Equation 9.28). 
UC_.infection..r / vir..avg Vir+ UC -------=----==-----+ IC1 (9.16) 
The viral particle is consumed in the process. We do not consider ulterior inter-
actions between viral particles and cells at other stages other than uninfected. Viral 
particles are eliminated from the system according to Equation 9.31. 
In this first stage of infection, the capsid of the viral particle is intact, and stays 
in a latent state. 
150 
240 h 400 h 560 h 
720 h 880 h 1040 h 
1200 h 1360 h 1520 h 
1680 h 1840 h 2000 h 
Figure 9.17 : Stochastic evolution of full model with infection rate = 1/(250 mol h) 
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9.9.0.2 Second stage of infection: viral genome release 
Viral particle capsid opens releasing the viral genome, which uses the cell's machinery 
to produce viral double stranded mRNA intermediates and proteins. 
I C_deterioration...r IC1------------~IC2 (9.17) 
The intermediates are sensed by toll-like receptors and RIG-I proteins, starting an 
immune response that in the next two stages will produce interferon (see Equation 9.19 
and 9.23). 
9.9.0.3 Third stage of infection: cell releases interferon 
The interferon gene is activated: 
IC_deterioration...r IC2------------4IC3 (9.18) 
and the cell starts to produce interferon molecules, releasing them into the medium: 
IC_ifn_production...r IC3------------~IC3 +Ifu (9.19) 
There is a chance that the cell will undergo apoptosis: 
IC_death...r / 4 IC3 ____ _;___~ DC (9.20) 
The cell continues to produce viral proteins and genomes. 
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Parameter Value 
U C Jnfection_r 1/(2.5 mol h) 
u c_resistance_r 1/(50 mol h) 
RC _recover _r 1/(24 h) 
I C _deterioration_r 1/(3 h) 
I C_ifn_prod uction_r 1/(10 s) 
I C _vir _prod uction_r 1/(30 s) 
IC_death_r 1/(1 h) 
ifn_degr_r 1/(1.5 h) 
vir_degr_r 1/(1 h) 
DJfn_lit 5. 75 X 10-5 mm2 js 
D_virJit 2.326 X 10-6 mm2 js 
Table 9.1 : Parameters used in reference system. The values are suitable to be directly 
used in a grid of 100 x 100 compartments. For other grid densities, the top two constant 
rates need to be rescaled accordingly. 
9.9.0.4 Fourth stage of infection: cell releases viral particles and inter-
feron 
Viral proteins and genomes have undergone the processes needed to assemble: 
IC_deterioration..r IC3 --------+ IC4 (9.21) 
and the cell starts releasing viral particles into the medium at half rate: 
IC_vir_production..r I 2 
IC4 --------"""* IC4 +Vir (9.22) 
Viral proteins interfere with interferon production, that progresses at half rate: 
IC_jfn_production..r I 2 
IC4 -------'----+ IC4 + lfn (9.23) 
There is a higher chance that the cell will undergo apoptosis: 
IC_death..r I 2 IC4 ---------t DC (9.24) 
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The cell continues to produce viral proteins and genome. 
9.9.0.5 Fifth stage of infection: cell releases viral particles and finally 
dies 
Viral proteins shut down interferon production: 
I C_deterioration_r IC4 --------+ ICs (9.25) 
Cell releases viral particles into the medium at full rate: 
IC_ vir _production_r ICs ----=-------+ ICs +Vir (9.26) 
Infected cell finally dies: 
IC_death.-r ICs -----+DC (9.27) 
9.9.0.6 Cell resistance 
Interferon molecules interact with uninfected cells in a competitive fashion with viral 
particles (see Equation 9.16). 
Ifn + U C __ u_c_.-r_es_is_ta_n_ce_.-r_/:__ifn_...a_:v--=g---t RC (9.28) 
The interferon molecule is consumed in the process. We do not consider ulte-
rior interactions between interferon molecules and cells at other states other than 
uninfected. Interferon molecules are eliminated from the system according to Equa-
tion 9.30. 
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Cell resistance is a temporary property that the cell looses at certain point: 
RC_recover _r RC ------+ UC 
9.9.0. 7 Interferon molecule degradation 
Interferon molecules degrade: 
ifn_degr_r Ifn __ ....,:_---+ ® 
9.9.0.8 Viral particle degradation 
Viral particles degrade: 
vir_degr_r Vir -------7 0 
(9.29) 
(9.30) 
(9.31) 
Chapter 10 
Discussion 
We are interested in the study of molecular cell biology systems, both in the cases 
where spatial effects can be neglected, and in the cases where it cannot. 
The first part of this work concerns biological systems in which it is normal to 
assume that reactions happen in a container with constant volume where all reactants 
are perfectly mixed and in thermal equilibrium. In this formulation, each kind of 
reaction has a propensity function, or hazard h, associated. Propensity has a specific 
form that depends on the type of reaction considered, and is usually a function of the 
number of reacting species present at a given time. 
Under such assumptions, the probability that a particular reaction will take place 
in a time interval [t, t + ~t], is equal to h~t + o(~t), and the time to such a reac-
tion, in the absence of other reactions taking. place, is exponentially distributed with 
parameter h. This stochastic process is a time-continuous Markov chain. 
It is customary, under the additional assumption that the number of molecules 
of each reacting species is sufficiently high, to model such a system using a set of 
ordinary differential equations (ODEs). Given initial conditions, this system can be 
solved, in most cases only numerically, and its solutions are interpreted as the time 
evolutions of the expected values of the species of the associated stochastic process. 
However, eukaryotic cells have at most two gene copies, with corresponding mRNA 
levels in the order of 102 - 103 molecules. In prokaryotic cells, mRNA molecules are 
present in low numbers and most of them are unstable [67]. As a consequence, the 
assumption of high number of reacting molecules of each type seldom applies in the 
biological systems we study. 
In the introductory Chapter 2 we discussed conditions under which the solution 
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of a system of ordinary differential equations coincides with the expected value of the 
original stochastic kinetic model. The conclusion is that both approaches coincide 
if all reactions have either zero or first order mass action kinetics, regardless of the 
number of molecules involved. 
However, in most but the simplest biological networks, it is common to find re-
actions that are of second order mass action kinetics. Examples include: binding of 
transcription factors and repressors to genes, dimerization of proteins, formation of 
complexes, catalytic action, phosphorylation, signal molecules binding to receptors, 
or viral particles infecting a cell. There also are cases in which nonlinear functions, 
such as Michaelis-Maenten function, are used. Reactions of order higher than two are 
seldom used and can be, perhaps more correctly, modeled as a succession of second 
order reactions. 
In Chapter 4 we presented an original software tool, named bioPN (biological 
Petri Nets), that allows, given a set of coupled chemical reactions represented as 
Petri nets, and initial conditions, to numerically solve the resulting system of ODEs, 
and to simulate, using a range of methods, stochastic trajectories. 
After validating the algorithms against theoretical results, we used the tool to 
compare deterministic and stochastic results in simple systems. We started from an 
unregulated network composed of a gene, which transcribes mRNA, which translates 
a protein. As all the reactions involved were first order mass action kinetics, we 
verified the agreement of the results of both methods. 
However, when inhibition of the gene by its own protein was considered, the agree-
ment between both methods ended. Varying the mRNA translation and degradation 
rates but keeping their ratio constant, we observed discrepancy in values by a factor of 
four in the time evolution of the protein. The deterministic solution under-estimates 
the expected value of the stochastic process. After further modification of the model 
by introducing dimerization of the protein and replacing the repressing protein by its 
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dimer, we observed, after tuning mRNA rates as described above, three different be-
haviors in the time solution of the dimer: 1) the deterministic solution over-estimating 
the stochastic mean, 2) agreement between both, and 3) the deterministic solution 
under-estimating the stochastic mean. 
We conclude Chapter 4 by showing results, already published [58], of the effect of 
hi-stability that the deterministic solution failed to capture. 
In Chapter 5 we presented current work on a model of cellular sensing of dou-
ble stranded RNA, a joint effort with researchers at the University of Texas Medical 
Branch and Institute of Fundamental Technological Research, Polish Academy of Sci-
ences, Warsaw, Poland. As this work involves a deterministic model, we compared 
the results with its stochastic counterpart. As expected, in the cases of regulated 
genes, discrepancies between the two approaches are observed, both in levels and 
in dynamics of different constituents. However, during the first hours after dsRNA 
electroporation, both systems react similarly. This effect may be related to the in-
stantaneous introduction of 105 dsRNA molecules, leading to a strong response that 
overcomes any other effects. 
The second part of the thesis is devoted to systems in which spatial effects cannot 
be neglected. We review the relevant mathematical background for deterministic and 
stochastic reaction-diffusion systems in Chapter 6. In Chapter 7 we presented sbioPN, 
an extension of bioPN to spatial systems. In compartment-based approach adopted 
in sbioPN, diffusion is modeled as a series of first order reactions. Therefore, in a 
purely diffusive model, or in a reaction-diffusion model where all reactions are zero or 
first order mass kinetics, the deterministic evolution should agree with the averages 
of stochastic runs .. This has been verified. 
In Chapter 8 we presented the stochastic extension of a one-dimensional reaction-
diffusion model of early carcinogenesis that exhibits Turing instabilities in its deter-
ministic formulation. We compared two hundred and fifty cases of each system by 
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modifying three parameters: 1) the number of peaks of the cosine perturbation of the 
spatially homogeneous steady state, which constituted the initial conditions, 2) the 
diffusion coefficient, and 3) the grid density. 
These parameters only affect the spatial system. The model without diffusion 
exhibits a four fold discrepancy in the time evolution of pre-cancerous cells and bound 
growth factor. The reaction-diffusion system, as a consequence, shows a similar effect: 
no stochastic system could keep, when averaged over a large number of realizations, 
the initial levels of the spikes generated by the corresponding deterministic system; 
all the stochastic cases exhibited a sudden drop in spike levels. 
Diffusion and grid density play a role in the ability of the stochastic system to 
maintain, when averaged over a large number of realizations, the initial structure of 
spikes after the drop. Higher diffusion coefficients favor the preservation of the initial 
spikes. Moreover, for 'Y = 1 and 'Y = 10, the stochastic system maintains spike levels 
indefinitely. Regarding grid density, when using a diffusion coefficient too low to 
maintain spike levels ("' = 100), coarser grids make the decay more gradual whereas 
denser grids make it more steep. 
Finally, in Chapter 9 we studied a two-dimensional reaction-diffusion model of 
viral infection and interferon production, and compared the deterministic runs to 
single realizations of the stochastic version. The results are interesting. On one hand, 
the deterministic model frequently evolves faster than the stochastic model. On the 
other hand, rich dynamics of the stochastic system are not always captured by the 
deterministic evolution. Systems without diffusion show analogous discrepancies. 
Based on these examples, we conclude that deterministic and stochastic approaches 
seldom agree, at least in cases that explore dynamics in regulated biological systems, 
unless unrealistically high numbers of molecules are used. The disagreement between 
both approaches is manifested in both reaction-only and reaction-diffusion systems. 
Appendix A 
Appendix for Part 1 
A.l Chapter 2 
Petri net graphical representations for eactions 2 to 8 of the model defined in Chapter 2 
are presented in Figures A.l to A.7. 
G D. h2 c· a+ 1mer~ 1 
Pre[2,]=(0 1 0 0 1) 
Post[2,) = (1 0 0 0 0) 
Figure A.l : Reaction 2: Gene inactivation. 
Ga~Ga+mRNA 
Pre(3 , ] = (0 1 0 0 0) 
Post[3 , ] = (o 1 1 0 0) 
Figure A.2 : Reaction 3: Transcription. 
mRNA~mRNA +Protein 
Pre[4, ] = ( 0 0 1 0 0) 
Post[4, ] = (o 0 1 1 0) 
Figure A.3 : Reaction 4: Translation. 
Pre(5 , ] = (0 0 1 0 0) 
Post[5 , ] = (o 0 0 0 0) 
Figure A.4 : Reaction 5: mRNA Degradation. 
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P . h6 tO.. rote1n -=-t '<Y 
Pre [ 6, J = ( 0 0 0 1 0) 
Post[6 , ] = (0 0 0 0 0) 
Figure A.5 : Reaction 6: Protein Degradation. 
2 P . h7 n· rote1n ~ 1mer 
Pre[7, ] = (0 0 0 2 0) 
Post[7, J = ( 0 0 0 0 1) 
Figure A.6 : Reaction 7: Protein Dimerization. 
Dimer~ 2 Protein 
Pre[8, J = ( 0 0 0 0 1) 
Post[8 , J = (0 0 0 2 0) 
Figure A. 7 : Reaction 8: Dimer Dissociation. 
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A.l.l Derivation of Equation 2.31 
This derivation can be found on Wilkinson [69] (page 159). 
d d d 
dt E [Xt] = dt L x p(x, t) = L x dtp(x, t) 
xEM xEM 
~ ~ { x t, [ hi(x- S(;), e;) p(x- sCi), t) - h;(x, c;) p(x, t) l} 
= t{L [xhi(x-S(i),c;)p(x-S(i),t)]- I: [xhi(x,c;)p(x,t)J} 
t=l xEM xEM 
~ t. {~ [ (x +sCi)) hi(x, c;) p(x, t) ]-•~ [ x h;(x, c;) p(x, t) l } 
v 
= ~ { E [(Xt + S(i)) hi(Xt,ci)]- E [xt hi(Xt,Ci)]} 
t=l 
v 
= L:E [s(i) hi(xt,c;)] 
i=l 
v 
= 2:: S(i) E [ hi(Xt, c;)] 
i=l 
A. 2 Chapter 4 
A.2.1 Hybrid simulations. Stochastic: reactions that modify gene and 
mRN A. Deterministic: reactions that modify protein 
The variance of mRNA is the same as the one on the previous subsection. The 
variance of Protein is given by [53]: 
[ ·] 1+c+b+r 2 [ ·] Var Protem =rb c(1 + r)(1 + c + b)(r + c +b) E Protem + 
r E 2 [Protein] (A.1) 
1+rE[mRNA] 
This case was used to validate the function HaseltineRawlings. Results are shown 
in Figure A.8. 
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Figure A.8 : Hybrid: Gene activation/inactivation and mRNA reactions stochastic, pro-
tein reactions deterministic. Horizontal axis: time units. Vertical axis: number of units. 
Green lines: Theoretical results. Red lines: Simulations using bioPN (1000 runs). 
A.2.2 Hybrid simulations. Stochastic: reactions that modify gene. De-
terministic: reactions that modify protein and mRN A 
The variance of mRNA and Protein is given by [53]: 
Var [mRNA] 
Var [Protein J 
b E 2 [mRNA] 
c(1 + c +b) 
b 1 + c + b + r E 2 [P . ] r rote1n 
c( 1 + r) ( 1 + c + b) ( r + c + b) 
(A.2) 
(A.3) 
This case was also used to validate the function HaseltineRawlings. Results are 
shown in Figure A.9. 
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Figure A.9 Hybrid: Gene activation/inactivation stochastic, mRNA and protein reac-
tions deterministic. Horizontal axis: time units. Vertical axis: number of units. Green 
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B.l Availability 
Updated versions of the manual, as well as the code needed to run the examples, and 
the library (currently version 1.0.0), can be found on http:/ jwww.stat.rice.edu/I'Vmathbio/bioPN. 
B.2 Functions in the Library 
The library has 4 kind of functions: 
• Exact stochastic simulation ( 4 functions) 
- GillespieOptimDirect: "in house" optimized version of the Gillespie SSA al-
gorithm. 
- GillespieDirectGB: optimized version of the Gillespie SSA algorithm accord-
ing to Gibson and Bruck [18] 
- GibsonBruck: Next reaction method by Gibson and Bruck [18]. 
- GillespieDirectCR: constant-time composition/rejection algorithm [64]. 
• Pure deterministic integration ( 1 function) 
- RungeKuttaDormandPrince45: Runge-Kutta Dormand and Prince algorithm 
• A hybrid of the above (1 function) 
- HaseltineRawlings: Haseltine and Rawlings method with deterministic 
integration of fast transitions [27] 
• Dynamic re-partitioning algorithm (1 function) 
- PartitionedLeaping: Partitioned leaping algorithm (PLA) [24]. Transi-
tions are dynamically re-partitioned between 4 categories (very slow, slow, 
medium, and fast) and simulated accordingly (SSA, T-leaping, CLE, de-
terministic) . 
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B.2.1 Usage 
GillespieOptimDirect (model, timep, delta = 1, runs = 1) 
2 
3 GillespieDirectGB (model, timep, delta = 1, runs = 1) 
4 
5 GibsonBruck(model, timep, delta = 1, runs = 1) 
6 
1 GillespieDirectCR (model, timep, delta = 1, runs 1) 
8 
9 
10 
11 
12 
13 
14 
15 
16 
RungeK uttaDormandPrince45 (model, timep, delta 1' ect 1e-09) 
HaseltineRawlings (model, timep, delta 1' runs 1' ect 1e-09) 
PartitionedLeaping (model, timep, delta 1' runs 1) 
B.2.2 Arguments 
• model: list containing the following named elements: 
- pre: pre matrix, with as many rows as transitions (reactions), and columns 
as places (reactants). It has the stoichiometries of the left sides of the 
reactions. 
- post: post matrix, with as many rows as transitions, and columns as places 
(products). It has the stoichiometries of the right sides of the reactions. 
- h: list of propensity constants or functions returning the propensity (with 
as many elements as transitions). 
slow: vector of zeros for slow transitions and ones for fast transitions. Only 
needed for HaseltineRawlings. Ignored otherwise. 
M: Initial marking (state) of the system. 
place: vector with names of the places. 
transition: vector with names of the transitions. 
• timep: It can be either a numeric, indicating for how long (in the same time 
units as the propensity constants) the process will run, or a functions (R or C), 
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in which case can be used to change the protocol at time intervals. See below. 
• delta: Interval time at which the state will be saved. 
• runs: How many runs will be performed. 
• ect: Precision for the fast reactions. 
B.2.3 Returned Value 
The functions return a list with the following elements: 
• place: vector with the names of the places if supplied. If not, the function 
creates names as follows: Pl, P2, ... 
• transition: vector with the names of the transitions if supplied. If not, the 
function creates names as follows: Tl, T2, ... 
• dt: vector containing the discretized times at which the state is saved (according 
to delta) 
• run: list with as many elements as runs. We will describe the first element, 
run[[l]], as the rest have exactly the same structure. It is also a list, with the 
following elements: 
- run [ [1] J $M: list with as many elements as places, each of them containing 
the state of the system sampled according to delta. 
- run [ [1] J $transitions: vector with as many elements as transitions, with 
the total of time each slow reaction fired. 
- run [ [1] J $tot. transitions: numeric with the summ of run [ [1]] $transitions. 
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B.3 Example: Stochasticity in Gene Regulation 
The first example is a simple model that has steady state theoretical solutions [53]. 
B.3.1 Reactions 
I4A 
A~I 
A~A+mRNA 
mRN A ~ mRN A+ protein 
1 
mRNA-+ ® 
protein .2:t ® 
This model consists in 4 places (reactants, products) and 6 transitions (reactions). 
They are illustrated in the following table 
Places Transitions 
1. inactive gene I 1. gene activation 
2. active gene A 2. gene inactivation 
3. mRNA 3. transcription 
4. protein 4. mRN A degradation 
5. translation 
6. protein degradation 
B.3.2 Model Definition: First Approach 
B.3.2.1 Pre Matrix 
The first needed structure is the 6 x 4 matrix pre, which accounts for the stoichiome-
tries of the left sides of the reactions. 
1 pre<- matrix(c(1,0,0,0, 
2 0,1,0,0, 
3 0,1,0,0, 
4 0,0,1,0, 
5 0,0,1,0, 
6 0,0,0,1)' 
1 ncol=4, byrow=T) 
Transitions (reactions) are associated with rows, while places (reactants, products) 
are associated with columns. 
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B.3.2.2 Post Matrix 
Define post, to account for the stoichiometries of the right side of the reactions. 
1 post <- matrix( c (0, 1 ,0 ,0, 
2 1,0,0,0, 
3 0,1,1,0, 
4 0,0,0,0, 
5 0,0,1,1, 
6 0,0,0,0), 
1 ncol=4, byrow=T) 
B.3.2.3 Propensities 
Define the vector of propensities or hazards 
1 I h <- list ( c=3, b=2, H=10, 1, K=6, r =0.25) 
B.3.2.4 Initial Conditions 
1 IM<- c(1,0,0,0) 
B.3.2.5 Fast and Slow Transitions 
Only necessary for HaseltineRawlings. Ignored by the other functions. 
1 I slow<- c(1 ,1 ,0 ,0 ,0 ,0) 
This case will treat gene inactivation/activation as slow, while the rest as fast. 
B.3.2.6 Model Definition 
1 model <- 1 is t ( pre=pre , post=post , h=h, M=l\t:l, slow=slow) 
B.3.2. 7 Load the Library 
Load the library (can be done at any point before the call to the functions) 
1 I library (bioPN) 
B.3.2.8 Calling the Functions 
1 timep <- 200 
2 delta <- 1 
3 
4 ## Completely deterministic run 
5 Sim <- RungeKuttaDormandPrince45(model, timep, delta) 
6 
7 runs <- 10000 
8 ## Completely stochastic run 
9 set.seed(19761111) ##Set a seed 
10 Sim <- GillespieOptimDirect (model, timep, delta , runs) 
11 #Sim <- GibsonBruck (model, timep, delta, runs) 
12 #Sim <- GillespieDirectGB (model, timep, delta, runs) 
13 #Sim <- GillespieDirectCR (model, timep, delta, runs) 
14 
15 ## Hybrid run 
16 set.seed(19761111) ##Set a seed 
11 Sim <- HaseltineRawlings(model, timep, delta, runs) 
B.3.3 Model Definition: Second Approach 
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This approach is closer to the way reactions are defined. It uses the functions in the 
file "helper .R" provided in the section devoted to R code. Other approaches may be 
implemented in the future. The model has to be defined in the main body (not inside 
a function), and its use has the side effect of generating three name variables: model, 
L (for left side of the reaction), and R (for right side of the reaction), which are used 
as part of the definition. It will also create variable names for the defined places. 
B.3.3.1 Names of Places and engine start 
1 source ("helper. R") 
2 
3 #W0',f,f1,n' Constants definition (convenient but not required) 
4 H <- 10 
5 K <- 6 
6 r <- 0.25 
7 c <- 3 
8 b <- 2 
9 ,f~/';/',J',f/1// 
10 
11 
12 
place <- c( "Gi" "Ga" "mRNA" "Protein") 
' ' ' 
13 ini t (place) ## This will create the structures model, L, and R 
14 ## and variables for each place. 
B.3.3.2 Reaction (transition) definition 
1 ## Gi -> Ga 
2 h <- c 
3 L[Gi] <- 1 
4 R[Ga] <- 1 
5 at r () ## Add this reaction 
6 
1 ## Ga -> Gi 
8 h <- b 
9 L[Ga] <- 1 
1o R[Gi] <- 1 
n atr () 
12 
13 ## Ga -> Ga + mRNA 
14 h <- H 
15 L[Ga] <- 1 
16 R[Ga] <- 1; R[mRNA] <- 1 
11 atr () 
18 
19 ## mRNA -> mRNA + Protein 
20 h <- K 
21 L [mRNA] <- 1 
22 R[mRNA] <- 1; R[ Protein] <- 1 
23 atr () 
24 
25 ## mRNA -> 0 
26 h <- 1 
27 L[mRNA] <- 1 
28 atr () 
29 
30 ## Protein -> 0 
31 h <- r 
32 L [Protein] <- 1 
33 atr () 
B.3.3.3 Initial Conditions 
1 model$M <- rep ( 0 , model$ p 1 aces ) 
2 model$M[ Gi] <- 1 
B.3.3.4 Calling the Functions 
1 ,~W##I/#1/#1/tfi?'tfifNitf/l,ftfl#/1##/ll/1#1/# 
2 ## Completely Deterministic ## 
3 ll##/;'#1/#ifl/l#,fif/hf/1/1/l§,f,fl##,f,f,f,f'//# 
4 Sim <- RungeKuttaDormandPrince45 (model, timep, delta , ect) 
5 
6 ,'/if,f#,f,f,f,f,f'l/#tf/11/,f;?'/;';9'/;'##,fll/##;9' 
7 ## Completely Stochastic ## 
s R~f,f/;'/l#A'#l/#,f#,~'l',~'#,f,f',f',f',f',f'/;'A'#A',f 
9 set.seed(19761111) 
10 Sim <- GillespieOptimDirect (model, timep, delta, runs) 
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11 Sim <- GibsonBruck(model, timep, delta, runs) 
12 Sim <- GillespieDirectGB (model, timep, delta, runs) 
13 Sim <- GillespieDirectCR(model, timep, delta, runs) 
14 
176 
1s ##ifR'###A'##l',f,~',f,~',fi11##tf#,f,fA'#/;7f,f,f/I#/I###R',~',f;f###llA',fA'A'A'#A'##Il,f###,f#R'##Il//A'##A'## 
16 ## Hybrid: mRNA and protein fast, gene activation/ inactivation slow ## 
11 ##,WI/hf#/l/l/lif'#ll,f'if',f'if'###'A'lli/INII/8'8'l8'##8'1/8'8'####/l,f',f'#,~WA'I/,W/#/I#/II/,f/l#l#l/l8'/18'l## 
18 slow<- rep(O, transitions) 
19 slow [gene_activation] <- 1 
20 slow [gene_inactivation] <- 1 
21 model$slow <- slow 
22 
23 set. seed (19761111) 
24 Sim <- HaseltineRawlings (model, timep, delta, runs, ect) 
B.3.3.5 Example of Value Returned by the Functions 
1 > str (Sim) 
2 $ place : chr [ 1: 4] "I" "A" "mRNA" "protein" 
3 $ transition: chr [ 1: 6] "gene_activation" "gene_inactivation" 
transcription" "mRNA_degradation" 
4 $ dt : num [ 1: 201] 0 1 2 3 4 5 6 7 8 9 ... 
5 $ run :List of 10000 
6 .. $ :List of 3 
7 .. $ M :List of 4 
8 .. $ num [1: 20 1] 1 0 1 0 0 0 0 0 0 0 
9 .. .. $ num [1: 20 1] 0 1 0 1 1 1 1 1 1 1 
10 .. .. $ num [1: 20 1] 0 2 2 2 7 6 10 10 6 9 . .. 
11 .. .. $ num [1: 20 1] 0 2 18 16 48 82 105 142 147 168 . .. 
12 .. $ transitions int [ 1: 6] 245 245 1201 1192 6696 6540 
13 .. $ tot. transitions: int 16119 
14 .. $ :List of 3 
15 .. $ M :List of 4 
16 .. $ num [1: 20 1] 1 0 0 0 0 1 1 0 1 0 ... 
17 .. .. $ num [1: 20 1] 0 1 1 1 1 0 0 1 0 1 . .. 
18 .. .. $ num [1: 20 1] 0 1 2 5 6 5 4 8 10 10 . .. 
19 .. .. $ num [1: 20 1] 0 7 18 39 47 81 88 92 103 128 . .. 
20 .. $ transitions int [ 1: 6] 243 242 1217 1205 7290 7156 
21 .. $ tot. transitions: int 17353 
22 ••••••••••• 0 •••• 0 ••• 0. rest of the 10,000 runs follows ... 
The above result is from a completely stochastic run. 
B.3.4 How to assign a function to a propensity 
II 
All the reactions in this example are mass-action ones, so the function calculates the 
corresponding propensity on the fly. However, there are cases where specific pro pen-
sities need to be provided. Using as an example the first reaction (gene activation) 
the corresponding propensity is c x I. 
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B.3.4.1 R function 
1 I h <- function() { C*Y [I]} 
NOTE: Declaring a function in R will result in a sensible performance degradation. 
B.3.4.2 C function 
h <- load. cfn (place , paste ( 11 
2 #define c 3. 
3 double cfn (double time, double *Y) { 
4 return C*Y [Gi] ; 
5 } II)) 
B.3.5 How to manage time with a function 
If the simulation needs to be separated into different sections (for example the first 50 
seconds with one behaviour, and the second 150 with another), instead of assigning 
T a number, it can be assigned a function (R or C). 
B.3.5.1 R function 
1 timep <- function() { 
2 StartTime = round(StartTime ,0) 
3 EndTime = 200 
4 if (StartTime = 0) { 
5 y[IJ = 5 
6 EndTime = 50 
7 } else if (Start Time 50) { 
8 y[IJ = 10 
9 } 
10 list (EndTime,y) 
11 } 
L---------------------------------------------------------------------~ 
B.3.5.2 C function 
h <- load. cfn (place , paste ( 11 
2 #include <Rmath.h> 
3 
4 double cfn(double dStartTime, double *Y) { 
s dStartTime = fround(dStartTime,O); 
6 if (dStartTime == 0) { 
7 y [I] = 5; 
8 return 50; 
9 } else if (dStartTime 50) { 
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10 I y [I] 11 } 
:: . ) ";;turn 
= 10; 
200; 
B.3.6 Removing temporary C files 
After running the simulations, use the following to unload c objects created and delete 
the temporary files generated. 
1 I unload. cfns () 
Appendix C 
Additional material for Chapter 5 
Figures C.l to C.4 are interpreted as follows: each figure represents the knock-
down of one of the target genes and the time series of its effect is shown. Blue lines are 
simulations of model without knock-down. Black dots are the observed experimental 
fold increase/decrease relative to blue lines. Dotted red lines are simulation of knock-
down experiment. The closer red lines are to black dots, the better the fit. 
C.l Methodology used for mRNA experiments 
On experiments 1 and 3, the harvested RNA was reversely transcribed into corre-
sponding eDNA and run for quantitative real-time PCR (Q-RT-PCR) to examine the 
target gene expression level. Q-RT-PCR produces a curve showing the changes in 
the amount of product with each cycle. The cycle threshold (Ct) is used to quantify 
the amount of transcript, that is, where the amount of product is above background 
and in the linear range of PCR amplification. Relative changes in mRNA were cal-
culated, normalizing to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal 
in each well using the delta-delta-Ct (~~Ct) algorithm [42]: first, the amount of 
target transcript is normalized to the amount of internal GAPDH control in each 
plate (~Ct); second, the difference between the dsRNA "infection" (timel) and "un-
infected" (timeO), is calculated by: 
Fold change = 2-(f>.Cttimel -f>.Cttimeo) (C.l) 
For each target, a standard curve was generated using serial dilution of a plasmid 
containing the same PCR region as that measured by Q-RT-PCR. 
For absolute quantification, the following protocol by Bustin [6] was used: 
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• Internal standard plasmids containing the same PCR sequence were used to 
determine the number of transcript copies per cell. 
• Serial dilutions of plasmid were assayed in Q-PCR. 5 J.1L of the standard was 
used in each reaction. Molecular weight of plasmid is given as 2 * 320gmjmole * 
3973bp = 2.5426gmjmol. 
• Ct is linearly related to the log of the standard (in number of molecules). 
• Least squares regression was determined for Ct measurements of standard curve. 
C.2 Complete set of coupled chemical equations that speci-
fies the model 
C.2.1 dsRNA, RIGI, MAVS, and TRAF3 interaction 
C.2.1.1 RIGI ubiquitylation 
RIGI + dsRNA dsRNA_recogn_r I prot..avg RIGiub (C.2) 
C.2.1.2 Ubiquitylated RIGI degradation 
RIG Iub prot..phosph_degr _r 0 (C.3) 
C.2.1.3 RIGI-MAVS complex formation 
RIGiub +MAYS 5e-l * prot..bind_r I prot..avg RIGI-MAVS (C.4) 
C.2.1.4 RIGI-MAVS degradation 
RIGI-MAVS prot..phosph--<iegu 0 (C.5) 
C.2.1.5 RIGI-MAVS-TRAF3 complex formation 
RIGI-MAVS + TRAF3 5e-1 * prot_bind_r I prot..avg RIGI-MAVS-TRAF3 (C.6) 
C.2.1.6 RIGI-MAVS-TRAF3 degradation 
RIGI-MAVS-TRAF3 prot_phosph_degr_r ® 
C.2.2 IKKl, RIGI-MAVS-TRAF3, and A20 interaction 
C.2.2.1 IKKl activation 
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(C.7) 
RIGI-MAVS-TRAF3+IKK1i 6e-1 * prot_activ_r I prot_avg RIGI-MAVS-TRAF3+IKK1a 
(C.8) 
C.2.2.2 Active IKKl degradation 
IKKla lel * prot_phosph_degr_r ® 
C.2.2.3 Active IKKl degradation induced by A20 
IKKla + A20 prot_phosph_degr_r I prot..avg A20 
C.2.3 IRF3 and IKKl interaction 
C.2.3.1 IRF3 activation 
IKKla + IRF3i 5 * prot..actiu I prot..avg IKKla + IRF3a 
C.2.3.2 Active IRF3 degradation 
IRF3a 3 * prot_phosph_degr_r ® 
C.2.3.3 Active IRF3 nuclear import 
IRF3a prot..import_r IRF3 
an 
C.2.3.4 Nuclear active IRF3 degradation 
IRF3an 3 * prot_phosph_degr_r ® 
(C.9) 
(C.lO) 
(C.ll) 
(C.l2) 
(C.l3) 
(C.l4) 
C.2.4 NFIL6 and IKKl interaction 
C.2.4.1 NFIL6 activation 
IKKla + NFIL6i 5 * prot_activ...r I prot_avg IKKla + NFIL6a 
C.2.4.2 Active NFIL6 nuclear import 
NFIL6a proLimporLr NFIL6 an 
C.2.4.3 Nuclear active NFIL6 degradation 
NFIL6an prot_phosph_degr_r 0 
C.2.5 dsRNA, TLR3, TRIF, and TRAF6 interaction 
C.2.5.1 TLR3 activation 
TLR3i + dsRNA dsRNA...recogn_r I proLavg TLR3a 
C.2.5.2 Active TLR3 degradation 
TLR3a proLphosph_degr_r 0 
C.2.5.3 TLR3-TRIF complex formation 
TLR3a + TRIF prot_bind...r I prot_avg TLR3-TRIF 
C.2.5.4 TLR3-TRIF degradation 
TLR3-TRIF proLphosph_degr...r 0 
C.2.5.5 TLR3-TRIF-TRAF6 complex formation 
TLR3-TRIF + TRAF6 prot_bind...r I prot-avg TLR3-TRIF-TRAF6 
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(C.15) 
( C.16) 
(C.l7) 
(C.l8) 
(C.19) 
(C.20) 
(C.21) 
(C.22) 
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C.2.5.6 TLR3-TRIF-TRAF6 degradation 
TLR3-TRIF-TRAF6 prot...phosph_degr..r ® (C.23) 
C.2.6 IKK2, TLR3-TRIF-TRAF6, and A20 interaction 
C.2.6.1 IKK2 activation 
TLR3-TRIF-TRAF6 + IKK2i prot...activ ..r I prot_avg TLR3-TRIF-TRAF6 + IKK2a 
(C.24) 
C.2.6.2 Active IKK2 degradation 
IKK2a prot_phosph_degr..r ® (C.25) 
C.2.6.3 Active IKK2 degradation induced by A20 
IKK2a + A20 prot_phosph_degr..r I prot_avg A20 (C.26) 
C.2.7 NF,;B, I,;Ba, and IKK2 interaction 
C.2.7.1 I,;Ba phosphorylation 
IKK2a + I ""B'"" lel * prot_activ..r I prot_avg IKK2 I B "' .._. a+ K L¥p (C.27) 
C.2.7.2 Phosphorylated I,;Ba degradation 
I B lel * prot_phosph_degr..r 
,; ap ® (C.28) 
C.2.7.3 NF,;B-I,;Ba degradation 
NF,;B-I,;Ba prot_degr..r ® (C.29) 
C.2.7.4 NF,;B-I,;Ba phosphorylation 
IKK2a + NF ""B-I"'"B"' lel * prot_activ..r 1 prot_avg IKK2 NF B I B 
"' "' .._. a + K - K L¥p (C.30) 
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C.2. 7.5 Phosphorylated NF ~B-I~Bo: dissociation and degradation of I~Bo: 
NF~B-I~Bo:p lel * prot-phosph_degr_r NF~B (C.31) 
C.2.7.6 NF~B and I~Bo: binding 
NF ~B + I~Bo: lel * prot-bind_r 1 prot...avg NF ~B-I~Bo: (C.32) 
C.2.7.7 NF~B-I~Bo: spontaneous dissociation 
NF ~B-I~Bo: prot_diss_r NF ~B + I~Bo: (C.33) 
C.2.7.8 NF~B nuclear import 
NF ~B proUmport_r NF ~Bn (C.34) 
I~Bo: nuclear import and export are treated in C.2.9, equations C.50 and C.52. 
C.2.7.9 Nuclear NF~B and I~Bo: binding 
NF B I B 5 * lel * proLbind_r I prot...avg NF B I B ~ n + ~ O:n ---~------'-~----'---+ ~ n- ~ O:n (C.35) 
C.2.7.10 Nuclear NF~B-I~Bo: degradation 
(C.36) 
C.2.7.11 NF~B-I~Bo: nuclear export 
(C.37) 
C.2.8 A20 regulation 
C.2.8.1 A20 gene activation by NF~Bn 
NF~Bn + A20g le-1 * gene..act_r I prot-avg A20g-NF~Bn (C.38) 
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C.2.8.2 A20 gene inactivation by h;Ban 
(C.39) 
C.2.8.3 A20 mRNA transcription 
(C.40) 
C.2.8.4 A20 transcript degradation 
A20t 2 * mRNA--<I.egr..r ® (C.41) 
C.2.8.5 A20 protein translation 
A20t proUransLr A20t + A20 (C.42) 
C.2.8.6 A20 protein degradation 
A20 proLdegr _r ® (C.43) 
C.2.9 IKBa regulation 
C.2.9.1 IKBa gene activation by NFKBn 
NF B I B le-1 * gene_act_r / proLavg I B NF B K n + K a 9 -----------t K a 9 - K n (C.44) 
C.2.9.2 IKBa gene inactivation by IKBan 
(C.45) 
C.2.9.3 IKBa mRNA transcription 
I .,.B~9-NF"'"Bn mRNA_transc_r I B NF B I B "' ._.. .-. K a 9 - K n + K C¥t (C.46) 
C.2.9.4 IKBa transcript degradation 
(C.47) 
C.2.9.5 IKBa protein translation 
I B proLtransL.r K D!t 
C.2.9.6 IKBa protein degradation 
lKBa prot-degr_r 0 
C.2.9.7 IKBa nuclear import 
C.2.9.8 Nuclear IKBa protein degradation 
C.2.9.9 IKBa nuclear export 
5e-1 * prot_export_r I""Br., lKBan ------~ "' <-< 
C.2.10 IFN,B regulation 
C.2.10.1 IFN,B gene partial activation by NFKBn 
NFKBn + IFN,Bg 1e-1 * gene_act_r I prot-avg IFN,Bg-NFKBn 
C.2.10.2 Partially active IFN,B gene inactivation by IKBan 
C.2.10.3 Partially active IFN,B gene spontaneous inactivation 
C.2.10.4 IFN,B gene partial activation by IRF3an 
IRF3an + IFN,B9 1e-1 * gene_act_r I prot-avg IFN,B9 -IRF3an 
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(C.48) 
(C.49) 
(C.50) 
(C.51) 
(C.52) 
(C. 53) 
(C. 54) 
(C. 55) 
(C. 56) 
C.2.10.5 Partially active IFN,B gene spontaneous inactivation 
IFN,B9-IRF3an 5e-2 * gene_inact..r IFN,B9 + IRF3an 
C.2.10.6 IFN,B gene full activation by IRF3an 
IRF3an + IFN,B9-NF~Bn gene..act..r I prot_avg IFN,B9-NF~Bn-IRF3an 
C.2.10.7 IFN,B gene full activation by NF~Bn 
NF~Bn + IFN,B9-IRF3an le-l * gene..act..r I prot..avg IFN,B9-NF~Bn-IRF3an 
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(C. 57) 
(C.58) 
(C. 59) 
C.2.10.8 Fully active IFN,B gene partial inactivation by I~Ban 
I~Ban+IFN,B9-NF~Bn-IRF3an le-2 * gene_inact..r 1 prot..avg IFN,B9-IRF3an+NF~Bn-I~Ban 
(C.60) 
C.2.10.9 Fully active IFN,B gene spontaneous partial inactivation 1 
(C.61) 
C.2.10.10 Fully active IFN,B gene spontaneous partial inactivation 2 
C.2.10.11 IFN,B mRNA transcription by fully activated gene 
IFN ,89 - NF ~Bn-IRF3an mRNA_transc..r IFN ,89- NF ~Bn-IRF3an + IFN ,Bt 
(C.62) 
(C.63) 
C.2.10.12 IFN,B mRNA transcription by gene partially activated by NF~Bn 
(C.64) 
C.2.10.13 IFN,B mRNA transcription by gene partially activated by IRF3an 
IFN,B9-IRF3an 3e-1 * mRNA_transc..r IFN,B9-IRF3an + IFN,Bt (C.65) 
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C.2.10.14 IFN,B transcript degradation 
IFN,Bt mRNA_degr_r 0 (C.66) 
C.2.10.15 IFN,B cytokine translation 
IFN ,Bt prouransl...r IFN ,Bt + IFN ,8 (C.67) 
C.2.10.16 IFN,B cytokine degradation 
IFN ,8 proLdegr_r 0 (C.68) 
C.2.11 IL6 regulation 
C.2.11.1 IL6 gene partial activation by NF!i;Bn 
(C.69) 
C.2.11.2 Partially active IL6 gene inactivation by 1/'\;Betn 
(C.70) 
C.2.11.3 Partially active IL6 gene spontaneous inactivation 1 
(C.71) 
C.2.11.4 IL6 gene partial activation by NFIL6an 
NFIL6an + IL6g _l_e_l_*_ge_n_e __ ac_t_...r_/_p_ro_L_a_vg---7 IL6g-NFIL6an (C.72) 
C.2.11.5 Partially active IL6 gene spontaneous inactivation 2 
IL69 - NFIL6an gene_jnact...r IL69 + NFIL6an (C.73) 
C.2.11.6 IL6 gene full activation by NFIL6an 
NFIL6an + IL6g-NF "Bn gene_act...r I prot_avg IL6 NF B NFIL6 
'" g- /'\; n- an (C.74) 
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C.2.11.7 IL6 gene full activation by NFI'\;Bn 
(C.75) 
C.2.11.8 Fully active IL6 gene partial inactivation by Ifl;Ban 
Iu-B"'n + IL6g-NFu-Bn-NFIL6an gene_jnact..r / proLavg '" .__. "' -=---___:.-=--~ IL69-NFIL6an + NFI'\;Bn-Ifl;Ban 
(C.76) 
C.2.11.9 Fully active IL6 gene spontaneous partial inactivation 2 
(C.77) 
C.2.11.10 Fully active IL6 gene spontaneous partial inactivation 2 
(C.78) 
C.2.11.11 IL6 mRNA transcription by fully activated gene 
(C.79) 
C.2.11.12 IL6 mRNA transcription by gene partially activated by NFI'\;Bn 
(C.80) 
C.2.11.13 IL6 mRNA transcription by gene partially activated by NFIL6an 
IL69-NFIL6an 3e-1 * mRNA-transc..r > IL69-NFIL6an + IL6t (C.81) 
C.2.11.14 IL6 transcript degradation 
IL6t mRNA_degr..r ® (C.82) 
C.2.11.15 IL6 protein translation 
IL6t prot-transl..r IL6t + IL6 (C.83) 
C.2.11.16 IL6 protein degradation 
116 prot_degr_r ® 
C.2.12 Inactive TLR3 regulation 
C.2.12.1 TLR3 mRNA basal transcription 
TLR3g mRNA_ba.saLtransc...r TLR3g + TLR3t 
C.2.12.2 TLR3 transcript degradation 
TLR3t mRNA_degr_r ® 
C.2.12.3 Inactive TLR3 protein translation 
TLR3t prouransLr TLR3t + TLR3i 
C.2.12.4 Inactive TLR3 protein degradation 
TLR3i prot_degr_r ® 
C.2.13 TRAF3 regulation 
C.2.13.1 TRAF3 mRNA basal transcription 
TRAF3g le-1 * mRNA_ba.saLtransc_r TRAF3g + TRAF3t 
C.2.13.2 TRAF3 transcript degradation 
TRAF3t mRNA_degr_r ® 
C.2.13.3 TRAF3 protein translation 
TRAF3t prouranst...r TRAF3t + TRAF3 
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(C.84) 
(C.85) 
(C.86) 
(C.87) 
(C.88) 
(C.89) 
(C.90) 
(C.91) 
C.2.13.4 TRAF3 protein degradation 
TRAF3 le-1 * proLdegr...r 0 
C.2.14 TRAF6 regulation 
C.2.14.1 TRAF6 mRNA basal transcription 
TRAF6g mRNA_basaLtransc_r TRAF6g + TRAF6t 
C.2.14.2 TRAF6 transcript degradation 
TRAF6t mRNA_degr_r 0 
C.2.14.3 TRAF6 protein translation 
TRAF6t prouransl_r TRAF6t + TRAF6 
C.2.14.4 TRAF6 protein degradation 
TRAF6 prot_degr...r 0 
C.2.15 TRIF regulation 
C.2.15.1 TRIF mRNA basal transcription 
TRIF g mRNA_basaLtransc_r TRIF g + TRIF t 
C.2.15.2 TRIF transcript degradation 
TRIFt mRNA_degr...r 0 
C.2.15.3 TRIF protein translation 
TRIF t prouransLr TRIF t + TRIF 
193 
(C.92) 
(C.93) 
(C.94) 
(C.95) 
(C.96) 
(C.97) 
(C.98) 
(C.99) 
C.2.15.4 TRIF protein degradation 
TRIF prot_degu 0 
C.2.16 TLR3dTF regulation 
C.2.16.1 TLR3dTF mRNA basal transcription 
TLR3dTF 9 mRNA_basaLtransc-r TLR3dTF 9 + TLR3dTFt 
C.2.16.2 TLR3dTF transcript degradation 
TLR3dTFt mRNA_degu 0 
C.2.16.3 Inactive TLR3dTF protein translation 
TLR3dTFt prouransb TLR3dTFt + TLR3dTFi 
C.2.16.4 Inactive TLR3dTF protein degradation 
TLR3dTFi prot_degu 0 
C.2.16.5 TLR3dTF activation 
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(C.lOO) 
(C.lOl) 
(C.102) 
(C.103) 
(C.104) 
TLR3-TRIF-TRAF6+TLR3dTFi prot_activ_r 1 prot_avg TLR3-TRIF-TRAF6+TLR3dTFa 
(C. lOS) 
C.2.16.6 Active TLR3dTF nuclear import 
TLR3d TF a proumport-r TLR3d TF an (C.106) 
C.2.16.7 Nuclear active TLR3dTF degradation 
TLR3dTF an 3e-1 * prot_phosph_degr_r 0 (C.107) 
----- --------------
195 
C.2.17 RIGI regulation 
C.2.17.1 RIGI gene activation by TLR3dTF 
TLR3dTF an + RIGI9 6e-1 * gene_act_r I prot-avg RIGI9- TLR3dTF an (C. lOS) 
C.2.17.2 RIGI gene inactivation 
RIGI9- TLR3dTF an gene_jnact_r RIGI9 + TLR3dTF an (C.109) 
C.2.17.3 RIGI mRNA transcription 
RIGI9-TLR3dTFan mRNA_transc_r RIGI9-TLR3dTFan + RIGit (C.110) 
C.2.17.4 RIGI mRNA basal transcription 
RIGig 1e-1 * mRNA_basaLtransc_r RIGig + RIGit (C.111) 
C.2.17.5 RIGI transcript degradation 
RIGit mRNA_degr_r ® (C.l12) 
C.2.17.6 RIGI protein translation 
RIGit prouransl_r RIGit + RIGI (C.113) 
C.2.17.7 RIGI protein degradation 
RIGI 1e-1 * proLdegr_r ® (C.114) 
C.2.18 Inactive IKKl regulation 
C.2.18.1 IKKl gene activation by TLR3dTF 
TLR3dTF an+ IKK19 gene__act_r I prot-avg IKK19- TLR3dTF an (C.115) 
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C.2.18.2 IKKl gene inactivation 
IKK 1 -TLR3dTF gene_inact-r IK 1 g an K g + TLR3dTF an (C.116) 
C.2.18.3 IKKl mRNA transcription 
IKK1g-TLR3dTF an 6e-l * mRNA_transo IKK1g-TLR3dTF an + IKK1t (C.117) 
C.2.18.4 IKKl mRNA basal transcription 
IKK1 mRNA_basaLtransc_r IKK1 + IKK1 g g t (C.118) 
C.2.18.5 IKKl transcript degradation 
IKK1t mRNA_degr_r ® (C.119) 
C.2.18.6 Inactive IKKl protein translation 
IKK1t prouransLr IKK1t + IKK1i (C.120) 
C.2.18.7 Inactive IKKl protein degradation 
IKK1i le-1 * prot_degr_r Q9 (C.121) 
C.2.19 Inactive IKK2 regulation 
C.2.19.1 IKK2 gene activation by TLR3dTF 
TLR3dTF an + IKK2g gene_acu I prot_avg IKK2g-TLR3dTF an (C.122) 
C.2.19.2 IKK2 gene inactivation 
IKK2g-TLR3dTF an gene_inact_r IKK2g + TLR3dTF an (C.123) 
C.2.19.3 IKK2 mRNA transcription 
IKK2g-TLR3dTF an mRNA_transc_r IKK2g-TLR3dTF an + IKK2t (C.124) 
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C.2.19.4 IKK2 mRNA basal transcription 
IKK2g mRNA_basaLtransc_r IKK2g + IKK2t (C.125) 
C.2.19.5 IKK2 transcript degradation 
IKK2t mRNA_degr_r ® (C.126) 
C.2.19.6 Inactive IKK2 protein translation 
IKK2t prouransLr IKK2t + IKK2i (C.127) 
C.2.19. 7 Inactive IKK2 protein degradation 
IKK2i proLdegr_r ® (C.128) 
C.2.20 MAYS regulation 
C.2.20.1 MAYS gene activation by TLR3dTF 
TLR3dTF an + MAYS9 gene_act_r 1 prot_avg MAYS9- TLR3dTF an (C.129) 
C.2.20.2 MAYS gene inactivation 
MAYS9-TLR3dTFan gene_inacLr MAYS9 + TLR3dTFan (C.l30) 
C.2.20.3 MAYS mRNA transcription 
MAYS9-TLR3dTFan se-l * mRNA_transc_r MAYS9-TLR3dTFan +MAYSt (C.131) 
C.2.20.4 MAYS mRN A basal transcription 
MAYS9 le-1 * mRNA_basaLtransc_r MAYS9 +MAYSt 
C.2.20.5 MAYS transcript degradation 
MAYSt mRNA_degr_r ® 
(C.132) 
(C.133) 
C.2.20.6 MAVS protein translation 
MAYSt prouransLr MAYSt + MAYS 
C.2.20.7 MAVS protein degradation 
MAYS le-1 * prot-degu ® 
C.2.21 Inactive IRF3 regulation 
C.2.21.1 IRF3 gene inhibition by NFKB 
C.2.21.2 IRF3 gene inhibition inactivation 
IRF39--NFKBn gene_jnact-r IRF39 + -NFKBn 
C.2.21.3 IRF3 gene activation by TLR3dTF 
TLR3dTF an + IRF39 2 * gene_acu I prot-avg IRF39- TLR3dTF an 
C.2.21.4 IRF3 gene inactivation 
IRF39- TLR3dTF an gene_jnacu IRF39 + TLR3dTF an 
C.2.21.5 IRF3 mRNA transcription 
IRF39- TLR3dTF an 3 * mRNA_transc..r IRF39- TLR3dTF an + IRF3t 
C.2.21.6 IRF3 mRNA basal transcription 
IRF3g mRNA_basaLtransc..r IRF3g + IRF3t 
C.2.21. 7 IRF3 transcript degradation 
IRF3t mRNA_degr_r ® 
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(C.l34) 
(C.135) 
(C.136) 
(C.l37) 
(C.l38) 
(C.139) 
(C.140) 
(C.l41) 
(C.l42) 
C.2.21.8 Double-inactive IRF3 protein translation 
IRF3t 1e-1 * prouransLr IRF3t + IRF3ii 
C.2.21.9 Double-inactive IRF3 protein degradation 
IRF3ii 1e-1 * proLdegr_r 0 
C.2.21.10 Maturation of double-inactive IRF3 protein 
IRF3ii 1e-1 * prot_bind..r IRF3i 
C.2.21.11 Inactive IRF3 protein degradation 
IRF3i 1e-1 * prot_degr_r ® 
C.2.21.12 Inactive IRF3 nuclear import 
IRF3' prot-import_r IRF3 
" in 
C.2.21.13 Inactive IRF3 nuclear export 
IRF3in 1e1 * prot_export..r IRF3i 
C.2.21.14 Nuclear inactive IRF3 protein degradation 
IRF3in 1e-1 * proLdegr_r 0 
C.2.22 Inactive NFIL6 regulation 
C.2.22.1 NFIL6 gene activation by TLR3dTF 
TLR3dTF an+ NFIL69 gene_act..r 1 prot_avg NFIL69- TLR3dTF an 
C.2.22.2 NFIL6 gene inactivation 
NFIL69- TLR3dTF an gene_inact..r NFIL69 + TLR3dTF an 
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(C.l43) 
(C.144) 
(C.l45) 
(C.146) 
(C.l47) 
(C.148) 
(C.149) 
(C.150) 
(C.151) 
C.2.22.3 NFIL6 mRNA transcription 
NFIL69- TLR3dTF an mRNA_transcr NFIL69- TLR3dTF an + NFIL6t 
C.2.22.4 NFIL6 mRNA basal transcription 
NFIL6g mRNA_basaLtransc..r NFIL6g + NFIL6t 
C.2.22.5 NFIL6 transcript degradation 
NFIL6t mRNA_degr..r 0 
C.2.22.6 Inactive NFIL6 protein translation 
NFIL6t prouransLr NFIL6t + NFIL6i 
C.2.22.7 Inactive NFIL6 protein degradation 
NFIL6i prot_degr..r 0 
C.2.23 NFKB regulation 
C.2.23.1 NFKB gene inhibition by IRF3 
IRF3an + NFKB9 5 * gene_act..r I prot_avg NFKB9-IRF3an 
C.2.23.2 NFKB gene inhibition inactivation 
NF KB9- IRF3an le-l * gene_inact..r NF KB9 + IRF3an 
C.2.23.3 NFKB gene activation by TLR3dTF 
TLR3dTF an + NF KB9 gene_act..r I prot-avg NF KB9- TLR3dTF an 
C.2.23.4 NFKB gene inactivation 
NF KB 9 - TLR3d TF an gene_inacu NF KB9 + TLR3dTF an 
200 
(C.152) 
(C.l53) 
(C.154) 
(C.155) 
(C.156) 
(C.157) 
(C.158) 
(C.159) 
(C.160) 
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C.2.23.5 NFA:B mRNA transcription 
NFA:B9-TLR3dTFan 5e-l * mRNA_transc...r NFA:B9-TLR3dTFan + NFKBt (C.161) 
C.2.23.6 NFA:B mRNA basal transcription 
(C.l62) 
C.2.23.7 NFA:B transcript degradation 
(C.163) 
C.2.23.8 Inactive NFKB protein translation 
(C.l64) 
C.2.23.9 Inactive NFA:B protein degradation 
(C.l65) 
C.2.23.10 Activation of NFA:B protein 
(C.166) 
C.2.23.11 NFKB protein degradation 
NF A:B proLdegr_r Q9 (C.167) 
C.2.23.12 Nuclear NFKB protein degradation 
(C.l68) 
C.2.24 ISG56 regulation 
C.2.24.1 ISG56 gene activation by IRF3 
SG 6 5 * gene_acLr / proLavg IRF3an +I 5 9 ---'----'------t ISG569-IRF3an (C.169) 
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C.2.24.2 ISG56 gene inactivation 
ISG569-IRF3an gene_inact_r ISG569 + IRF3an (C.170) 
C.2.24.3 ISG56 mRNA transcription 
ISG569-IRF3an mRNA_transcr ISG569-IRF3an + ISG56t (C.171) 
C.2.24.4 ISG56 mRN A basal transcription 
ISG56g le-2 * mRNA_basaLtranscr ISG56g + ISG56t (C.172) 
C.2.24.5 ISG56 transcript degradation 
ISG56t mRNA_degr_r 0 (C.l73) 
C.2.24.6 ISG56 protein translation 
ISG56t prot_transl_r ISG56t + ISG56 (C.174) 
C.2.24. 7 ISG56 protein degradation 
ISG56 prot_degr_r 0 (C.175) 
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Figure D.l : Cross sections of evolution of perturbed deterministic systems for different 
number of subdivisions. Free growth factor. Horizontal axis shows number of subdivisions 
of interval 0 - 1. 
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Figure D.2 : Cross sections of evolution of perturbed deterministic systems for different 
number of subdivisions, rescaled to show the same spatially homogeneous steady state as 
the main case (100 subdivisions). Free growth factor. Horizontal axis shows number of 
subdivisions of interval 0 - 1. 
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Figure D.3 : Stochastic reaction-diffusion system. Pre-cancerous cells. Averages of 1000 
runs for different number of subdivisions. Initial conditions: end values of corresponding 
perturbed deterministic system rounded to nearest integer. 
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Figure D.4: Stochastic reaction-diffusion system. Pre-cancerous cells. Mean and standard 
deviation of 10,000 runs. Initial conditions: end values of perturbed deterministic system 
rounded to nearest integer. Left: mean. Right: standard deviation. 
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E.l Complete set of model reactions 
Vir+ UC UC.Jnfection__r I vir_avg IC1 
IC1 IC_deterioration__r IC2 
IC2 IC_deterioration__r ICa 
ICa IC.Jfn_production_r IC3 + Ifn 
ICa 
IC_death__r I 4 
DC 
ICa IC_deterioration_r IC4 
IC4 
IC.Jfn_production__r I 2 
IC4 + Ifn 
IC4 
IC_vir_production__r I 2 
IC4 +Vir 
IC4 
IC_death__r I 2 
DC 
IC4 IC_deterioration__r IC5 
IC5 
IC_vir _production__r IC5 +Vir 
IC5 IC_death__r DC 
Ifn+ UC 
UC__resistance_r I ifn_avg 
RC 
RC RC__recover__r uc 
Ifn ifn_degr__r ® 
Vir vir_degr_r ® 
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Figure E.l : Different ways of presenting the same deterministic result, for different 
number of compartments. First column: grid of 140x140 compartments (64 cells per com-
partment). Second column: grid of 280x280 compartments (16 cells per compartemnt). 
Third column: grid of 560x560 compartments ( 4 cells per compartment). Each row is 
a different presentation of the same deterministic result (row 1: fioor+maximum, row 2: 
floor+ maximum aggregated, row 3: probability, row 4: maximum). 
Appendix F 
R code 
F .1 Code for chapters 5 
Listing F.l: helper.R 
init <- function(place) { 
model <- I i s t ( t r a n s i t i o n s = 0 , 
place=place, 
4 places=length (place) , 
5 h=list ()) 
6 assign ("model", model, en vir = . GlobalEnv) 
7 
8 
9 
assign("L", array(O, dim<- c(1, model$places)), envir 
assign("R", array(O, dim<- c(1, model$places)), envir 
10 
11 
12 
for (n in 1:model$places) { 
assign(place [n], n, envir 
13 } 
14 } 
15 
. GlobalEnv) 
16 atr <- function(trans .name=NULL) { 
17 model<- get("model",envir = .GlobalEnv) 
18 model$transitions <- model$transitions + 1 
19 if (!is.null(trans.name)) { 
. Globa!Env) 
. GlobalEnv) 
20 assign(trans.name, model$transitions, envir . GlobalEnv) 
21 } 
22 if (model$ t ran sit ions = 1 ) { 
23 model$ pre <- get ( "L" , en vir = . GlobalEnv) 
24 model$post <- get("R", envir = .GlobalEnv) 
25 } else { 
26 model$ pre <- rbind (model$ pre, get ( "L" , en vir = . GlobalEnv)) 
27 model$ post <- rbind (model$ post, get ( "R", en vir = . GlobalEnv)) 
28 } 
29 model$h [ [model$t ransi tions ]] <- get ( "h", en vir = . Globa!Env) 
3o assign ("model", model, en vir = . GlobalEnv) 
31 
32 
33 
34 } 
35 
assign("L", array(O, dim<- c(1, model$places)), envir 
assign("R", array(O, dim<- c(1, model$places)), envir 
36 load. cfn <- function (place , code) { 
37 for (i in 1:length(place)) { 
38 if ( i = 1) { 
39 concat. places <- place [ i] 
40 } else { 
. GlobalEnv) 
. GlobalEnv) 
41 concat. places <- paste ( concat. places , " place[i], sep="") 
42 } 
43 } 
44 this. tempfile <- basename( tempfile ( pattern="tmp-cfn-" , tmpdir=". ")) 
45 
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46 c. file <- paste( 11 typedef enum { 11 , concat. places, 11 } enum_places; \n 11 , 
code, 11 \n 11 , 
47 sep = II II) 
48 cat(c.file, file=paste(this.tempfile, 11 .c 11 , sep= 1111 )) 
49 cat (c. file) 
50 
51 system. str <- paste ( 11 R CMD SHLIB 11 , this. tempfile, 11 • c 11 , sep= 1111 ) 
52 if (. Platform$08. type = 11 windows 11 ) { 
53 shell (system . s t r ) 
54 } else { 
55 system (system . s t r ) 
56 } 
57 dyn.load (paste (this. tempfile, . Platform$dynlib. ext , sep=1111 )) 
58 getNativeSymbollnfo ( 11 cfn 11 , PACKAGE=this. tempfile) $address 
59 } 
60 
61 unload. cfns <- function () { 
62 f i l e s <- list . f i l e s (path = 11 11 , 
63 pattern= 11 ~tmp-cfn-[[:xdigit:]]*\\.(soldlllclo)$ 11 
' 64 full.names = F, recursive =F) 
65 for (file in files) { 
66 split.file <- strsplit(file, 11 \\. 11 )[[1]] 
67 file. extension <- paste ( 11 • 11 , split. file [2] , sep=1111 ) 
6s if (file. extension = . Platform$dynlib. ext & 
69 is.loaded( 11 cfn 11 , split.file[1])) { 
10 cat(paste(file, 11 unloaded\n 11 )) 
n dyn. unload (file) 
72 } 
73 cat(paste(file, 11 deleted\n 11 )) 
74 unlink ( file ) 
75 } 
76 } 
L-----------------------------------------------------------------------~ 
F .2 Examples of jumping patterns, for different boundary 
conditions 
Listing F .2: Two-dimensional deterministic Neumann boundary conditions 
1 jumps. per. place <- 2* (tot. rows* (tot. cols -1)+tot. cols * (tot. rows -1)) + 
2 2* (tot. rows+tot. cols) 
3 jumps <- array ( 0, dim=c (jumps. per. place , 3)) 
4 jumps [ ,3] <- 1 
5 jump. idx <- 0 
6 if (tot.cols > 1) { 
7 for (r in 1:tot.rows) { 
s for (cl in 1:(tot.cols-1)) { 
g jump. idx <- jump. idx + 1 
10 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
11 jumps [jump. idx, 2] <- (r-1}*tot. cols + cl + 1 
12 if ( cl = tot. cols -1) { 
13 jumps [jump. idx , 3] <- 2 
14 jump. idx <- jump. idx + 1 
15 jumps [jump. idx, 1] <- (r-1}*tot. cols + cl + 1 
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Figure F.l : Jumping pattern for deterministic diffusive system with Neumann bound-
ary conditions, two dimensional case. 
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Figure F.2 : Jumping pattern for stochastic diffusive system with Neumann boundary 
conditions, two dimensional case. 
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Figure F .3 : Jumping pattern for deterministic and stochastic diffusive system with 
periodic boundary conditions, two dimensional case. 
16 jumps [jump. idx, 2] <- 0 
17 jumps [jump. idx, 3] <- 0 
18 } 
19 jump. idx <- jump. idx + 1 
20 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl + 1 
21 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
22 i f ( c I = 1 ) { 
23 jumps [jump. idx, 3] <- 2 
24 jump. idx <- jump. idx + 1 
25 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
26 jumps [jump. idx, 2] <- 0 
27 jumps [jump. idx , 3 J <- 0 
28 } 
29 } 
30 } 
31 } 
32 if (tot. rows> 1) { 
33 for (cl in 1:tot.cols) { 
34 for (r in 1:(tot.rows-1)) { 
35 jump. idx <- jump. idx + 1 
36 jumps[jump.idx, 1] <- (r-1)*tot.cols + cl 
37 jumps [jump. idx, 2] <- ( r) *tot. cols + cl 
38 if (r =tot .rows-1) { 
39 jumps [jump. idx, 3] <- 2 
40 jump. idx <- jump. idx + 1 
41 jumps[jump.idx, 1] <- (r)*tot.cols + cl 
42 jumps [jump. idx, 2] <- 0 
43 jumps [jump. idx, 3] <- 0 
44 } 
45 jump. idx <- jump. idx + 1 
46 jumps[jump.idx, 1] <- (r)*tot.cols + cl 
47 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
48 if ( r = 1) { 
49 jumps [jump. idx, 3] <- 2 
5o jump. idx <- jump. idx + 1 
51 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
52 jumps [jump. idx, 2] <- 0 
53 jumps [jump. idx, 3] <- 0 
54 } 
55 } 
56 } 
57 } 
58 JumpingPattern <- list (jumps) 
Listing F.3: Two-dimensional stochastic Neumann boundary conditions 
1 jumps. per. place <- 2* (tot. rows* (tot. cols -1)+tot. cols * (tot. rows -1)) 
2 jumps <- array ( 0, dim=c (jumps. per. place , 3)) 
3 jumps[,3] <- 1 
4 jump. idx <- 0 
5 for (r in 1:tot.rows) { 
s for (cl in 1:(tot.cols-1)) { 
7 jump. idx <- jump. idx + 1 
8 jumps[jump.idx, 1] <- (r-l)*tot.cols + cl 
9 jumps [jump. idx, 2] <- (r-l)*tot. cols + cl + 1 
10 jump. idx <- jump. idx + 1 
u jumps [jump. idx, 1] <- (r-1)*tot. cols + cl + 1 
12 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
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13 } 
14 } 
15 for (cl in 1:tot.cols) { 
16 for (r in 1:(tot.rows-1)) { 
11 jump. idx <- jump. idx + 1 
18 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
19 jumps [jump. idx, 2] <- r*tot. cols + cl 
20 jump. idx <- jump. idx + 1 
21 jumps[jump.idx, 1] <- utot.cols + cl 
22 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
23 } 
24 } 
25 JumpingPattern <- list (jumps) 
Listing F .4: Two-dimensional deterministic and stochastic periodic boundary conditions 
1 jumps. per. place <- 4*tot. rows* tot. cols 
2 jumps<- array(O, dim=c(jumps.per.place, 3)) 
3 jumps[,3] <- 1 
4 jump. idx <- 0 
5 for (r in 1:tot.rows) { 
6 for (cl in 1:(tot.cols-1)) { 
7 if ( cl = 1) { 
8 jump. idx <- jump. idx + 1 
9 jumps[jump.idx, 1] <- (r-1)*tot.cols + 1 
w jumps [jump. idx, 2] <- (r-1)*tot. cols + tot. cols 
11 jump. idx <- jump. idx + 1 
12 jumps [jump. idx, 1] <- (r-1)*tot. cols + tot. cols 
13 jumps [jump. idx, 2] <- (r-1)*tot. cols + 1 
14 } 
15 jump. idx <- jump. idx + 1 
16 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
11 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl + 1 
18 jump. idx <- jump. idx + 1 
19 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl + 1 
20 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
21 } 
22 } 
23 for (cl in 1:tot.cols) { 
24 for (r in 1:(tot.rows-1)) { 
25 if(r=1){ 
26 jump. idx <- jump. idx + 1 
21 jumps [jump. idx, 1] <- cl 
28 jumps [jump. idx, 2] <- (tot. rows -1)*tot. cols + cl 
29 jump. idx <- jump. idx + 1 
3o jumps[jump.idx, 1] <- (tot.rows-1)*tot.cols + cl 
31 jumps [jump. idx, 2] <- cl 
32 } 
33 jump. idx <- jump. idx + 1 
34 jumps [jump. idx, 1] <- (r-1)*tot. cols + cl 
35 jumps [jump. idx, 2] <- utot. cols + cl 
36 jump. idx <- jump. idx + 1 
37 jumps [jump. idx, 1] <- r*tot. cols + cl 
38 jumps [jump. idx, 2] <- (r-1)*tot. cols + cl 
39 } 
40 } 
41 JumpingPattern <- list (jumps) 
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